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ABSTRACT 
This thesis explores psychological group treatment provided to people with co-
existing substance misuse and serious mental health problems in secure settings.  The 
work presented draws from existing research evidence to design an empirical research 
study. Chapter one provides an introduction to the research literature relating to co-
existing serious mental health problems and substance misuse, theoretical approaches 
to understanding aetiololgy and the links with offending behaviour.    Chapter two 
presents a systematic literature review examining the effectiveness of substance 
misuse treatment provided within secure settings.  The review aimed to investigate the 
efficacy of current structured substance misuse intervention treatment in secure 
settings for offenders with co-existing serious mental health problems.  Chapter three 
provides a critique of the Stage of Change and Treatment Readiness scale, a 
psychometric tool widely used in the field of substance misuse treatment.  The 
psychometric properties of this measure are critically examined and the scale’s 
clinical utility considered.   Chapter four provides a piece of empirical research 
exploring the efficacy of a specifically designed substance misuse group intervention 
developed for those with serious mental health problems within the context of two 
clinical settings.  A mixed methods repeated measures programme evaluation design 
was used and is reported.    Study findings are discussed in relation to methodological 
limitations, implications for practice and recommendations for future research.  In 
conclusion, Chapter five discusses the full thesis findings in the context of previous 
literature, exploring the limitations of the current thesis and considering future 
directions for research and practice. 
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CHAPTER ONE: 
INTRODUCTION TO THE THESIS 
 
Co-existing substance use and serious mental health problems 
Co-existing substance misuse and serious mental health problems have been 
associated with a myriad of negative consequences, posing significant challenges for 
the clinical management of this population (Department of Health, 2004).  Negative 
impacts associated with this problem have been indicated at both personal and 
societal levels.  Treatments for combined mental health problems and problematic 
substance use, both in terms of inpatient and outpatient care, have been identified to 
have significantly higher costs than treatments of a single psychiatric diagnosis (Hoff 
& Rosenheck, 1999).  Indeed, co-existing serious mental problems and substance 
misuse has been suggested as the most significant problem facing health provision 
services (McKeown, 2010).  Services provided to treat mental health problems and 
substance misuse are commonly fragmented, with a lack of integrated treatment, 
potentially impacting negatively upon this client group (Baker, Kay-Lambkin & 
Lewin, 2007).  The need for development of effective and tailored intervention to 
target the needs of those with co-existing problematic alcohol and/or drug use and 
serious mental health problems has been emphasised (Graham et al., 2001). 
This initial chapter aims to set the scene for the thesis and provides a 
background including a discussion of definitions used, theoretical perspectives and 
prevalence, followed by outcomes related to both mental health and substance use and 
violent and offending behaviours associated with this client group.  
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Definitions 
Despite the indicated consensus on the significance of this problem, definitions of 
combined serious mental health problems and substance misuse remain open to 
debate within the literature, with a lack of agreement on one definition.  The terms 
‘dual diagnosis’ or ‘comorbidity’ are used interchangeably to describe substance 
misuse occurring in conjunction with serious mental health disorders (Drake & 
Mueser, 2000).  The definition provided by the Department of Health (2009a) 
considers co-occurring serious mental health problems and substance misuse within 
four contexts, as detailed below: 
• A primary mental health problem that provokes the use of substances 
• Substance misuse and/or withdrawal leading to serious mental health problems 
• Serious mental health problems that are worsened by substance misuse 
• Substance misuse and mental health problems that do not appear to be related 
to one another 
This more encompassing approach to definition indicates the complexity of 
the problem, reflecting both the subjective and fluid relationship between mental 
health problems and substance misuse and the diversity of this heterogeneous 
population (Drake & Wallach, 2000).  For the purposes of this thesis, the term serious 
mental health problems encompasses those with more enduring problems including 
psychosis, schizophrenia, schizoaffective disorder, bipolar disorder, post traumatic 
stress disorder and personality disorder.  The term substance misuse refers to those 
with problematic drug and/or alcohol use.    
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Theoretical explanations for comorbidity   
The utility of theoretical models in providing insight into difficulties experienced 
amongst groups of people with similar presenting problems is widely noted.  A 
number of alternate theories have been proposed within the literature to explain co-
morbid substance use and serious mental health problems.  Mueser, Drake & Wallach, 
(1998, cited in Hussein Rassool, 2002) suggest that, within the general aetiological 
framework for combined serious mental health problems and substance misuse, 
theories predominantly fall within two discrete approaches; psychosocial risk factor 
models and supersensitivity models.   It is suggested that the same psychosocial risk 
factor models explaining substance misuse in the general population are also 
applicable for those with serious mental health problems.  Factors including social 
pressure, problems relating to others and prolonged experience of negative affect have 
been identified as motivating substance use in those with serious mental health 
problems (Bellack, Bennett & Gearon, 2007).   
Additional psychosocial risk factors applicable to the general population are 
also indicated as relevant to substance use amongst those with serious mental health 
problems.  These include alleviation of boredom, social interaction with drug using 
associates and limited alternate activities in which to engage (McMurran, 2002).  It is 
suggested that the increased prevalence of substance misuse in those with serious 
mental health problems, when compared with the general population, may be due to 
higher vulnerability to these risk factors resulting from the additional difficulty of 
managing difficulties associated with comorbidity (McMurran, 2002).   
The individualised psychosocial risk factor approach has some empirical 
support.  In recent research investigating reasons for substance use in those with 
mental health problems, Thornton, Baker, Johnson, Kay-Lambkin and Lewin (2012) 
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found that alcohol consumption appeared to be related to social pressure.   Findings of 
this study indicated that alcohol consumption was influenced by social norms, 
essentially drinking in compliance with perceived expectations of others was cited as 
a major motivation for alcohol intake amongst participants.  In comparison, cannabis 
use was reported to arise from more internal motivational factors, with pleasurable 
intoxication effects indicated as the most influential reason for usage.  In research 
exploring motivation for cocaine use in bipolar disorder, reasons for drug use have 
been reported as consistent with substance users without bipolar disorder (Bizzarri et 
al., 2007).  The most common factors reported to drive cocaine use were relief of 
boredom; alleviation of negative mood; relief of tension and feelings of euphoria.    
The supersensitivity model suggests that a heightened vulnerability to the 
effects of substance use arising from a combination of genetic and environmental 
factors increases an individual’s potential to culminate in the onset of a psychotic 
episode or relapse.  This vulnerability is suggested to predispose the individual to 
experience severe, negative consequences as a result of what would be considered 
relatively minor substance use.  Research is reported as providing some support for 
this model, with several studies indicating relapse, trigger of clinical symptoms and 
physical dependence associated with low quantities of drugs or alcohol use (Hussein 
Rassool, 2002).  Within their study of factors relating to dual diagnosis, Di Lorenzo, 
Galliani, Guicciardi, Landi & Ferri (2014) found that, where patients’ histories were 
available, the majority of patients within their study reported family histories of 
psychiatric disorder or substance misuse problems and/or stressful life events 
indicating support for the supersensitivity model.  Only 6% of patients did not report 
any familial history or negative events during childhood or adolescence.   
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The benefits of establishing a temporal relationship between serious mental 
health problems and co-existing substance misuse have been suggested in helping to 
further understand aetiology, that is, where one factor is identified as having preceded 
the other, a better understanding of causal mechanisms may be ascertained (Phillips & 
Johnson, 2010).  Increasing the understanding of the relationship between serious 
mental health problems and substance use may support identification of groups most 
at risk, in turn, providing more opportunity to effectively address the problem 
(Bowers & Jeffrey, 2008).  However, identifying a temporal relationship between the 
two factors has proved difficult, due to the gradual development of both disorders and 
associated difficulties in identification of which was first established (Gregg, 
Barrowclough & Haddock, 2007).  Research findings appear to be inconsistent, 
providing some support for both causal pathways leading to comorbidity; with 
substance misuse found to precede mental health problems (e.g. Cantwell et al., 1999; 
Di Forti et al., 2014; Di Lorenzo et al., 2014) and mental health problems found to 
precede substance misuse (e.g. Bellack & DiClemente, 1999; Kessler et al., 1994).  
Differences have been suggested between alcohol and drug use and comorbid serious 
mental health problems, with cannabis use associated with the onset of psychosis and 
alcohol use related to the development of psychiatric disorder (Di Lorenzo et al., 
2014).   
Mueser et al., (1998) postulate that individual differences in this diverse 
population may account for variability among proposed explanations.  People with 
coexisting serious mental health problems and substance misuse have been identified 
as a heterogeneous group with complicated developmental trajectories lacking 
common causal pathways (Crome, Chambers, Fisher, Bloor & Roberts, 2009).  It is 
suggested that multiple risk factors need to be considered in understanding the 
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problem of comorbidity (Gregg et al., 2007).  As such, further development of holistic 
theories adopting a more individualised approach to dual diagnosis, may be beneficial 
in further understanding the complexities of the problems presented by this client 
group. 
 
 
Comorbidity prevalence 
Difficulties in understanding the onset and development of comorbid substance use 
and serious mental health problems extend to the accurate identification of the extent 
of the problem, which has proved challenging to ascertain.  Within the general 
population, estimations of co-morbidity vary greatly, ranging between 30% and 70% 
of individuals presenting to mental health services (Crome et al., 2009).  A recent 
systematic review of interventions for comorbidity suggested that over 50% of 
individuals with serious mental health problems experience substance misuse 
disorders at some point during their lifetime (Hunt, Siegfried, Morley, Sitharthan & 
Cleary, 2014).  Furthermore, lifetime prevalence of comorbidity has been reported to 
be as high as 50% (Mueser, Drake & Miles, 1997) due to continued or increased 
substance misuse (Lambert et al., 2005) and limited presentation to mental health or 
substance misuse services arising from multiple social complications (Crome et al., 
2009).   A recent European cohort study investigating schizophrenia and comorbid 
substance misuse (Carrà et al., 2012) indicated that the prevalence of lifetime 
substance use was higher in the UK (35%) than in both Germany (21%) and France 
(19%).  As such, combined mental health and substance misuse problems remain both 
serious and enduring for a significant number of people.   
Evaluation of the true extent of the problem is suggested as being 
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compounded by general inconsistencies in prevalence data reporting (Gregg et al., 
2007).  It has been suggested that statistical data relating to those with complex needs, 
including dual diagnosis, is not effectively recorded by government services, resulting 
in a paucity of information (APPG, 2014).  Furthermore, a range of methodological 
limitations within the research for co-existing serious mental health problems and 
substance use have been identified, including variations in definitions of comorbidity, 
variations in diagnostic criteria, population differences and varying validity and 
reliability in measures used to assess this population (Gregg et al., 2007).  An 
increased reluctance within this client group to access services may result in further 
under-estimation of the extent of combined mental health and substance misuse 
problems.  Under-recognition of comorbid serious mental health problems has been 
indicated in clinical treatment services for substance misuse.  Significant associations 
have been found between a failure to address comorbidity and treatment attrition 
(Schulte, Meier, Stirling & Berry, 2010).   A number of factors have been suggested 
as barriers to accessing services including ‘chaotic’ life-styles, shame regarding 
substance use, fears of information relating to illegal drug taking being passed to the 
police and concerns of being denied access to services (IAPT, 2012).  
Specifically within the forensic population, co-existing substance misuse and 
serious mental health problems has been estimated to be even higher than in general 
community samples (Carrà & Johnson, 2009; Department of Health, 2009a).  
Retrospective research investigating substance use in the offending population with 
serious mental health problems, found regular substance use in 38.3% of patients in 
the twelve months prior to detention in secure hospital (D’Silva & Ferriter, 2003).  A 
national survey of treatment outcome in patients with mental illness and substance 
misuse identified 76% of patients discharged from secure services had a history of 
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substance use (Scott, Whyte, Burnett, Hawley & Maden, 2004).  In more recent years, 
dual diagnosis rates, both in community and prison populations, have been suggested 
as rising due to the significant increase in the range and availability of street drugs 
(Department of Health, 2009a).   
In particular, identification of dual diagnosis prevalence within the forensic 
population has been found to be more problematic than in general community 
samples.  A number of reasons have been suggested as contributing to these 
difficulties, including a limited ability within the secure environment to encompass 
the diversity of the dual diagnosis population (Thylstrup & Johanson, 2009), along 
with under identification of substance misuse disorders within forensic samples 
(Ogloff, Lemphers & Dwyer, 2004) and under diagnosis of serious mental health 
problems in offending samples (McMillan et al., 2008).  Fragmented and disjointed 
services for the treatment of mental health and substance misuse within forensic 
services, exacerbated by ineffective sharing of information, may go some way to 
explaining the difficulties in identification of the problem.  This, in turn, may result in 
limited opportunity to manage and treat the problem, thus, increasing the risk of 
adverse associated consequences.  
 
Mental health outcomes 
Comorbidity has been associated with a range of adverse consequences, negatively 
impacting both the individual and the wider community.  Research has indicated 
problems with life quality and functioning arising from depression and anxiety 
associated with this disorder (Barrowclough, Gregg, Loban, Bucci & Emsley, 2014).  
Withdrawal symptoms and physical health problems have been commonly associated 
with comorbid serious mental illness and substance misuse (Gregg et al., 2007).  
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Further serious consequences have included a detrimental impact on the prognosis of 
and severity of mental disorder (NICE, 2011) with increased symptoms at short-term 
follow-up (Chakraborty, Chatterjee & Chaudhury, 2014).  An increased likelihood of 
medication non-compliance and relapse in those with co-existing serious mental 
health problems and substance misuse has been found (Drake & Wallach, 2000).   
Responses to mental health treatment appear to be more limited, with poorer 
outcomes suggested for comorbidity (Bahorick, Newhill & Eack, 2013).  
Furthermore, research has suggested high rates of self-harm, suicidal ideation (Walsh 
& Copello, 2014), completed suicide and homicide (Department of Health, 2001) in 
people with serious mental health problems and combined drug and/or alcohol misuse. 
 
Substance misuse outcomes 
In addition to poorer responses to mental health treatment, poorer substance misuse 
intervention outcomes are reported for this population (Sacks & Pearson, 2003).  
Problems with engagement in treatment have been associated with comorbidity 
(Banerjee, Clancy & Crome, 2002; Bellack, 2007).  Research has indicated low 
motivation to address difficulties (Drake et al., 2001) and difficulties remaining in 
treatment arising from a lack of community support, medical problems and ‘chaotic’, 
unstable living conditions (Bellack et al., 2007).  Consequently, high rates of 
treatment attrition are reported for this client group (Brady, Krebs & Laird, 2004).  
However, findings have not been conclusive regarding treatment attrition, with a 
systematic review of dual diagnosis and treatment retention suggesting that this client 
group are no more likely than counterparts without mental health problems to drop 
out of substance misuse treatment (Meier & Barrowclough, 2009).  In view of the 
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high rates of substance misuse treatment attrition in the non dual-diagnosis 
population, this remains an important consideration for both those with and without 
serious mental health problems.    
 
Comorbidity and violence 
Alongside poorer outcomes for substance use and mental health, a further adverse 
consequence is that of violent behaviour.  The association between comorbidity and 
elevated risk of violence has been widely discussed in the literature, with a number of 
studies having investigated the relationship between serious mental health problems, 
substance use and aggression.  Whilst the association between mental health and risk 
of violence is a contentious issue (Walsh, Buchanen & Fahy, 2002), it would appear 
that there is more consensus for the relationship between co-existing serious mental 
health problems, substance use and risk of violence.  A large-scale epidemiologic 
study explored the association between violence and mental disorder and found that, 
whilst 8% of people with schizophrenia alone reported violent behaviour, this 
increased to 30% when combined with comorbid substance use (Swanson, Holier, 
Ganju & Iono, 1990).  A more recent National Epidemiologic Survey explored 
alcohol and related conditions in the US and provided further support for co-occurring 
substance use significantly increasing risk of violence for those with mental illness 
when compared with severe mental illness alone (Elbogen & Johnson, 2009).   
Mericle and Havassy (2008) in their US study of individuals accessing services and 
recent experience of violence, found that comorbid substance misuse and mental 
health problems appeared to increase the risk of both perpetrating violence towards 
others and also being victim to violence.  In particular, alcohol was indicated as 
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having been consumed in 45% of incidents of perpetration or victimization (Mericle 
& Havassy, 2008).   
Systematic review and meta-analyses of epidemiological studies of violence 
and mental health have indicated strong associations between serious mental health 
problems, comorbid substance use disorder and increased risk of violence (Soyka, 
2000; Volavka, 2013; Walsh et al., 2002).  Fazel, Långström, Hjern, Grann & 
Lichtenstein, (2009) suggested a mediating effect of substance misuse on the 
association between schizophrenia and violence in their longitudinal study.  Findings 
indicated that 27.6% of patients with co-occurring substance use and schizophrenia 
had been convicted of a violent offence, compared with 8.5% of those with a 
diagnosis of schizophrenia without comorbid substance use.  In a systematic review of 
risk and protective factors for violence in mental illness, a very strong association was 
found between violence and polysubstance misuse.  Strong associations were found 
between comorbid substance misuse and violence, and recent substance misuse and 
violence.  Moderate associations were also found between recent alcohol misuse, a 
history of alcohol misuse, a history of substance misuse and a history of drug misuse 
(Witt, Van Dorn & Fazel, 2013).   
 
Offending 
Elevated risk of violence in comorbid serious mental health problems and substance 
use would suggest serious implications for offending.  Research has indicated an 
increased risk of offending behaviour in comorbid mental health problems and 
substance misuse (Daff & Thomas, 2014; Fazel, Lichtenstein, Grann, Goodwin & 
Långström, 2010; Morgan et al., 2013).  As with risk factors for substance use in 
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serious mental health problems, risk factors for offending in those with serious mental 
health problems are suggested as similar to those within the general population.  
Andrews and Bonta (2010) proposed criminogenic risk factors for offending as 
offence supportive attitudes, antisocial personality, pro-criminal associates, poor 
education, lack of employment, relationship instability, substance misuse and limited 
prosocial activities.  Non-criminogenic risk factors increasing vulnerability for 
offending are suggested as limited self-esteem, major mental disorder, previous 
victimisation, lack of ambition, and experience of emotional discomfort (Andrews & 
Bonta, 2010).  As such, those already encountering potential risk factors for offending 
through the experience of serious mental health problems and substance misuse may 
be more vulnerable to other criminogenic and non-criminogenic factors.  Limited 
coping skills, lack of opportunity and challenging social circumstances frequently 
associated with major mental illness (Phillips & Johnson, 2010) may further 
exacerbate vulnerability to risk factors with the potential to increase likelihood of 
offending behaviour.   
Serious mental health problems have been suggested as a risk factor for 
violent offending irrespective of substance use, however, substance use has been 
identified as further increasing this risk, reinforcing the need to treat mental illness as 
well as substance use in order to reduce risk of offending.  Types of offending 
associated with comorbidity are not exclusively limited to violence and include a 
range of non-violent offences (Short, Thomas, Mullen & Ogloff, 2013).  Increased 
vulnerability for involvement in a drug subculture to reduce social isolation is 
suggested as potentially increasing the risk of offending in this client group 
(Williams, 2002).   
  
 13  
Additionally, an elevated likelihood of recidivism has been found to be 
associated with substance misuse in offenders with serious mental health problems 
(Baillargeon et al., 2010; Balyakina et al., 2104; Bonta, Blais & Wilson, 2013).  
Reasons for heightened risk of recidivism have been suggested to include continued 
contact with the criminal justice system through the use of illicit drugs, increased 
alcohol related violence suggested as arising from the maintenance of hostile and 
angry feelings (Bonta et al., 2013) and poorer compliance with anti-psychotic 
medication resulting in experience of psychotic symptoms (Balyakina et al., 2104).  
Furthermore, increased likelihood of returning to live in a ‘chaotic’ environment 
without the provision of adequate support following discharge and failure to engage 
with follow-up services has been noted as a risk factor for recidivism (Edeh, 2002).  
Consequently, elevated risks for offending and re-offending in those with comorbid 
mental illness and substance misuse places significant economic demands on the 
criminal justice and health systems.    
Furthermore, comorbidity has been found to persevere once individuals are 
detained within the secure environment with associated negative consequences.  A 
survey of 28 NHS managed medium secure units in England suggested significant 
problems with continued use of drugs and/or alcohol, with reports of substance use 
within the past month from the majority of units included in the study (Durand, 
Lelliott & Coyle, 2006).  Consequences of continued alcohol and/or drug use included 
negative impact upon mental health, implications for treatment processes and 
increased problematic behaviour (Durand et al., 2006).  A number of inpatient studies 
of alcohol and drug use are consistent with these findings indicating continued 
substance use whilst in secure hospital settings (Bowers & Jeffery, 2008; Derry, 2008; 
Phillips & Johnson, 2003; Wheatley, 1998). 
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Thesis aims 
The overall aim of this thesis was to gain a better understanding of the problems 
associated with co-existing serious mental health problems and substance misuse in 
the offending population and evaluate a treatment available for offenders detained 
within secure environments.  The literature has highlighted limited provision of 
treatment for comorbid serious mental health problems and substance misuse within 
forensic services.  The treatment available for individuals with co-existing serious 
mental health and substance misuse problems has been identified as lacking empirical 
support, with the need for additional treatment provision and associated empirical 
investigation recommended.  Therefore, the current thesis aimed to add to this under-
researched area through review of empirical studies of treatment for coexisting 
serious mental health problems and substance misuse provided in secure settings.  
Furthermore, a study using mixed methods explored the efficacy of a specifically 
designed substance misuse treatment for offenders with serious mental health 
problems aimed to provide further understanding into intervention available for this 
pervasive and complex problem.   It was anticipated that by increasing empirical 
research and insight into intervention this would be beneficial in contributing to the 
continued development of treatment available to those with mental health and 
substance misuse problems. 
  
Structure of the thesis 
Chapter one of this thesis has outlined some of the background research literature 
relating to comorbid serious mental health problems and substance misuse, the extent 
of the problem and the impact that it has on the individual and society as a whole.  
Comorbidity is identified as a complex and pervasive problem, impacting the lives of 
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many.  A number of serious negative consequences associated with co-existing 
serious mental health problems and substance misuse problems have been suggested 
including an increased likelihood of violence and general offending behaviour.    
Chapter two is a systematic literature review examining the effectiveness of 
substance misuse treatment provided within secure settings.  The purpose of the 
review was to establish the efficacy of current structured substance misuse 
intervention treatment in secure settings for offenders with co-existing serious mental 
health problems. 
Chapter three critically reviews the Stage of Change and Treatment Readiness 
scale (SOCRATES), a psychometric tool widely used in the field of substance misuse 
treatment.  The psychometric properties of this measure are critically examined and 
the scale’s clinical utility considered.   
Chapter four reports an empirical research study exploring the efficacy of a 
specifically designed substance misuse group intervention developed for those with 
serious mental health problems within the context of two clinical settings.  A mixed 
methods repeated measures programme evaluation design was used for the research.    
Study findings are discussed in relation to methodological limitations and 
implications for practice.  
Chapter five includes a critical discussion of the thesis findings in the context 
of previous literature, exploring the limitations of the current thesis and considering 
practice implications of findings reported.  
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CHAPTER TWO:   
ASSESSING THE EFFECTIVENESS OF SUBSTANCE MISUSE 
PSYCHOSOCIAL INTERVENTIONS FOR INDIVIDUALS WITH CO-
EXISTING SERIOUS MENTAL HEALTH PROBLEMS IN THE SECURE 
FORENSIC ENVIRONMENT: A SYSTEMATIC REVIEW  
Abstract 
Aim:  To systematically review existing studies assessing the effectiveness of 
structured substance misuse interventions in the secure forensic environment for 
offenders with co-existing serious mental health and substance misuse problems.    
Method:  A scoping exercise was completed to assess the need for and originality of 
the current review.  A systematic approach was taken towards identifying and 
reviewing research literature.  Six database searches were completed and additional 
searches conducted by hand on journals and reference lists of identified articles.  Key 
researchers in the field were contacted.  Articles were selected for the review through 
the application of set inclusion/exclusion criteria and were quality assessed.  Data was 
extracted from all articles, results analysed and findings synthesised narratively.  
Results:  Thirteen studies met inclusion criteria and were selected for the review.  
The very limited evidence base was reflected in the number of eligible studies 
published assessing intervention for dual diagnosis in the secure setting.  As such, no 
studies were excluded from the current review on a quality basis.  A Cognitive 
Behavioural approach was the most frequent intervention approach in studies.  
Preliminary findings suggest a positive impact of intervention in terms of change in 
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attitudes towards substance use, some improvements in psychological functioning and 
indications of reduction in recidivism and substance use.  However, the 
methodological limitations of the included studies appear to reflect similar 
methodological limitations identified within empirical assessment of treatment 
provided for these needs outside of the forensic environment. Limitations influenced 
reliability and generalisability of findings.    
Conclusions:  Despite emerging evidence suggesting that structured substance misuse 
treatment intervention may have some positive impact in reduction of risk and 
improvement of quality of general functioning, a need for further research in the field 
is evident.  The development of methodologically robust evidence based trials will 
provide opportunity for reliable conclusions to be drawn and aid in the development 
of intervention treatment integrity, in order to more consistently meet the needs of this 
vulnerable population.    
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Introduction 
As discussed within Chapter One, the impacts of co-existing substance use and 
serious mental health problems are significant for many.  The association between 
substance misuse, serious mental health problems and increased risk of offending and 
recidivism has much empirical support.   However, despite the extent of this problem 
within the forensic population, treatment has been fragmented and inadequate to meet 
the needs of this vulnerable group.   The aim of this chapter is to gain an 
understanding of the effectiveness of structured psychosocial treatment intervention, 
available within secure settings, for individuals with forensic histories and co-existing 
substance misuse and serious mental health problems, through a systematic review of 
the literature.   This aim will be achieved by:  
• gaining an understanding of the treatment programmes available  
• identification of differences within approaches  
• exploring the efficacy of treatment in terms of treatment outcomes  
• quality assessing the associated research  
• considering findings in the context of implications for practice and future 
research 
The literature base, assessing the efficacy of psychosocial interventions 
outside of the secure forensic environment in people with co-occurring serious mental 
health problems and substance misuse, has been suggested to be considerable 
(McKeown, 2001).  Associated research includes numerous studies evaluating 
individual psychosocial treatment approaches for dual diagnosis and several 
systematic and meta-analytic reviews evaluating treatment in community and non-
secure settings (e.g. Cleary, Hunt, Matheson, Siegfried & Walter, 2008).  However, 
despite the considerable availability of literature, findings are inconclusive with a 
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number of methodological limitations suggested as contributing to this.  A systematic 
review of studies of psychosocial interventions for people with co-occurring severe 
mental illness and substance misuse disorder identified a large, heterogeneous base 
for interventions making recommendations for methodological standardisation and 
more longitudinal approaches (Drake, O’Neal & Wallach, 2008).   Furthermore, 
systematic review of psychosocial treatment for comorbid mental health problems and 
substance use in general community samples indicated problems with methodological 
design, sample selection and unclear reporting, all contributing to problems in 
drawing clear conclusions from the data (Cleary et al., 2008). 
As discussed in Chapter One, the literature indicates a strong association 
between co-existing serious mental health problems, substance misuse and offending 
(e.g. Daff & Thomas, 2014; Morgan et al., 2013).  However, there is comparatively 
little research available relating to structured psychosocial substance misuse treatment 
for offenders with co-existing serious mental health problems in forensic settings.  
Limited provision of treatment for substance misuse problems in the forensic 
environment has been highlighted, with significant need for development of 
intervention and associated evaluation emphasised (Derry, 2008).  A recent forensic 
mental health services report highlighted the paucity of empirical research in this area 
and the need for development of the evidence base for dual diagnosis treatment in 
secure settings (Clark & Sandbrook, 2013).   
The results of a national survey in medium secure units in the UK raised 
concerns regarding diverse and inconsistent approaches to intervention being used in 
situations outside of evidence from trials, resulting in inadequate treatment provision 
(Durand et al., 2006).  An independent review of mental health provision in the 
criminal justice system commissioned by the Department of Health (The Bradley 
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Report, 2009), highlighted disconnected mental health and substance misuse services 
within the prison environment, with a dual diagnosis often restricting access to these 
services.  This report made recommendations for the urgent development of improved 
services for prisoners with a dual diagnosis of mental health and substance misuse 
problems.   
In view of the indicated serious implications of inaccessibility of intervention, 
inconsistent approaches and limited associated empirical research, further research is 
necessary to gain perspective on treatment provision and indicated efficacy of the 
treatment that is available to address these needs in secure forensic environments.   
The current review 
In order to assess the need for the current review, a search was completed to identify 
relevant literature and existing reviews in the related area.  Searches were completed 
during May 2014 of the following:   
• The Centre for Reviews and Dissemination (DARE) 
• Cochrane Library  
• PsycInfo  
• The Campbell Collaboration Library of Systematic Reviews   
No systematic reviews or meta-analysis were found for the psychosocial 
treatment of drug misuse in dual diagnosis offenders in secure forensic settings. A 
recent systematic review of research of psychosocial research on psychosocial 
interventions for people with both severe mental illness and substance misuse (Hunt 
et al., 2013) was found in the Cochrane Collection, however, this review focused 
upon a general sample of co-morbid mental illness and substance misuse rather than 
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the more specific dual diagnosis for forensic populations.  Google Scholar searches 
identified a systematic review exploring research methods for psychosocial 
interventions for co-occurring severe mental and substance use disorders (Drake et al., 
2008) and a review of empirical evidence of psychosocial interventions for dual 
disorders (Horsfall, Cleary, Hunt & Walter, 2009).  As with the previous review, both 
of the populations within these reviews were general populations with co-existing 
substance misuse problems and serious mental disorder rather than focusing upon the 
forensic population, as is the aim of the current review.  
 
Aims and Objectives 
The aim of the current review is to take a systematic approach to exploring research 
findings for the effectiveness of substance misuse psychosocial interventions for dual 
diagnosis in secure forensic environments.  For the purposes of this review dual 
diagnosis will refer to co-existing serious mental health problems and substance misuse problems, including both illicit drugs and alcohol.   
Objectives of the review are: 
• To identify psychosocial treatment approaches for dual diagnosis in forensic 
settings 
• To determine whether psychosocial treatment approaches change attitudes 
towards substance use  
• To determine whether psychosocial treatment approaches change behaviour in 
reducing substance use 
• To determine whether psychosocial treatment approaches reduce recidivism 
• To determine whether psychosocial treatment improves psychological 
functioning and well-being 
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• To identify further areas of research required  
Method 
Search strategy 
A scoping search was conducted to identify the existing literature base for structured 
group interventions addressing substance misuse in offenders with co-existing serious 
mental health problems.  This search provided a basis for the review, helped to define 
the research question, review parameters, identify a review plan and generate key 
search terms.  Searches of six electronic databases were conducted on 18 and 19 June 
2014 and updated in June 2016 to identify potential studies to be included in the 
review;  
• OVID PsycINFO (1987 to June Week 3 2016)  
• OVID EMBASE (1988 to June Week 3 2016) 
• OVID MEDLINE (1946 to June Week 3 2016)  
• Health Management Information Consortium (HMIC) (1979 to June 2016) 
• Web of Science (1985-2016) 
• Applied Social Sciences Index and Abstracts (ASSIA) (1985-2016)   
Databases were selected as being most relevant for the search topic, informed 
by the scoping exercise and by existing reviews in similar areas.  Date ranges (latest 
date 1988) were selected due to the relative recent introduction of structured 
interventions in secure settings and corresponding time frames of associated studies 
(Scott et al., 2004).  Searches were restricted to English language due to time and 
financial implications involved with the translation of studies.  Book chapters, 
editorials, reviews, narratives and opinion papers were excluded.   
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Search terms were identified and adapted accordingly for each database.  Full 
details of database search terms can be found in Appendix 1.  Keywords associated 
with substance misuse, co-existing serious mental health problems, psychosocial 
interventions and the forensic population were used to retrieve studies (see Figure 1).  
Following application of search terms to the databases, the total number of 
initial hits was 1281.  Removal of duplicates left a remainder of 920 publications.  
Initial sifting by reviewing the title and abstract, or full text where required, resulted 
in the removal of a further 906 articles.  Reasons for removal of studies included 
exclusively community samples, juvenile or adolescent samples, focus on dual 
diagnosis prevalence, focus on measurement tool evaluation, court diversion to 
community treatment, non-offending samples and focus on risk factors for offending 
or factors predicting treatment attendance or attrition.   
In order to attempt to widen the search area and limit potential effects of 
publication bias the following additional searches were undertaken:   
• Contacting three key experts in the field via email.  Articles supplied resulted 
in one additional article being included in the current review.  Details of 
experts contacted and copy of the email sent can be found in Appendix 2. 
• Handsearching reference lists of relevant papers identified a further 8 studies 
as potentially suitable for inclusion in the review. 
• Manually searching key journals resulted in identification of 2 publications for 
potential inclusion in the review. 
• Conducting a search using the Google search engine.  No additional articles 
were sourced using this search method.  
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Figure 1.  Search terms applied to electronic databases 
Drug by itself or with any letters following, for example, drugs OR 
Alcohol by itself or with any letters following, for example, alcoholic OR 
Poly-drug by itself or with any letters following, for example, poly-drugs OR 
Substance by itself or with any letters following, for example, substances OR 
Narcotic by itself or with any letters following, for example, narcotics OR 
Heroin OR Cocaine OR Crack OR Amphetamine OR Ecstasy OR Cannabis OR Benzodiazepines 
AND 
Abus with any letters following, for example, misuse OR 
Misus with any letters following, for example, misusing OR 
Disorder by itself or with any letters following, for example, disordered OR 
Depend with any letters following, for example, dependent OR Use OR 
Addict with any letters following, for example, addiction OR 
Withdraw with any letters following, for example, withdrawal OR 
Rehab with any letters following, for example, rehabilitate OR 
Abstain with any letters following, for example, abstaining OR 
Illegal with any letters following, for example, illegally OR 
Habit with any letters following, for example, habits OR 
Relapse prevent with any letters following, for example, relapse prevention 
AND 
Dual diagnos with any letters following, for example, dual diagnosis OR 
Dual disorder with any letters following, for example, dual disordered OR  
Co-morbid with any letters following, for example, co-morbidity OR 
Co-occur with any letters following, for example, co-occurring OR Dual within 3 words of diagnosis 
AND 
Serious mental health problems OR Serious mental disorder with any letters following, for example, 
serious mental disorders OR Mentally ill offender with any letters following, for example, mentally ill 
offenders OR Mentally disordered offender with any letters following this, for example, mentally 
disordered offenders OR  
Serious mental illness OR Psychiatric illness OR Bipolar disorder OR Schizophrenia OR Mental 
health OR Major mental illness 
AND 
Forensic inpatient with any letters following this, for example, forensic inpatients OR 
Offend with any letters following this, for example, offenders OR 
Crime with any letters following this, for example, crimes OR  
Crimin with any letters following this, for example, criminal OR 
High secur with any letters following this, for example, high secure OR Medium secur with any letters 
following this, for example, medium secure OR Low secur with any letters following this, for example, 
low secure OR Special hospital OR Forensic psychiatry OR Sentence with any letters following this, 
for example, sentenced OR Criminal justice OR Jail OR Incarcerated OR Prison with any letters 
following this, for example, prisoner OR Custod with any letters following this, for example, custodial 
OR Forensic service with any letters following this, for example, forensic services OR Forensic 
hospital with any letters following this, for example, forensic hospitals OR Special hospital with any 
letters following this, for example, special hospitals OR Secure within 3 words of hospitial OR 
Forensic within 5 words of patient  
AND 
Intervention OR Treatment OR CBT OR 
Motivational interview with any letters following this, for example, motivational interviewing OR 
Contingency manage with any letters following this, for example, contingency management OR  
Therap with any letters following this, for example, therapy OR  
Psychosocial OR Groupwork OR Skills training OR Relapse prevention OR 
Behaviour with any letters following this, for example, behaviours OR  
Behaviour with any letters following this, for example, behaviors OR Programme OR  
Cognitive techniques OR Psychotherap with any letters following this, for example, psychotherapy OR  
Rehabilitat with any letters following this, for example, rehabilitation OR  
*therapy/ OR Cognitive behav* therapy OR Behaviour with any letters following or behaviour with 
any letters following or cognitive or psycho with any letters following this within 3 words of therapy 
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Inclusion/exclusion criteria 
Table 1 presents the inclusion/exclusion criteria based upon the PICO 
framework applied to the remaining 25 articles to provide a more detailed assessment 
of suitability of studies to be included in the review.  Appendix 3 provides details for 
the full inclusion checklist. This process resulted in the removal of a further 12 
articles, study details and reasons for exclusion can be found in Appendix 4.  A total 
of 13 studies were assessed as meeting inclusion criteria.  One researcher was 
responsible for this assessment process.   
Table 1.   
Inclusion/Exclusion criteria 
PICO Inclusion Criteria Exclusion Criteria 
Population Dual diagnosis (substance 
misuse and co-existing 
serious mental health 
problems) 
All offence types 
Detained in the secure 
forensic environment due to 
risk to others and/or self 
Males and females 
Adults (aged 18 and over) 
Different ethnicities  
Different nationalities  
 
No co-existing serious mental 
health problems and substance 
misuse  
Aged under 18 
Not detained in secure 
environment 
Community based  
 
Intervention Exposure to psychosocial 
substance misuse treatment 
(drugs and/or alcohol) 
groupwork programmes 
 
Pharmacological interventions 
Solely individual intervention 
Somatic interventions 
Therapeutic community 
 
Comparator No comparator necessary 
 
 
Outcome Substance use 
Recidivisim 
Psychological functioning 
Behavioural change 
 
 
Study design Any study design with 
outcome measures 
 
Editorials, book chapters, 
narrative reviews, 
commentaries, opinion papers 
Other factors Publication language English  
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Rationale for inclusion/exclusion criteria  
The current review is focused upon the adult forensic population, therefore, 
studies with participants aged under eighteen at the time of commencing intervention 
were not included in the review.  For the purposes of this review dual diagnosis refers 
to the co-existence of serious mental health problems and substance misuse problems.  
In order to be included in the current review, the presence of both serious mental 
health problems and substance misuse needed to be established.  At the time of 
attending intervention participants were required to be detained in the secure forensic 
environment (secure hospital or prison).  
Attending psychosocial substance misuse intervention was a key requirement 
of the current review.  Psychosocial treatment encompassed a variety of different 
intervention approaches including cognitive behavioural therapy, motivational 
interviewing, psychoeducation, relapse prevention and behavioural therapies, to 
provide the widest approach to psychotherapy possible.  Therapeutic community 
studies were excluded from the current review as the review focused upon structured 
psychosocial intervention programmes addressing dual diagnosis rather than the 
overall treatment environment provided by therapeutic communities.    
No comparator was defined for the review due to the nature of the intervention 
and the setting.  Those with co-existing mental health and substance misuse problems 
are a vulnerable population in a secure environment requiring rehabilitative treatment.  
To withhold treatment from this population in order to create a control condition 
would be highly unethical.  The likelihood of the availability of a comparator group in 
the form of alternate treatment provision is unlikely in view of the reported limited 
treatment availability for this group (Scott et al., 2004).   
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Treatment efficacy was assessed through a number of different treatment 
outcomes: recidivism/readmission rates, continued substance use, change in attitude 
towards substance use, motivation to change, increased self-efficacy and self-reported 
change in quality of lifestyle.  All outcomes measured have the potential to reduce 
risk in terms of changing attitude and/or behaviour and improve general functioning 
in participants.  
Quality assessment 
Formal assessment of the quality of included articles has been noted to impact 
positively on reliability of results and conclusions of literature reviews (Centre for 
Reviews and Dissemination, 2008).  In order to appraise the quality of articles within 
the current review, research designs for each study were identified.  One article was 
qualitative in design, three articles were mixed methodology design including both 
qualitative and observational designs and nine articles were observational design 
before-and-after studies.  Observational studies without control/comparison groups 
were included in the current review due to the lack of published randomised control 
trials and controlled clinical trials in this area (Amato et al., 2007).  Quality 
assessment criteria for the qualitative study designs were guided by the Critical 
Appraisal Skills Programme (CASP) checklist (Appendix 5).  A total of fifteen items 
were included in the qualitative checklist.  Individual items assessed within the 
checklist covered broader areas of sample selection bias, study design, data collection 
and analysis and study findings.    
Checklists for the observational designs were developed by the author, guided 
by a variety of sources including the QUADAS tool (BioMed Central: Whiting, 
Rutjes, Reitsma, Bossuyt & Kleijnen, 2003) and the STROBE statement checklist 
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(2007), in the absence of a CASP checklist tool for this study design (see Appendix 6 
for full checklist details).  A total of twenty-three items were included in the 
quantitative quality checklist.  Individual items assessed within the checklist covered 
broader areas of sample selection, study design, intervention delivery, outcome 
measures, data collection and analysis, attrition rates and study findings to incorporate 
the six major areas of potential research bias (Deeks et al., 2003).   For the three 
mixed methods design studies, both quality assessment tools were applied to the 
relevant aspects of the articles. 
In order to be included in the review, a study was required to satisfy minimum 
quality criteria.  Criteria included addressing a clearly focused issue, appropriate 
methodology, clearly identifying outcomes and describing the study population.  All 
articles included in the current review met the minimum criteria specification.  
Articles were then quality assessed against a number of items with a rating scale of 
two through to zero, with ‘yes’ scoring two, ‘partial’ scoring one and ‘no’ scoring 
zero.  The maximum score achievable was 46 for quantitative studies or 30 for 
qualitative studies, with higher scores indicative of better quality.  Once total quality 
scores had been calculated for each study, scores were converted into percentages. 
For mixed method studies, scores for both aspects were summed cumulatively and 
converted into percentages.  In terms of inter-rater reliability, in order to try to 
minimise bias in quality assessment of studies, a random sample (n = 2) of the 
included studies were quality scored by a second assessor (Forensic Psychologist in 
Training qualified to a post graduate level).  Results of double scoring were within 1 
and 2 points of each other respectively which was considered acceptable to indicate 
reliability of scoring.     
  
 29  
Data extraction 
Data was extracted from all studies through the use of a data extraction form which 
can be found in Appendix 7.  The data extraction form was constructed by the 
researcher and quality percentage scorings were recorded on the form.  The following 
data was extracted for each study:   
• General article details – author, title, journal, year, volume, page numbers and 
location 
• Study design 
• Participants – sample size, gender, age, recruitment method 
• Intervention – approach, duration, frequency 
• Measures – quantitative – measures used, validity of measures;          
qualitative – data collection measures 
• Outcomes -  quantitative – statistical analysis used, findings;             
qualitative – themes, findings 
• Limitations 
• Quality score 
The same form was used to extract data from all studies included in the review 
with data extracted by one researcher.   
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Results 
A total of 13 studies met the inclusion criteria and were included in the review.  No 
studies were removed on the basis of quality due to very limited research available in 
the field.  Figure 2 provides details of the study selection process followed within the 
current review.   Table 2 presents a summary of individual article information as 
obtained from the quality assessment and data extraction process.  
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 Number of hits from electronic databases: 
 
PsycINFO  n=398 
Medline  n=320 
Embase  n=476 
ASSIA   n=65 
HMIC   n=10 
Web of Science n=12 
 
Total   n=1281 
Number of duplicates excluded 
n=361 
 
Total remaining articles  
n=920 
Articles removed after initial sifting 
n=906 
 
Publications 
included from 
reference lists 
 
n=8 
Studies 
identified from 
hand searching 
journals 
 
n=2 
Studies 
identified from 
contact with 
professionals 
 
n=1 
Unobtainable articles      n=0 
Articles removed after application of PICO  n=12 
Articles removed on quality assessment basis  n=0 
Total articles included in review    n=13 
Figure 2.   Study selection process 
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Table 2   
Characteristics of publications included in the review 
Authors, 
publication 
date, country 
and quality 
assessment 
Study design Population Intervention Outcome 
measures 
Findings Study strengths and 
weaknesses 
Ritchie, 
Billcliff, 
McMahon & 
Thomson 
(2004) 
 
UK study 
 
 
52% quality 
score 
Observational 
before-and-
after study 
 
Prospective 
51 adult male 
participants  
 
Age range 20-
53 years, with a 
mean age 34.5 
years 
 
Detained in 
medium and 
high secure 
hospital 
providing care 
for patients with 
dangerous, 
violent and 
criminal 
behaviours 
 
Referred by 
clinical team 
Drug and alcohol 
group awareness 
intervention  
 
Designed to 
increase 
knowledge, 
enhance internal 
control and 
increase 
motivation.   
 
8 x sessions 
delivered on a 
weekly basis.   
Session structure 
outlined in article 
 
Minimum of 4 and 
maximum of 8 
participants per 
Drug knowledge 
questionnaire 
 
Alcohol 
knowledge 
questionnaire 
 
Stages of change 
questionnaire 
 
Multidimensional 
locus of control 
Pre and post 
intervention measures 
 
Repeated measures 
ANOVA used on all 
measures 
 
Significant difference 
in alcohol knowledge 
(p =.002) and drug 
knowledge (p =.017) 
between pre and post 
measures.   
 
No significant 
difference pre and 
post treatment in 
locus of control or 
stage of change  
Strengths – demographic, 
forensic and clinical 
information provided, 
measures adequately 
described; intervention 
clearly described; 
appropriate statistical 
analysis used;  
 
Limitations – 2 x measures 
developed locally lacking 
reliability and validity 
information; lack of 
comparison/control group; 
no follow up measures; 
ethical approval process 
not documented 
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 group 
 
Miles, Dutheil, 
Welsby & 
Haider (2007) 
 
UK study 
 
65% quality 
score 
Observational 
before-and-
after pilot 
study 
 
Prospective 
18 adult male 
participants 
 
Details not 
provided for 
age range for 
participants 
 
Detained in 
medium secure 
hospital for a 
variety of 
challenging 
aggressive 
behaviour and 
offences 
 
All admissions 
to the unit with 
history of 
substance use 
referred to 
intervention 
Substance Use 
Treatment 
Groupwork 
Programme 
adopting a CBT 
and relapse 
prevention 
approach 
 
Designed to 
enhance 
engagement, 
increase 
motivation to 
change, treat and 
prevent relapse 
 
Stage 1 -12 x 
weekly sessions 
Stage 2 – 12 x 
weekly sessions 
delivered on a 
weekly basis   
Session structures 
outlined in article 
 
Weekly urine 
drug screens 
(UDS) – drug 
abstinence 
testing 
 
 
 
 
 
 
3 x locally 
designed 
measures:  
i)Beliefs have 
problems with 
substances 
ii)Need to change 
substance use 
iii)Confidence to 
make change  
 
 
Beliefs about 
Substances 
questionnaire  
 
Pre and post measures 
 
13 (72%) negative on 
weekly UDS by end 
of pilot treatment 
(Dec 2005).  
Significant effect of 
treatment in becoming 
drug free by Dec 2005 
(p =.043) but no 
significant effect by 
June 2006 (6 month 
follow up) 
 
Post treatment: 
i) Beliefs increased 
ii) Beliefs decreased 
iii) Confidence 
increased 
6 months post: 
i)Beliefs decreased 
slightly 
ii)Beliefs increased 
iii)Confidence 
decreased slightly 
 
Post treatment and 6 
Strength – demographic, 
forensic and clinical 
information provided, 6 
month post intervention 
follow-up, range of 
outcome measures 
including physiological 
testing for drug use 
(objective measure), 
statistical testing for 
association between 
demographic, forensic and 
clinical factors and 
treatment outcome, ethical 
approval process discussed 
 
Limitations – limited 
sample size, treatment 
satisfaction questionnaire 
not administered for first 
cohort of treatment, focus 
upon Marijuana limits 
generalisibiliy of findings, 
absence of reliability and 
validity indications for 
some measures included, 
lack of statistical analysis 
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Marijuana 
Craving 
Questionnaire   
 
Locally designed 
satisfaction 
questionnaire 
 
month follow-up: 
Beliefs more adaptive 
 
Post treatment and 6 
month follow-up: 
Less craving reported 
 
Satisfaction reported 
in all those 
completing the 
measure 
 
for attitudes towards 
substance use findings 
 
 
Derry & 
Batson (2008) 
 
UK study 
 
48% quality 
score 
Comparison 
group study  
 
Retrospective  
Experimental 
group  
6 treatment 
completers  – 
not specified 
male or female 
 
Comparison 
group 
19 treatment 
non-completers 
- not specified 
male or female 
 
Details not 
provided for 
age range  
Cognitive 
Behavioural drug 
and alcohol 
treatment 
programme  
 
Designed to 
develop motivation 
to change, 
understand 
substance use, 
mental health and 
offending, relapse 
prevention and 
skills 
development. 
 
Proportion of 
time spent in 
community 
following release  
 
 
 
 
 
 
 
Electronic patient 
notes and 
interviews with 
responsible 
medical officers 
to report on 
Intervention 
completers were 
found to spend a 
significantly 
proportionally greater 
time in the 
community than those 
who had not 
completed the 
intervention (p 
=0.015).   
 
Significantly lower 
known substance use 
following release in 
intervention 
completers (50%) 
Strengths – comparison 
group, follow-up period 
length  
 
Limitations – control 
group included treatment 
dropouts – higher risk 
group; follow-up data only 
available for 6 participants 
completing substance 
misuse treatment 
compared with 19 who had 
not; limited details 
provided as to sources of 
reporting of substance use 
following release; ethical 
approval process not 
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Detained in 
medium secure 
hospital 
 
Participation in 
intervention 
voluntary 
 
24 sessions in 3 
modules, brief 
intervention 
structure details 
provided 
  
substance use 
following release 
compared with those 
who had not 
completed 
intervention (74%) 
 
documented; no 
demographic, forensic and 
clinical information 
provided 
Morris & 
Moore (2009) 
 
UK study 
 
59% quality 
score 
Mixed 
methods 
(quantitative 
and 
qualitative) 
 
Prospective 
22 adult male 
participants (30 
started 22 
completed) 
 
Age range 27-
58 years, mean 
age 37 years 
 
Detained in 
high secure 
hospital  
 
Patients 
referred to 
intervention  
 
 
Substance misuse 
intervention taking 
a CBT approach  
 
4 groups lasting 
between 9 and 14 
months, weekly 2 
hour sessions 
 
Programme 
structure and 
material covered in 
group outlined in 
article 
 
Minimum of 4 
participants and 
maximum of 7 per 
group 
Quantitative -
Stages of Change 
Readiness and 
Treatment 
Eagerness Scale 
(SOCRATES) 
 
Psychological 
Inventory of 
Drug-Based 
Thinking Styles 
(PIDTS) 
 
Staff Incident 
Reports (urine 
drug screening) 
 
Qualitative – 
semi-structured 
Pre and post 
measures: 
Wilcoxon’s matched 
pairs signed rank tests 
and reliable change 
index 
 
SOCRATES -
significant reduction 
on the ambivalence 
scale (p =0.047), no 
significant change on 
other subscales 
 
PIDTS – significance 
differences found for 
4 scales: mollification 
(p =0.046), cut-off (p 
=0.012), entitlement 
Strengths – demographic, 
forensic and clinical 
information provided; 
reliable change index 
calculated to indicate 
clinical change; measures 
established and valid; 
measures described in 
article; semi-structured 
interviews completed by 
independent researcher to 
minimise response bias; 
semi-structured interview 
piloted before use 
 
Limitations –limited 
sample size: only 10 
participants completed pre 
and post measures – 
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interview (p =0.011) and 
cognitive indolence (p 
=0.045) 
 
No programme 
completers tested for 
urine drug screening 
 
Post qualitative: 
Informal thematic 
analysis 
3 programme 
completers provided 
overall positive 
feedback, found 
group useful, 2 had 
abstinence goals, 1 
did not want to 
change drug use 
Programme non-
completer – fear of 
not being understood 
by other group 
members 
 
additionally only 4 
participants completed 
qualitative aspect of study; 
urine drug screening only 
carried out if staff incident 
reports indicated suspicion 
of substance possession or 
misuse; ethical approval 
process not documented 
 
Oddie & 
Davies (2009) 
 
UK study 
Mixed 
methods 
(quantitative 
and 
Quantitative -  
23 male 
participants 
 
Programme aimed 
to treat poly-
substance misuse, 
mental health 
Quantitative –  
Readiness to 
Change 
Questionnaire – 
Pre and post 
measures: 
RCQ-TV - No 
significant differences 
Strengths – demographic, 
forensic and clinical 
information provided; 
mixed design providing 
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56% quality 
score 
qualitative) 
 
Prospective  
Qualitative – 9 
participants 
 
Age range 21-
44 years, mean 
age 32 years 
 
Detained in 
medium secure 
hospital with 
forensic history 
or extremely 
challenging risk 
behaviour 
 
Patients 
referred to 
intervention  
 
problems  
and offending 
behaviours 
 
Motivational 
interviewing, CBT 
and relapse 
prevention 
approach 
 
Aims to enhance 
readiness to 
change and 
increase 
understanding of 
relationship 
between substance 
misuse, mental 
health problems 
and offending 
 
Programme briefly 
described, no 
details for session 
structures 
 
4 groups, weekly 
groupwork 
sessions, 1 hour 
duration and 5 
Treatment 
Version (RCQ-
TV) 
 
Situational 
Confidence 
Questionnaire 
(SCQ-8) 
 
Concordance 
between self-
report and 
facilitator report 
of stage of 
change 
 
 
Qualitative – 
semi structured 
interview 
found in readiness to 
change between pre 
and post measures 
 
SCQ-8 – for drugs 
significant increase in 
confidence to resist 
over four out of eight 
situations over time (p 
<0.05), for alcohol 
significant increase in 
confidence in one out 
of eight situations (p 
<0.05) 
 
Concordance – no 
statistical reporting, 
12 out of 17 self-
reports on RCQ-TV 
for drugs in 
concordance with 
facilitator report 
(70.6%), 12 out of 15 
for alcohol in 
concordance (80%) 
 
Qualitative 
Thematic analysis and 
descriptive statistics: 
eight themes 
wider insight into 
treatment effects;  
established valid and 
reliable pre and post 
psychometric measures; 
ethical approval detailed 
 
Limitations – missing data 
for some pre/post 
measures; lack of 
control/comparison; 
limited sample size; 
potential bias – first author 
lead facilitator on the 
programme 
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individual sessions 
 
including overall 
experiences, benefits 
of group, factors 
impacting abstinence, 
service improvements 
and ongoing support 
 
Long, Fulton, 
Fitzgerald & 
Hollin (2010) 
 
UK study 
 
61% quality 
score 
 
Observational 
before-and-
after study 
 
Prospective 
23 adult female 
participants, 
medium secure 
hospital 
 
Mean age 31.45 
years 
 
Detained in 
medium secure 
hospital 
 
Offered a place 
on programme 
by clinical team 
 
 
Understanding and 
Overcoming 
Substance Use 
Treatment 
Programme 
 
CBT approach 
 
Delivered as group 
intervention over a 
16 week period, 11 
x 75 minute 
sessions with one 
individual session 
at the end 
 
Details of 
programme 
structure in article 
 
Individual sessions 
run concurrently 
Drug and 
Alcohol Taking 
Confidence 
Questionnaire 
(DTCQ: 8) 
 
Alcohol and 
Drug Taking 
Consequences 
Questionnaire 
(ADCQ) 
 
Camberwell 
Assessment of 
Need, Forensic 
Version 
(CANFOR) 
 
Brief Psychiatric 
Rating Scale 
Expanded 
(BPRS-E) 
Pre to post measures: 
 
DTCQ – substance 
related self-efficacy 
significantly 
improved (p <.01) 
 
ADCQ – significant 
reduction in perceived 
costs at post treatment 
(p <.01) and greater 
benefits from change 
(p <.05) 
  
CANFOR – 
significantly fewer 
unmet needs (p <.05) 
 
BPRS-E – 
significantly reduced 
scores for anxiety (p 
<.01) and tension (p 
Strengths – ethical 
approval detailed; 
assessment measures 
administered by trained 
staff independent of 
treatment administration; 
wide range of 
psychometric measures 
appropriate for use with 
the study sample; 
description provided for 
each measure; 
demographic, forensic and 
clinical information 
provided 
 
Limitations – individual 
sessions run concurrently 
potential impact on 
dependent variable 
measures adequately 
described;  used non-
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Generalised Self-
Efficacy Scale 
(GSES) 
 
<.01) 
 
GSES – significantly 
increased self-
efficacy (p <.01) 
 
completers as a 
comparison group; limited 
sample size 
Edwards, Guy, 
Bartholomew 
& Buckland 
(2011) 
 
UK study 
 
47% quality 
score 
 
Qualitative– 
evaluating 
pilot study 
 
Prospective 
 
 
7 adult male 
participants,  
 
Detained in 
medium secure 
hospital 
 
Details of age 
not provided 
 
Referred by 
clinical team 
 
 
 
Behavioural, 
motivational and 
relapse prevention 
approach 
incorporating 
contingency 
management and 
harm reduction for 
substance use 
 
24 week 
programme, 2 hour 
sessions delivered 
twice weekly 
 
8 participants per 
group 
 
Details of 
programme 
structure in article 
 
Information 
collected via a 
feedback form  
Summary of main 
themes: 
 
Repetitive nature of 
goal setting; Group 
found to be more 
enjoyable than useful; 
Contingency 
management ‘good 
idea’; Mixed 
perceptions of 
usefulness of role 
play; Education and 
skills training very 
useful; Sessions too 
long and too frequent;  
 
Strengths – good detail 
provided for intervention; 
range of themes identified  
 
 
Limitations – no 
demographic, forensic and 
clinical information 
provided; no details of 
analysis used; copy of 
feedback form not 
included in study; data 
collection method may 
have limited breadth of 
response 
Ritchie, Observational 83 adult male Drug and Alcohol Inventory of Pre and post Strengths – study aims and 
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Weldon, 
Freeman, 
MacPherson & 
Davies (2011) 
 
UK study 
 
46% quality 
score 
before-and-
after study 
 
Retrospective  
programme 
completers  
 
Detained in 
high secure 
hospital 
 
Age range 22-
58 years, 
average age 
36.5 years 
 
Referred by 
responsible 
clinician team 
 
 
Relapse prevention 
programme – 
cognitive 
behavioural 
approach 
 
Groupwork plus 
five individual 
meetings with 
facilitator to 
discuss progress 
and support 
provision 
 
Programme 
structure and aims 
described 
 
6 – 8 participants 
per group 
 
Drug Taking 
Situations 
(IDTS) 
 
Drug Taking 
Confidence 
Questionnaire 
(DTCQ) 
 
Multidimensional 
Locus of Control 
(IPC LOC) 
 
Stages of Change 
Questionnaire 
(SOC) 
 
Rosenberg Self-
Esteem (RSE) 
 
measures: paired t-
tests 
 
IDTS – 40 
participants 
completed primary 
substance – most 
frequent alcohol, 
cannabis or heroin 
 
DTCQ –significant 
increase in confidence 
to refrain post 
programme (p 
<.0005) 
 
IPC LOC - complete 
data available for 60 
participants internal 
and powerful others, 
62 for chance – no 
significant differences 
found 
 
SOC – no significant 
differences found 
 
RSE – no significant 
differences found 
 
hypotheses clearly stated;  
ethical approval detailed; 
consent procedure 
documented; good sample 
size; demographic, clinical 
and forensic information 
provided; discussed 
confounding factors e.g. 
participation in previous 
group intervention, 
findings discussed based 
upon data and 
explanations explored; 
recommendations made 
for future dual diagnosis 
programmes; implications 
for practice clearly 
described 
 
Limitations – no control 
group; missing data for a 
number of measures; no 
follow-up measures, 
previous experiences of 
intervention may have 
biased findings 
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Kesten, 
Leavitt-Smith, 
Rau, Shelton, 
Zhang, 
Wagner & 
Trestman 
(2012) 
 
US study 
 
61% quality 
score 
Comparison 
group study 
 
Retrospective 
 
 
Male and 
female adult 
participants 
 
88 experimental 
group, 39 male, 
49 female, age 
range 23 to 58 
years, average 
age 39 years 
 
883 control 
group, 786 
male, 97 
female, age 
range 18 to 77 
years, average 
age 35 years 
 
Prison based 
 
Participation 
voluntary 
 
Experimental 
group: 
Connecticut 
Offender Reentry 
Program (CORP) 
adopting a 
Cognitive 
Behavioural 
approach 
 
8 programme 
modules, lasting 9-
12 months, 
delivered twice 
weekly,  
 
Module structure 
detailed in article 
 
Control group: 
Department of 
Mental Health and 
Addiction Services 
(DMHAS)  – 
treatment as usual  
 
Recidivism 
(rearrest within 6 
months following 
discharge) 
Experimental group: 
 – 9.1% rearrested 
within 3 months of 
discharge, additional 
4.5% rearrested 
between 3-6 months – 
total 13.6% 
recidivism 
 
Control group: 
15.6% rearrested 
within 3 months of 
discharge, additional 
12.6% rearrested 
between 3-6 months – 
total 28.2% 
recidivism 
 
 
 
Strengths – comparison 
group; good sample size; 
comprehensive 
programme description; 
demographic and forensic 
information provided; 
ethical approval detailed 
 
Limitations – comparison 
group inbalanced sample 
size; limited follow-up 
period to assess recidivism 
Wolff, Frueh, 
Shi & 
Schumann 
Mixed 
methods 
(quantitative 
74 adult female 
programme 
completers 
Seeking Safety 
group therapy – 
Cognitive 
Quantitative 
Brief Symptom 
Inventory (BSI) 
Pre and post 
measures: 
Paired t-tests 
Strengths - demographic, 
clinical and forensic 
information provided; 
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(2012) 
 
US  study 
 
63% quality 
score 
and 
qualitative) 
 
Prospective 
 
Mean age 36 
years  
 
Prison based – 
maximum, 
medium or 
minimum 
security 
 
Participation 
voluntary 
 
 
Behavioural 
approach to 
treating substance 
use disorder and 
mental illness 
 
19 groups, 6 -12 
participants per 
group, 28 sessions 
twice weekly for 
90 minutes per 
session 
 
 
 
 
PTSD Checklist 
(PCL) 
 
End-of-treatment 
questionnaire 
 
Qualitative 
Focus group 
feedback 
BSI – significant 
decrease in mental 
health symptoms (p 
<0.01) 
 
PCL – significant 
decrease in PTSD 
symptoms (p <0.01) 
 
End-of-treatment 
questionnaire – 
overall helpfulness 
reported on 1-5 scale 
(mean=4.7, SD=0.54) 
 
 
 
Qualitative 
Themes – felt safe, 
supported and 
comfortable in groups 
 
assessments conducted by 
researchers outside of 
programme delivery team; 
good sample size  
 
Limitations: no follow-up; 
no control group; high 
attrition rate 
Baker, 
Harwood, 
Adams, Baker 
& Long 
(2014) 
 
UK study 
Observational 
before-and-
after study 
 
Prospective 
32 male adult 
participants  
 
Average age 35 
years 
 
Detained in low 
The Substance 
Misuse Group 
adopting a 
cognitive 
behavioural 
approach 
 
Pre and post:  
 
Stages of 
Readiness and 
Treatment 
Eagerness 
(SOCRATES) 
Repeated measures t-
tests: 
SOCRATES -
significant change 
found in Taking Steps 
subscale (p <.05) and 
Ambivalence subscale 
Strengths – inclusion of 
follow up period; multi 
methods of assessment 
including self-report 
psychometrics, 
physiological and 
behavioural reporting; 
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67% quality 
score 
secure hospital 
 
Referred for 
groupwork 
 
Individual sessions 
to support 
homework and 
consolidation of 
skills 
 
Programme 
structure and 
contact detailed in 
article 
 
4 groups delivered 
over a 16 month 
period.  A 
maximum of 8 
participants per 
group 
 
 
The Programme 
Evaluation 
Questionnaire 
 
 
Post treatment 
substance use – 
assessed through 
self-report, 
electronic notes 
and physiological 
testing 
 
(p =.05) 
 
Enjoyment of the 
programme and 
benefits gained rated 
as 7/10 or above in 
81% of participants 
100% (n = 32)  intent 
of abstinence 
expressed in self-
report measures, 
follow-up at one year 
confirmed abstinence 
by case notes and 
physiological testing 
in 81% (n = 26) 
 
provision of demographic 
information 
 
Limitations – no 
control/comparison group; 
limited sample size;  
individual sessions run 
concurrently potential 
impact on dependent 
variable    
Downsworth 
& Jones 
(2014) 
 
UK study 
 
42% quality 
score 
Mixed 
methods 
(quantitative 
and 
qualitative) 
 
Prospective  
10 adult male 
participants 
 
Age range 25-
49 
 
Detained within 
medium and 
low secure 
hospital 
 
The Addressing 
Substance Related 
Offending 
Treatment 
Programme 
(ASRO).   
 
CBT approach to 
substance misuse 
treatment adapted 
for use within 
Stage of Change 
Questionnaire 
(SOC) 
 
Barratt 
Impulsivity Scale 
(BIS) 
 
 
 
Multidimensional 
Paired samples t-tests 
comparing pre and 
post conditions: 
 
Significant increases 
found on the BIS 
Non-planning 
impulsivity subscale 
(p = 0.32) 
 
No significant change 
Strengths: mixed-methods 
design; range of measures 
to assess treatment 
outcomes; high completion 
rate 
 
 
Limitations: no 
control/comparison group; 
small sample size; no 
follow-up measures; 
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Referred by 
clinical team 
 
secure hospitals 
 
20 sessions 
delivered as a 
group intervention 
twice weekly, 2 
hours per session 
 
Programme aims 
described, no 
details of session 
structures 
Locus of Control 
(IPC LOC) 
 
Social Problem 
Solving 
Inventory (SPSI) 
 
Qualitative 
feedback relating 
to experience of 
the programme 
 
found on the IPC 
LOC 
 
No significant change 
found on the SPSI 
 
Key themes arising:  
enjoyment of 
programme, support 
of peers and relevance 
of content 
reliance on self-report 
data; no description of 
qualitative data analysis; 
no ethical considerations 
discussed 
Tibber, Piek & 
Boulter (2015) 
 
UK study 
 
63% quality 
score 
Observational 
before-and-
after study 
 
Retrospective 
80 adult male 
participants for 
stage 1 of 
treatment 
 
37 adult male 
participants for 
stage 2 of 
treatment 
 
Age range 19-
56 years with a 
mean age of 
34.93 years 
 
Detained in 
medium and 
Manual based 
group treatment to 
address substance 
use 
 
Takes a CBT and 
MI approach to 
increasing 
motivation to 
change substance 
use 
 
Delivered in 3 
stages; stage 1 
lasting 10 weeks, 
stage 2 lasting 16 
weeks and stage 3 
Alcohol and 
Other Drugs 
Knowledge 
Questionnaire 
(KNOW) 
 
Stage of Change 
Readiness and 
Treatment 
Eagerness Scale 
(SOCRATES) 
 
Treatment 
Motivation 
Questionnaire 
(TMQ) 
 
Pre and post 
intervention measures 
 
MANOVAS used 
where data was 
normally distributed 
(all measures with the 
exception of Change 
Ruler data) 
 
Wilcoxon Signed 
Ranks tests used for 
Change Ruler data 
Significant increase 
on scores on KNOW 
(p < 0.001) 
  
Strengths – large sample 
size; multiple measures 
used to assess range of 
treatment outcomes; 
appropriate statistical 
analysis used; manualised 
treatment approach; 
intervention described 
clearly; established 
psychometric measures 
used; 
 
Limitations – no control 
condition; reliance on self-
report data; lack of data 
from stage 3 of the 
treatment; high drop-out 
  45  
  
low secure 
hospital 
 
Referred by 
clinical team 
lasting 6-8 weeks 
 
Between 6 and 8 
participants in 
each group  
 
Effectiveness of 
Coping 
Behaviours 
Inventory (ECBI) 
 
Change Ruler 
assessment 
Significant increase in 
external motivation 
after stage 2 as 
indicated by the TMQ 
(p = 0.02) 
 
No significant effect 
of time in readiness to 
change found in 
SOCRATES 
subscales.  Significant 
main effect of drug 
type (p <0.05) 
 
No significant 
changes in ECBI or 
Change Ruler 
assessment 
 
rates; retrospective design; 
reliance on self-report 
measures; no follow-up 
measures included 
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Descriptive Data Synthesis 
Data was synthesised taking a narrative account from the thirteen studies meeting the 
inclusion criteria for the review.  Quality percentage scorings ranged from 42% to 
67%.  All studies included in the current review had research aims of exploring the 
effects of intervention for the dual diagnosis population in secure forensic settings.   
Participants 
A total of 1456 participants were included in the studies, 1188 of which were male 
(81.6%), 243 female (16.7%) and 25 gender not specified (1.7%).  Study samples 
were predominantly exclusively male (Baker et al., 2014; Downsworth & Jones, 
2014; Edwards et al., 2011; Miles et al., 2007; Morris & Moore, 2009; Oddie & 
Davies, 2009; Ritchie et al., 2004; Ritchie et al., 2011; Tibber et al., 2015), with two 
exclusively female samples (Long et al., 2010; Wolff et al., 2012), one mixed sample 
(Kesten et al., 2012) and one study where gender was not specified (Derry & Batson, 
2008).  Participant ages ranged from 18 years to 77 years, in the studies detailing age 
ranges.   It was not possible to calculate an overall average age due to missing data 
(Miles et al., 2007; Derry & Batson, 2008; Edwards et al., 2011).  Studies were 
predominantly conducted in the United Kingdom (84.61%), with the remainder 
conducted in the US (15.39%).   Figure 3 illustrates the forensic setting where 
intervention was undertaken.  Participation in intervention was either via referrals 
from professionals (76.92%) or through voluntary self-referral (23.08%).    
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Figure 3.  Intervention setting  
Intervention approach, session frequency and overall duration 
Intervention took a predominantly Cognitive Behavioural approach (69.2%) in 
included studies; 15.4% took an integrated CBT and Motivational Interviewing 
approach; 7.7% a Psychoeducational approach and 7.7% a Behavioural approach to 
treatment.  All intervention assessed was delivered in groupwork format, with a group 
size ranging from 4 to 12 members, where information was available.  Intervention 
length, where reported, ranged between 8 weeks to 14 months. Sessions were 
delivered on a weekly or twice weekly basis in all studies documenting session 
frequency, the most common mode of delivery being on a weekly basis.     
Methodological design and outcome measurement 
Table 3 presents the methodological designs for studies included in the 
review.  Ten of the studies included were prospective in design (Downsworth & 
Jones, 2014; Ritchie et al., 2004; Miles et al., 2007; Morris & Moore, 2009; Oddie & 
Davies, 2009; Long et al., 2010; Edwards et al., 2011; Ritchie et al., 2011; Wolff et 
01
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al., 2012; Baker et al., 2014) and three retrospective (Derry & Batson, 2008; Kesten et 
al., 2012; Tibber et al., 2015).   
  
Table 3   
Methodological designs of included studies  
Design Number of studies Study details 
Observational pre and post 6 Ritchie et al., 2004 
Miles et al., 2007 
Long et al., 2010 
Ritchie et al., 2011 
Baker et al., 2014 
Tibber et al., 2015 
Mixed methods 4 Downsworth & Jones 2014 
Morris & Moore, 2009 
Oddie & Davis, 2009 
Wolff et al., 2012 
Comparison group 2 Derry & Batson, 2008 
Kesten et al., 2012 
Qualitative 1 Edwards et al., 2011 
  
A variety of outcome measures were used to assess treatment outcomes.  
Assessment methods included self-report pre and post intervention psychometric 
measures, physiological testing methods, interviews, focus groups, feedback surveys, 
electronic patient records and criminal justice re-arrest data.  Figure 4 presents a 
summary of measures used within included studies.  Six of the thirteen included 
studies (46.2%) used single methods of outcome measurements as follows:  
• pre and post intervention psychometric self report measures were used solely 
in four studies (Long et al., 2010; Ritchie et al., 2004; Ritchie et al., 2011; 
Tibber et al., 2015) 
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• the use of a feedback form in one study (Edwards et al., 2011)  
• recidivism data in one study (Kesten et al., 2012).     
All other studies incorporated more than one method of assessment for 
intervention assessment as follows:   
• physiological testing measures were used in conjunction with pre and post 
psychometric measures (Miles et al., 2007)  
• readmission rates, interview and electronic notes relating to drug use (Derry & 
Batson, 2008) 
• pre and post intervention psychometric measures and semi-structured 
interview (Oddie & Davies, 2009) 
• pre and post intervention psychometric measures, semi-structured interview 
and physiological testing measures (Morris & Moore, 2009) 
• pre and post intervention psychometric measures and focus group (Wolff et 
al., 2012) 
• pre and post intervention psychometric measures and feedback activity 
(Downsworth & Jones, 2014) 
• pre and post intervention psychometric measures, electronic case notes and 
physiological testing measures (Baker et al., 2014)   
A benefit of methodological triangulation, made possible with the use of 
more than one method of measurement to assess intervention, is the ability to 
compare outcomes between methods to strengthen the validity of findings.   
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Figure 4. Summary of methods of measurement used in studies  
Study Outcomes 
All studies included in the current review indicated some measure of positive effect of 
substance misuse intervention for dual diagnosis in the secure environment.  The 
following sections will present findings as suggested in the articles reviewed.    
Attitudes towards substance use 
Six studies measured attitudes towards substance use in pre and post 
programme conditions.  Consistency was indicated in three studies in post 
intervention confidence to reduce substance use.  Long et al. (2010) reported 
significant improvements in self-efficacy towards reduction in substance use (p <.01) 
after completing intervention as indicated by the Drug and Alcohol Taking 
Confidence Questionnaire (Sklar & Turner, 1999).  Oddie & Davies (2009) found 
self-reported confidence to resist drugs significantly improved in four out of the eight 
situations measured (p <.05) in the Situational Confidence Questionnaire (Annis 
1998) following completion of intervention.  However, confidence to resist alcohol 
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only significantly increased in one situation out of eight (p <.05), indicating that 
intervention had more impact on attitudes towards drug use in comparison to alcohol.   
Ritchie et al., (2011) evidenced similar findings in the Drug and Alcohol Taking 
Confidence Questionnaire with a significant increase found in post programme 
confidence to refrain from substance use (p <.0005).   
Long et al., (2010) reported a significant reduction (p <.01) in perceived costs 
of changing behaviour towards substance use and significantly greater (p <.05) 
perceived benefits of change post treatment in findings from the Alcohol and Drug 
Taking Consequences Questionnaire.  Miles et al., (2007) reported an increase in 
beliefs of the need to change substance use indicated by a locally developed measure 
with more adaptive beliefs reported post intervention in the Beliefs About Substances 
Questionnaire, (Wright, Beck, Newman & Liese, 1993).  In addition, a reduction in 
reported marijuana cravings was found in the Marijuana Craving Questionnaire 
(Heishman, Singleton & Liguori, 2001) following completion of intervention.  The 
findings are reported descriptively as authors indicate that the small sample size (n = 
7) at follow-up restricted the use of statistical analysis.   
Qualitative findings from Oddie & Davies (2009), further support change in 
attitudes towards substance use following engagement in intervention.  Using 
thematic analysis to identify common themes arising from data obtained from semi-
structured interview, it was found that 67% (n = 6) of participants reported having a 
greater understanding of substance use impacting upon personal factors including 
mental health and offending.  Furthermore, 56% of participants (n = 5) acknowledged 
changes in substance cravings during the group.   
Morris & Moore (2009), using nonparametric Wilcoxon’s matched pairs 
signed rank tests to account for a small sample size, found significant improvements 
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on four of the eight thinking styles considered to foster a drug lifestyle; mollification 
‘justification of substance use behaviour’ (p =.046), cut-off ‘failed attempts to limit 
consumption’ (p =.012), entitlement ‘personal rights to have what is deserved’ (p 
=.011) and cognitive indolence ‘shortcut or easy way around something’ (p = .045) 
scales of the Psychological Inventory of Drug-Based Thinking Styles (Walters & 
Willoughby, 2000).  No significant differences were found on the remaining four 
scales.  In a thematic analysis of semi-structured interview information, 50% of the 
sample expressed confidence in changing substance use.  Ritchie et al., (2004) found 
significant differences in drug (p =.002) and alcohol knowledge (p =.017) at post 
treatment in locally developed measures.  Tibber et al., (2015) found a significant 
increase in Alcohol and Other Drugs Knowledge Questionnaire scores following 
completion of the psychoeducational phase of the programme (p <0.001).  In 
summary, all studies indicated some consistency in suggestions of attitudinal change 
towards substance use in post intervention measures.    
Impact upon substance use 
Substance use was measured in four of the thirteen included studies. Three 
studies provided consistency in findings towards indications of reduced substance use 
with one study not having any data in this respect to report.  Two studies employed 
objective measurements of substance use through urine drug screening.  One study 
tested abstinence through weekly urine drug testing, reporting 72% of programme 
completers testing as negative by the end of treatment (p =.043).  However, these 
changes did not appear to be maintained, no significant effect of treatment was 
indicated in six-month follow-up measures (Miles et al., 2007).   
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Baker et al., (2014) assessed abstinence from substances through physiological 
testing including breathalyser readings, urinalysis and blood tests in conjunction with 
patient self-report and electronic note recordings.  At one-year follow-up, twenty six 
out of thirty two participants (82%) who had expressed abstinence goals in 
intervention were self-reportedly abstinent, supported by physiological testing and 
electronic case notes.  A further study included urine testing measures completed in 
circumstances where staff reported concerns about potential drug related behaviour 
(Morris & Moore, 2009).  During the assessment period no programme completers 
were suspected by staff of accessing drugs, therefore, were not subject to urine 
testing.   
Derry and Batson (2008) measured post release substance use through 
electronic patient records and interviews with responsible medical officers with 
findings presented descriptively.   This study reported a lower incidence of substance 
use in the period following release in those who had completed treatment (50%) when 
compared with those who had not received treatment (74%).    
Impact upon rates of recidivism/readmission 
Two studies reported recidivism/readmission rates as outcome measures.  The 
findings of both studies suggest a positive impact of intervention upon rates of 
recidivism.  Derry and Batson (2008) using an independent sample t-test and 
Levene’s Test for equality of variance, found that intervention completers spent a 
significantly proportionally greater time in the community than those who had not 
completed intervention (p =.015).  Consistent with these findings, Kesten et al. 
(2012), found that in the six months following discharge from the secure 
environment, 13.6% of substance misuse intervention completers were rearrested, 
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compared with 28.2% who received treatment as normal.  Logistic regression analysis 
completed on the data from both groups indicated that age was the only variable with 
a significant association with rearrest (β = -.02, Wald = 7.14, df = 1, p < .01).  
Impact upon psychological functioning 
Study findings provide some consistency in suggesting a positive impact of 
intervention upon psychological functioning.  Long et al., (2010) when comparing 
mean pre-treatment scores with mean scores at six-month follow-up, found 
significantly fewer unmet needs in post treatment measures (t (17) = 2.64, p <.05) on 
the Camberwell Assessment of Need, Forensic version (Shaw, 2005).  Significantly 
reduced scores were found for Anxiety (t (18) = 2.94, p <.01) and Tension (t (18) = 
2.97, p <.01) on the Brief Psychiatric Rating Scale Expanded (Lukoff et al., 1986).  
Self-efficacy was found to significantly increase (t (18) = -2.90, p <.01) at follow-up 
as measured by the Generalised Self-Efficacy Scale (Jerusalem & Schwarzer, 1992).  
The research findings of Wolff et al., (2012) indicate further support for post 
treatment improvements in psychological functioning.  Using paired t-tests to 
compare pre and post intervention scores, they found a significant decrease in mental 
health symptoms (p <.01) measured by the Global Severity Index (ES = 0.47) and in 
PTSD symptoms (p <.01) measured by the PTSD Checklist (ES = 0.56) in post 
intervention conditions.   
However, Ritchie et al., (2011) found although self-esteem scores were 
slightly higher in post treatment measurement the differences were not statistically 
significant.  The authors note that group average scores reported fell within the 
‘normal’ range for this measure in both pre and post treatment conditions indicating 
that self-esteem was not a clinical concern in this group of participants.  Consistent 
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findings were reported by Tibber et al., (2015) with no significant increases indicated 
in confidence in coping strategies following treatment as measured by the 
Effectiveness of Coping Behaviours Inventory (Litman et al., 1984).  
Impact upon attitudes to change and locus of control  
Seven studies within the current review assessed the impact of intervention 
upon intention to change.  Three studies measured motivation to change using the 
Stages of Change Readiness and Treatment Eagerness Scale (Miller & Tonigan, 
1996).  Two studies reported similar findings on the ambivalence subscale.   Morris & 
Moore (2009) found a significant reduction on the ambivalence subscale (p <.047), 
with consistency in the findings of Baker et al., (2014) with repeated measures t-tests 
indicating a significant difference (p =.05) in ambivalence towards change.  
Additionally, in this study a significant change was also found in the taking steps 
subscale (p <.05), whereas, no significant change in this scale was found by Morris & 
Moore (2009).  However, using the reliable change index, a positive shift was 
indicated in post intervention scores across all three of the subscales, ambivalence (n 
=3), recognition (n=4) and taking steps (n =3).  When comparing pre and post 
intervention measures, Tibber et al., (2015) found no significant effect of time across 
any of the SOCRATES subscales, however, when comparing alcohol use with drug 
use, a significantly higher readiness to change was indicated in those using drugs (p < 
0.03).  In terms of motivation towards treatment, a significant effect of time was 
found in external motivation for treatment (p = 0.02) in the second phase of the 
intervention.   
  56  
The other four studies measuring readiness to change found no significant 
differences in change between pre to post measures completed (Downsworth & Jones, 
2014; Oddie & Davies, 2009; Ritchie et al., 2004; Ritchie et al., 2011).   
In terms of the impact of intervention upon locus of control, an individual’s 
expectation and willingness to take control over life events, three studies reported 
similar findings, with no significant differences in pre and post intervention scores 
(Downsworth & Jones, 2014; Ritchie et al, 2004; Ritchie et al, 2011) suggesting that 
intervention had little impact on locus of control.  However, in two of the three 
studies, the authors note that in both studies locus of control was significantly higher 
on internal measures in both pre and post programme conditions (p <.001) indicating 
that participants already perceived having control over their own life and substance 
use prior to commencing intervention.   
Intervention feedback and general satisfaction reporting 
Qualitative aspects of studies reported a number of arising themes relating to 
the participants’ experiences of intervention.  In all five studies incorporating 
qualitative findings, the group experience is reported as predominantly positive 
(Edwards et al., 2011; Downsworth & Jones, 2014; Morris & Moore, 2009; Oddie & 
Davies, 2009; Wolff et al., 2012).   
One study, using informal thematic analysis of semi-structured interview 
information (n = 4), found positive experiences of engaging in the group in treatment 
completers (n = 3).   Two participants reported perceived benefits of engaging in 
intervention towards changing future substance, one participant reported no intentions 
to change substance use and one participant did not complete intervention due to 
feeling vulnerable in the group (Morris & Moore, 2009).  In a second study (n = 9), 
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when asked to rate scores of how much the group had benefitted them on a scale of 0 
(no benefit) to 10 (huge benefit), the average score was 8.  Key benefits were 
identified as group formation and identification, the group atmosphere and learning 
from hearing about others’ experiences.  The most influential factor cited to be 
influencing current abstinence was incarceration.  Suggestions were made for 
programme improvement including increased focus on individual substances, 
additional sessions to enable further opportunity to consolidate learning and more 
external speakers.  78% of participants indicated that that they did not want carers or 
relatives to be involved in their treatment (Oddie & Davies, 2009). 
In the qualitative study reported by Edwards et al., (2011), five out of six 
participants reported finding the group enjoyable rather than useful with goal setting 
indicated as both the most enjoyable and least enjoyable aspect of the group 
experience.   Feedback indicated perceptions that goal setting was too repetitive but 
also of some value.  The contingency management aspect of the programme received 
positive or ambivalent feedback; education and skills training were rated the most 
useful elements of the programme; feedback towards facilitators was positive, as was 
group composition.  Sessions were generally felt to be too long and too regular (twice 
weekly).  Suggestions for future changes to the group included reduction of the 
emphasis on goal setting and increased emphasis on the implications of drug and 
alcohol use. 
Positive effects of treatment were indicated in the qualitative findings of Wolff 
et al., (2012).  In an end of treatment questionnaire, when asked to rate treatment 
feedback on a scale of 1 (not at all) to 5 (a whole lot), 75% or more participants 
reported intervention being helpful overall (mean = 4.7, SD = 0.54), helping with 
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trauma (mean = 4.4, SD = 0.78), helping with substance use (mean = 4.2, SD = 0.94), 
and learning safe coping skills (mean = 4.7, SD = 0.53).   
Methodological considerations  
Studies included within the current review achieved quality ratings ranging 
between 42% and 67%.  A number of research limitations were identified both within 
individual studies and in the body of research as a whole.  At the time of the current 
review, no randomised studies could be found assessing effects of dual diagnosis 
intervention in the secure forensic environment.  As such, all studies included in the 
review were non-randomised in design.  Furthermore, due to the limited availability 
of empirical research in this area, no studies were excluded from the current review 
on the basis of quality assessment.  In view of the identified need for intervention 
evaluation all available applicable research in the area was included.   
However, due to the inclusion of non-randomised studies the risk of 
systematic bias confounding findings is elevated.  Non-randomised studies have a 
higher risk of selection bias, attrition bias, detection bias and performance bias (Deeks 
et al., 2003).  Selection bias in non-randomised studies can arise as a result of 
participants being referred to intervention by clinical staff, therefore, the decision to 
treat is directly related to treatment outcomes which may in turn lead to bias in 
treatment effects.  A review of randomisation in healthcare trials suggested that the 
effect of not using randomisation or concealing allocation can have a potential effect 
size as large as the anticipated effects of intervention (Kunz, Vist & Oxman, 2007).   
Selection was not randomised for any of the studies included in the current 
review.  All participants were either referred to intervention by their clinical team or 
volunteered to participate with associated implications for selection bias.  In twelve 
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out of the thirteen included studies, participants were allocated to intervention with no 
comparison group treatment available.  In one study (Wolff et al., 2012) participants 
were able to volunteer for intervention if they met selection criteria rather than 
treatment as normal.  Randomisation or concealing allocation to a treatment group is 
challenging within secure settings and in the populations involved in the current 
review.  As previously discussed, treatment availability is limited, along with barriers 
to accessing intervention due to programme selection requirements in some settings.  
Therefore, random allocation of participants to treatment and comparison conditions 
would be difficult to achieve and could result in the withholding of treatment for a 
vulnerable population with serious ethical implications. 
Samples within included studies in the review were predominantly male 
(81.6% of participants), therefore, limiting generalisability of findings.  Additionally, 
sample sizes were small in the majority of included studies with only five studies with 
a sample size greater than 50 (Kesten et al., 2012; Ritchie et al., 2004; Ritchie et al, 
2011; Tibber et al., 2015; Wolff et al., 2012).  In one comparison study (Derry & 
Batson, 2008) the sample size of the treatment completion group was very small (n = 
6) limiting reliability of study findings (study quality rating 48%).  
With regards to detection bias, a number of different outcome measures were 
used to assess similar constructs between studies. For example, to measure motivation 
to change the following measures were used;  the Stages of Change Readiness and 
Treatment Eagerness Scale (Miller & Tonigan, 1996), the Stages of Change 
Questionnaire (McConnaughy et al., 1989), the Treatment Motivation Questionnaire 
(Ryan et al., 1995) and the Readiness to Change Questionnaire – Treatment Version 
(Heather, Luce, Peck, Dubar & James, 1999).  Although details are provided within 
studies regarding validity and reliability of scales measuring change in all studies, 
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different measures may have produced different results.  A lack of standardised 
measures used within studies has been noted to create difficulties when comparing 
constructs across studies.  
Furthermore, psychometric assessments used within two of the studies 
(Ritchie et al, 2004; Miles et al., 2007) included locally developed measures with no 
psychometric properties reported.  Additionally, a lack of information relating to 
normative samples for measure development was evident in studies.  Without the 
provision of this information, assessment of whether the measures used within studies 
are appropriate for the population in question is problematic. A further limitation is 
the limited detail relating to the administration of measures in pre and post treatment 
conditions.   All included studies lack details as to whether measures were 
administered by researchers, programme facilitators or staff independent of 
intervention delivery and research.  Neither were details provided regarding whether 
measures were administered individually or in a group environment and the time scale 
over which they were completed.   This lack of clarification makes assessment of 
appropriateness of measure administration challenging, with potential implications of 
researcher bias.    
Controlled trials provide the benefit of a comparison group against which 
intervention findings may be assessed.  Only two of the included studies had control 
groups (Derry & Batson, 2008; Wolff et al., 2012) making assessment of confounding 
variables problematic.  In the absence of comparison group findings assessment of the 
impact of intervention and impact of extraneous factors is difficult (Holloway, 
Bennett & Farrington, 2005).  Furthermore, the control group condition reported in 
Derry and Batson (2008) included treatment dropouts with associated implications for 
validity of findings, as this group have been indicated to have a higher risk of re-
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offending than those who have not been offered treatment (McMurran & Theodosi, 
2007).  
A further methodological limitation in a number of studies included in the 
current review is the lack of follow-up data.  An advantage of follow-up data is the 
opportunity to assess change over time, therefore, exploring longer-term effects of 
intervention.  Only four of the included studies provided follow-up data (Miles et al., 
2007; Derry & Batson, 2008; Kesten et al., 2011; Baker et al., 2014).  One of these 
studies (Kesten et al., 2011) measured recidivism in the six months following release, 
however, in a large scale 20-year follow-up study of outcomes after discharge for 
medium secure care, the mean time from discharge to reconviction was found to be 
3.2 years (Davies, Clarke, Hollin & Duggan, 2007).  This would suggest a follow-up 
period of six months an insufficient time frame in which to effectively assess 
recidivism.   
Incomplete data sets can increase the risk of attrition bias.  Incomplete data 
sets were reported in some studies, for example, one measure was not administered to 
the first cohort in research completed by Miles et al. (2007) due to the questionnaire 
not being devised at the start of treatment.  Furthermore, high attrition rates in some 
of the included studies may have confounded study findings.  Performance bias 
relates to non-standardisation of intervention, assessments and the recording of data.  
Although all studies included in the review followed structured guidelines for 
delivery, continuity between session content is unclear.  Some studies followed 
manualised guidelines, whereas, others followed a set structure for the delivery of 
intervention but without a manualised approach.  As such, variance between 
facilitators and group dynamics may have biased treatment outcomes. Studies with 
consistent facilitation teams throughout the whole of programme delivery may have 
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been more influenced by the treatment style of the facilitation team than those with 
diverse facilitation teams.  
Additional confounding factors potentially impacting upon study findings are 
the effects of previous related intervention completed and co-occurring individual 
intervention received alongside intervention being currently assessed.  Oddie and 
Davies (2009), Long et al. (2010), Ritchie et al. (2011) and Baker et al., (2014) all 
report the facilitation of individual sessions to support group intervention, therefore, 
the provision of additional intervention in an alternate mode of delivery may again 
influence the outcome of group intervention completed.  A complete absence in all 
included studies of specific details of previous associated treatment completed by 
study participants again potentially influences current study findings.   
The impact of the secure environment, where all studies were based, should be 
considered when evaluating findings from studies.  The secure environment typically 
restricts access to substances, especially in the medium and high secure settings where 
community leave is more limited and supervision levels are high.  In the study 
completed by Oddie and Davies (2009), the most influential factor cited for abstaining 
from substance was being detained in the secure environment.  The role of social 
desirability in responses (Saunders, 1991) may merit consideration, especially as a 
common goal in the secure environment is the desire to progress through detainment 
and work towards release into the community.     
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Discussion 
The current review aimed to explore the effectiveness of substance misuse 
intervention in adults with co-existing serious mental health problems and substance 
misuse problems in the secure forensic environment.  Thirteen studies were included 
in the review, six of which were observational in design, four used mixed method 
designs, two comparison group designs and one was based on a qualitative approach.   
The findings of the review are in agreement with previous literature indicating 
a paucity of research investigating dual diagnosis interventions in the secure forensic 
environment.  All available studies identified as a result of a variety of searching 
methods were included in the current review with no exclusion criteria based on 
experimental study design.  Rationale for including all identified studies was to 
provide the most comprehensive representation of interventions available and to 
indicate initial treatment findings within this area.   
The review presented mixed findings, with some provisional benefits 
indicated in substance misuse interventions in the secure environment for offenders 
with co-existing serious mental health problems.  These included indications of 
changes in attitudes towards substance use, in motivation to change, in reduction of 
substance use and reduction of risk behaviours likely to result in re-detainment in the 
secure environment.  Provisional benefits in psychological functioning were also 
indicated in several studies.  However, study findings were not consistent or 
comprehensive.  Findings of the included studies suggested that intervention did not 
change locus of control.   The methodological limitations previously discussed should 
be considered in terms of generalisability of findings to the wider population.    
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Strengths of the current review 
Despite the methodological limitations of the studies included, the current review has 
several strengths.  Search methods were robust and comprehensive with a number of 
databases searched across relevant disciplines in the field including psychological, 
sociological and medical databases, providing breadth to searches employed.  Search 
terms utilised were comprehensive, covering a diverse range of terms and spelling in 
order to capture any associated research that may have been appropriate to include in 
the review.  A number of reference lists of related articles were reviewed, with further 
potentially relevant articles identified and sourced.   Additionally, relevant journals 
were hand searched.  Contact was made with experts in the field, providing further 
opportunity for inclusion of relevant studies.  The current review has provided some 
insight into an under-researched area, highlighted as having significant need for 
evaluation and development.  The range of studies in the current review included a 
variety of secure forensic environments; high, medium and low secure hospitals and 
prisons.  Inclusion of this range of settings has provided a more representative view of 
the focus population for the review.    
Limitations of the current review 
Due to time and financial constraints the current review was limited to studies 
published in the English language.  This limitation may have introduced bias in the 
selection of studies included in the review and impacted findings.  Despite searching 
for unpublished research to include in the review, the author could not locate any 
studies outside of published literature.  The inclusion of exclusively published studies 
may have introduced publication bias into the review.  Furthermore, issues 
highlighted with methodological limitations and quality of included studies may have 
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impacted the findings of the current review.  Limitations included gender imbalance 
in samples, small sample sizes, high attrition rates, lack of control/comparison groups, 
variability in assessment measures, limited follow-up data and non-standardisation of 
intervention.  These factors have the potential to increase the risk of bias influencing 
study findings and negatively impact upon the ability to reliably generalise study 
results and findings to the wider population.    
Conclusions and recommendations 
Despite the limitations of the current review, findings appear to provide some insight 
into the impacts of substance misuse intervention for dual diagnosis in the secure 
environment.  Findings suggest a reduction in distress levels and improved 
psychological functioning in individuals who have completed intervention although 
conclusions should be tentative at this early stage.  Indications of changes in attitude 
towards substance use were suggested along with preliminary indications of 
reductions in both substance use and recidivism.  In consideration of the significant 
impact of dual diagnosis for both the individual concerned and potential victims of 
associated harmful behaviour, further investigation to inform and support 
development of intervention is recommended.  However, caution should be applied 
when considering generalisability of findings.  The current review was limited by the 
quality of studies included due to the lack of availability of related research in the 
area.   In order to effectively assess the impact of intervention and make 
recommendations for adaptations, follow-up data is required to investigate substance 
use once community exposure increases.  Furthermore, studies benefitting from a 
comparison or control group would provide more reliable evidence of change arising 
from intervention.   
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Further research is required for the continued development and assessment of 
treatment targeting co-existing substance misuse and serious mental health problems 
in secure forensic environments.  This is essential in working towards reducing risk, 
both in terms of potential harm to self and others and providing appropriate care 
required to work towards rehabilitation and improved life quality.  The literature 
reviewed within this chapter appears to indicate the current limited availability of, and 
diverse approaches to, substance misuse interventions developed for offenders with 
serious mental health problems, with mixed findings indicated for treatment efficacy.  
This reflects previous concerns raised within the literature regarding treatment 
provision operating at local levels taking a fragmented approach to treatment and 
lacking evidence supporting efficacy of the intervention (Durand et al., 2006).   
A more consistent approach underpinned by evidence based principles and 
empirical support is suggested as a more ethical and effective method to provide 
treatment to this vulnerable population.  The use of standardised, established 
measures would facilitate more reliable comparison between interventions and help 
with understanding whether specific models of treatment are more effective in 
meeting the needs of this population than other approaches and if so how.   As such, 
evaluations of the psychometric properties of measures used in assessment of 
problematic substance use and evaluation change are required to ensure that these 
psychometric tools are providing a comprehensive and reliable assessment of the 
concepts being measured.  As such, Chapter Three provides a critique of a 
psychometric measure widely used within the field of substance misuse treatment and 
used within several studies within the current literature review, the Stage of Change 
Readiness and Treatment Eagerness Scale (Miller & Tonigan, 1996).  
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CHAPTER THREE:   
CRITIQUE AND USE OF A PSYCHOMETRIC MEASURE:  THE 
STAGES OF CHANGE READINESS AND TREATMENT EAGERNESS 
SCALE (SOCRATES 8A/D) 
 
Introduction 
Motivation to change has been the subject of much discussion and investigation in 
recent years, especially within the field of problematic substance use.  Difficulties in 
engagement with treatment and treatment dropout have been associated with a 
number of adverse consequences including higher rates of reoffending (McMurran & 
Theodosi, 2007), increased severity of substance use problems and poorer 
psychosocial functioning (Palmer, Murphy, Piselli & Ball, 2009).  Particularly within 
the field of substance misuse treatment, poor treatment engagement and high attrition 
rates are suggested as a significant problem (Allen & Olson, 2015).  Treatment 
attrition is further compounded in those with co-existing severe mental health 
problems and substance misuse (Tull & Gratz, 2012).   Therefore, motivation to 
engage in treatment and a desire to change has been proposed to be a significant 
predictor of treatment outcomes (Miller & Rose, 2009). 
A number of theories relating to the concept of change are suggested within 
the literature base.  The Stages of Change transtheoretical model (Prochaska, 
Norcross & DiClemente, 1992) is arguably the most widely used in the field of 
substance misuse and behavioural change, underpinning much of the understanding of 
motivation to change problematic substance use (Prendergrast, Greenwell, Farabee & 
Hser, 2009).  The original model identifies five discrete stages of change that an 
individual is proposed to sequentially progress through when modifying behaviour.  
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Each stage builds upon the previous in increasing commitment to change.  The first 
stage of pre-contemplation is characterised by an absence of intention to make future 
changes to problematic behaviour.  The next stage is contemplation, where it is 
suggested that an individual will be considering change but has yet to make a 
commitment.  The third stage of preparation involves making a decision to change 
and plans to support decision making.  The action stage suggests that an individual 
will be actively modifying problematic behaviour and, during the final stage of 
maintenance, an individual will consolidate change and work to prevent relapse.  
Guidance of time frames and specific criteria of each specific stage is provided 
(Prochaska et al., 1992). 
The Stages of Change model initially proposed that individuals would 
progress discretely through each stage from initial stages through to final stages with 
no flexibility of movement between stages.  However, this model was subsequently 
modified to incorporate potential of relapse.  A spiral model was instead suggested, 
whereby, in the situation of relapse, an individual is proposed to revert to a previous 
stage rather than returning to an initial starting point.  The model indicates that an 
individual can only be in one stage at any one time.  This model is suggested as 
providing insight into an individual’s motivation and potentially informing treatment 
provision to address problematic substance use (e.g. Diclemente & Prochaska, 1998; 
Velasquez, von Sternberg, Dodrill, Kan & Parsons, 2005).  
However, the Stage of Change model has been subject to extensive debate in 
terms of utility and applicability in understanding change.  Burrowes and Needs 
(2009) raise concerns that the model is oversimplified, suggesting that change is a 
continuous fluid concept rather than a progression through discrete stages and that 
individuals may be likely to be in a number of stages at any one time.  A review of 
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Stage of Change model and problematic behaviours indicated that the data reviewed 
did not support exclusivity of stages and sequential movement through them (Littell 
& Girvin, 2002).  Cutoff boundaries between stages have been subject to criticism and 
the validity of the allocation of an individual to a specific ‘stage’ category questioned 
(Sutton, 2001).  Furthermore, this model is suggested as providing insufficient 
explanatory detail regarding readiness to change, with limited evidence to support the 
predictive power of the theory and under-emphasis of contextual factors in the role of 
change (Burrowes & Needs, 2009). 
The Stage of Change model was subsequently revised by Freeman and Dolan 
(2001) to incorporate additional stages to reflect the complexities of change, the 
awareness of the need for change and the collaborative process between an individual 
and treatment.  This revised model includes a noncontemplation stage to capture those 
who do not see a need for change and an anticontemplation stage to capture those who 
are actively aversive to changing behaviour and are being forced to seek treatment, 
for example, as part of a legal process.  These stages are followed by 
precontemplation whereby an individual will be starting to consider the costs and 
benefits of changing behaviour and contemplation where decisions about change are 
being made and a readiness indicated for this.  The action planning stage describes the 
collaborative process between an individual and treatment provider to plan for making 
change and the action stage refers to the active process of change being implemented.    
The revised model then introduces a further three stages to the process of 
change; prelapse, lapse and relapse.  Prelapse refers to the cognitions of the individual 
towards the changes introduced in the action stage and ambivalence towards the 
benefits of these changes when compared with the costs of changing behaviour.  
Lapse is suggested to occur when the dissonance between costs versus benefits 
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contributes to a brief return to the problematic behaviour.  At this point, if a resolution 
can be reached with the support of the therapist an individual will return to the action 
stage.  If the difference in cognitions towards change and behaviour cannot be 
resolved it is suggested that the individual will enter a relapse stage and will return to 
the problematic behaviour presented before treatment.    This revised model is 
suggested as a more dynamic approach to the process of change with the inclusion of 
additional stages capturing the complexities of this concept and, thus, providing more 
clinical utility (Dolan, Seay & Vallela, 2006). 
A number of measures have been developed to assess readiness to change 
including the Stages of Change Readiness and Treatment Eagerness Scale version 8 
(SOCRATES 8A/D) (Miller & Tonigan, 1996), the University of Rhode Island 
Change Assessment Scale (URICA) (Prochaska & DiClemente, 1992), the Readiness 
to Change Questionnaire (RCQ) (Rollnick, Heather, Gold & Hall, 1992), the 
Treatment Motivation Questionnaire (TMQ) (Ryan, Plant & O’Malley, 1995) and the 
Treatment Readiness Tool (TReaT) (Freyer, Tonigan, Keller et al., 2004).  
Furthermore, a variety of measures are available to specifically assess motivation in 
addressing substance misuse problems.  A critical review of measures assessing the 
concept of readiness to change including some of the above mentioned measures, 
indicated that no one measure was indicated as more effective in terms of clinical 
utility (Carey, Purnine, Maisto & Carey, 1999). 
The SOCRATES 8A/D is reported as a widely cited measurement of readiness 
to change (Burrow-Sanchez, 2014; Brubaker, Amatea, Torres-Rivera, Miller & 
Nabors, 2013) and a commonly used, ‘gold-standard’ measure of motivation (Kelly & 
Greene, 2014).  The current critique will review the Stages of Change Readiness and 
Treatment Eagerness Scale version 8 (SOCRATES 8A/D, Miller & Tonigan, 1996), a 
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measure specifically assessing attitudes towards changing alcohol and drug use.   The 
review will incorporate consideration of the psychometric properties of the scale, the 
development of the scale and it’s applicability for use in both clinical and research 
settings.  
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Overview of the measure 
The SOCRATES 8A/D is a 19-item self-report measure assessing readiness to change 
in those who misuse alcohol and drugs.  Version 8 of the measure was developed in 
1991 and is a short-form version based upon factor analysis conducted on previous 
versions.  The scale is designed to assess motivation to change and, additionally, 
provide a pre and post intervention measure of change.  There are two separate scales, 
one relating to alcohol use (SOCRATES 8A) and one to drug use (SOCRATES 8D).   
Both scales contain the same items, simply replacing the word ‘drinking’ with the 
words ‘drug use’ as applicable.   
The measure assesses readiness to change alcohol/drug use across three 
individual factorially-derived subscales; Recognition, Ambivalence and Taking Steps.   
The SOCRATES (8A/D) is a measure of interval level data.  The Recognition 
subscale has 7 items assessing acknowledgement that alcohol/drug use causes 
problems and a desire to change.  Scores for this subscale range from 7 to 35.  Higher 
scores on this subscale indicate higher problem recognition.  The Ambivalence scale 
has 4 items measuring the extent to which people wonder whether they are in control 
of their alcohol/substance use.  Scores for this subscale range from 4 to 20.  Higher 
scores indicate more uncertainty towards substance use.  The Taking Steps scale has 8 
items measuring the extent to which people believe they are already doing things to 
manage their alcohol/drug use.  Scores for this subscale range from 8 to 40.  Higher 
scores indicate that change is already taking place.  Each item is scored using a Likert 
scale ranging from 1 (No, strongly disagree) to 5 (Yes, strongly agree).  Total scores 
are interpreted against normative data.   
The measure was developed for use with those aged 19 years and over.  The 
scale is an experimental scale with no published manual guidelines.  Scoring and 
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normative data for interpretation of scores are available as online resources.  The 
measure has been adapted for use and tested in a variety of contexts amongst different 
populations. A two-factor model of the SOCRATES has been validated for use with 
adolescents who misuse substances (e.g. Hall, Stewart, Arger, Athenour & Effinger, 
2014; Maisto, Chung, Cornelius & Martin, 2003; Maisto et al., 2011).  The 
SOCRATES has been translated into other languages and validated for use in non-
English speaking populations (e.g. Chun, Cho & Shin, 2010; Demmel, Beck, Richter 
& Reker, 2004; Figlie, Dunn & Laranjeira, 2005; Yeh, 2009; Zullino et al., 2007).  
The measure has been used in offending populations (e.g. Brocato & Wagner, 2008; 
Prendergast et al., 2009) and within samples with co-existing substance misuse and 
serious mental illness (e.g. Zhang, Harmon, Werkner & McCormick, 2004). 
 
Self-report measures 
The measure is a self-report measure, requiring independent completion.  Self-report 
measures have the advantage of encouraging honest responses due to the direct nature 
of assessment.  The more complex interactions involved in an interview are suggested 
as having the potential to contribute to errors in measurement (Del Boca & Brown, 
1996).  However, conversely, self-report measures may be subject to response bias, 
whereby a respondee may attempt to present in a falsely positive or negative light, 
‘faking good’ or ‘faking bad’ (Weiner, 2003).  A further potential limitation of self-
report measures is the reliance on one source of data.   
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Psychometric properties 
Kline (2000) suggested that in order for a psychometric test to be considered robust it 
should meet a number of criteria.  Criteria include having good reliability, validity 
and appropriate norms.  The SOCRATES will be critiqued according to these criteria.   
 
Appropriate Norms 
The measure has been validated for use with an adult male and female clinical sample 
(n = 1672) (Project MATCH Research Group, 1993).  From this validation work, 
decile rankings were established to identify high, medium and low scores.  However, 
although the normative sample included both men and women, the majority of the 
sample was male (76%).  Furthermore, 80% of the sample was Caucasian, raising 
concerns regarding generalisation.   There is a lack of normative data for populations 
dually diagnosed with serious mental health and substance misuse problems or 
offending populations.  The scale authors advise against scale norms being applied to 
non-clinical samples due to validation occurring within a purely clinical sample.  
Additionally, this sample comprised only those abusing alcohol and did not include 
people with drug misuse.   This raises concerns regarding the utility of the tool with 
those misusing drugs.  
 
Reliability 
Internal Consistency 
Internal consistency examines how consistent all items of the scale are with one 
another and whether they measure a common concept (Hammond, 1995).  Internal 
consistency is measured through the extent to which scale factors and items correlate 
with one another.  Internal reliability is often measured using Cronbach’s alpha, with 
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higher alpha coefficients indicating that items are related to and consistent with one 
another.   
In the early stages of development, the measure included 32 items spread 
across four subscales.  Initial testing indicated mean alpha co-efficients of .72 for the 
overall scale, with the range for sub-scales between .67 and .90 (Miller & Tonigan, 
1996).  A short form 20-item scale was developed and administered as part of a pre-
treatment assessment battery in a large-scale multi-site clinical trial (n = 1672) of 
psychosocial treatment of alcohol misuse (Project MATCH Research Group, 1993). 
Good internal reliability for the Recognition scale was indicated, with mean alpha 
coefficients of 0.85.  Good reliability was also indicated for the Taking Steps scale 
with mean alpha coefficients of 0.83 reported.  Moderate reliability (a = .60) was 
indicated for the Ambivalence scale.  It is recommended that alpha coefficients need 
to have a minimum value of 0.70 (Kline, 2000; Nunnally, 1978) in terms of indicating 
acceptable reliability, therefore, the Ambivalence subscale did not meet minimum 
reliability requirements.   In a smaller second sample within the same clinical trial (n 
= 82), high internal consistencies were reported for all scales, 0.82 for Ambivalence, 
0.94 for Recognition and 0.91 for Taking Steps (Miller & Tonigan, 1996).   
Similar findings to the larger scale findings reported by the scale authors were 
reported in a study of 84 participants with co-occurring substance misuse and serious 
mental health problems.  High internal consistencies were reported for the 
Recognition (alpha coefficient = 0.91) and Taking Steps (alpha coefficient = 0.90) 
scales, however, again moderate reliability was reported for the Ambivalence scale 
(alpha coefficient = 0.60) (Carey, Maisto, Carey & Purnine, 2001).    Higher internal 
consistency was reported for the Ambivalence scale in a study of 390 patients with 
co-occurring severe mental illness and alcohol misuse issues (Zhang et al., 2004).  
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Findings indicated an alpha coefficient of 0.83 for the Ambivalence scale indicating 
increased support for reliability in this sample.  Zullino et al., (2007) investigated the 
internal reliability of a French translation of the SOCRATES administered to a 
sample of Swiss substance users.  Cronbach’s alpha values were 0.90 for Recognition, 
0.73 for Ambivalence and 0.91 for Taking Steps indicating good internal reliability 
for the measure.   
The inter-correlations between SOCRATES subscales indicate a small 
relationship between the scales.  The scale authors report that low positive 
correlations between the subscales indicate that scales are measuring distinct factors 
and that overlap is minimal.  Ambivalence has a weak relationship with Recognition 
(r = .03) and with Taking Steps (r = .03).  A modest relationship was identified 
between Recognition and Taking Steps (r = .33).  However, inter-correlation findings 
are not consistent.    Carey et al., (2001) report a higher positive correlation between 
the Recognition and Taking Steps subscales (r = .60).  A positive correlation was 
found between the Ambivalence and Recognition subscales (r = .49) suggesting some 
overlap between subscales. 
 
Test-retest reliability 
Test-retest reliability refers to whether similar scores are obtained from the same 
individual over a period of time in traits where stability would be expected or in the 
absence of intervention provision.  Kline (2000) highlights the importance of allowing 
a sufficient time lapse between tests to limit bias arising from subjects remembering 
previous responses and artificially inflating test retest reliability findings.  As such, a 
minimum of a three-month gap between tests is generally recommended for 
assessment of this type of reliability (Kline, 2000, p. 8).   
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However, readiness and motivation to change is identified as a dynamic 
construct (Miller, 1999) and, as such, is likely to be transient over time.  This can 
potentially result in difficulties in evaluating test retest reliability over longer periods 
of time as the opportunity for real change would need to be limited (Del Boca & 
Brown, 1996).  This could create difficulties in allowing sufficient time to increase 
reliability of findings whilst limiting opportunity for real change in attitude to occur.   
Test retest reliability was assessed during the Project MATCH trial in a 
second, smaller sample (n = 82).  Good test retest reliability was reported with 
intraclass correlations ranging from .82 to .94 (Miller & Tonigan, 1996).  However, 
due to the limited two-day time interval between test and retest conditions, potential 
recall effects are suggested as inflating results (Del Boca & Brown, 1996).  
Additionally, when considering these findings, it should be noted that the small 
sample size in this trial does not meet the recommended sample size of at least 100 in 
order to minimise opportunity for standard error (Kline, 2000). 
Carey et al., (2001) reported good temporal stability over an interval ranging 
from two to seven days, with test retest intraclass correlations of 0.82 for Taking 
Steps, 0.90 for recognition and 0.79 for ambivalence.  This would appear to suggest 
that the measure produces similar consistent results over a short-term period.  As with 
the findings of Miller & Tonigan (1996), the small sample size (n = 84) and limited 
time interval should be noted when considering these findings.   
 
Validity 
Face validity 
Face validity refers to the transparency of a test, whether the test actually appears to 
be measuring what it proposes to measure (Kline, 2000).   Clarity of item wording and 
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lack of ambiguity contribute to face validity.  However, whilst clarity of items is 
essential for this type of validity, the importance of not providing too much 
opportunity for impression management is also a key consideration. 
In order to improve face validity, the scale authors removed one problematic 
item during the development stages of the measure.  The removed item was ‘The only 
reason I’m here is that somebody made me come’.  It was felt that this item would be 
confusing for those having already completed treatment or for those not actively 
accessing treatment.  All items of the SOCRATES (8A/D) appear to correspond with 
the concept of readiness to change substance use.  Items are not overly long and do 
not have complex sentence structures, strengthening face validity.   
However, the context in which the measure is administered is not given 
consideration, potentially giving rise to confusion when using the measure within 
specific settings.  For example, use of the measure with detained samples (secure 
hospitals or prison environments) in those with no current access to substances may 
give rise to confusion in responding to items such as ‘My drinking/drug use is causing 
a lot of harm’ and ‘There are times when I wonder if I drink too much’.  It is 
suggested that temporal rewording of items or administration instructions could 
alleviate some of this confusion.  
Conflicting findings are reported regarding face validity when translating the 
measure into other languages.  A Brasilian study (Figlie, Dunne & Laranjeira, 2004) 
investigating the reliability and factor structure of the measure required translation of 
the measure into Portuguese.  Following translation it was reported that a number of 
the items were ambiguous and difficult for participants to respond to.  Conversely, 
when the measure was translated into French difficulties in terms of comprehending 
items were not reported (Zullino et al., 2007).  
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Concurrent validity 
Concurrent validity considers the extent to which a test corresponds to other tests 
measuring the same/similar variables.  The concurrent validity of the SOCRATES 
was investigated in a sample of military service members seeking treatment for 
substance misuse (Mitchell & Angelone, 2006).  Support for concurrent validity is 
indicated by the findings, with correlations found between SOCRATES subscales and 
subscales from the Addiction Treatment Attitude Questionnaire (ATAQ) 
(Morgenstern, Frey, McCrady, Labouvie & Neighbors, 1996).  The ATAQ is a self-
report measure assessing attitudes towards substance misuse treatment.   Effect sizes 
for correlations ranged from large to small (Pearson r > 0.5 to Pearson r > 0.1).  Large 
effect sizes were reported for the Recognition subscale of the SOCRATES and 
Powerlessness (r = 0.83), Commitment to Abstinence (r = 0.73), and Disease 
Attribution (r = 0.74) subscales of the ATAQ (Mitchell & Angelone, 2006).   
However, the sample in this study is limited to active duty military personnel with 
implications for generalization to wider populations.   An additional limitation of this 
study is the inclusion of only one other measure to assess concurrent validity.   
Findings of a study investigating psychometric properties of self-report 
measures in a dually diagnosed population indicated some consistency in responses to 
different measures (Carey et al., 2001).  Positive correlations were found between 
SOCRATES subscales and the Alcohol and Drug Consequences Questionnaire 
(ADCQ) (Cunningham, Sobell, Gavin, Sobell & Breslin, 1997).  The ADCQ is a self-
report measure assessing evaluation of the positive and negative outcomes of 
substance use. Positive relationships were found between the Taking Steps subscale 
and the cons of using subscale (r = .47) and the benefits of quitting subscale (r = .64).  
Negative correlations were found between Taking Steps and pros of using (r = -.45) 
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and costs of quitting (r = -.28).  However, the relative weakness of these correlations 
should be noted.  The Recognition subscale was found to have stronger relationships 
with cons of using (r = .69) and benefits of quitting (r = .70).  A limitation associated 
with this study is reported as the oral administration of the measures used.  In this 
respect, the measures were not administered according to standardised instructions, 
and, as such, may have influenced study findings. 
Chun et al., (2010) found correlations between scores from the three 
SOCRATES subscales and the Alcohol Use Disorders Identification Test (AUDIT) 
(Saunders, Aasland, Babor, de la Fuente & Grant, 1993), a ten item test developed as 
a collaborative World Health Organisation project for identification of alcohol related 
problems.   A positive correlation was found between Taking Steps and the AUDIT 
(.18, p < .05) and between Recognition and the AUDIT (.50, p < .01) and a negative 
relationship was found between the Ambivalence subscale and alcohol consumption 
measures (-.35, p < .01).  However, as previously mentioned, the weak range of the 
correlations should be considered. 
 
Predictive validity 
Predictive validity relates to how well a test predicts future behaviour in terms of the 
construct being assessed.  In secondary analysis of data investigating the effects of a 
harm reduction alcohol intervention in a homeless population, the predictive validity 
of the SOCRATES was indicated.  Collins, Malone and Larimer (2012) found a 
positive association between higher scores on the Recognition scale and higher 
alcohol consumption over a two-year follow-up.   A positive association was also 
found with Ambivalence scores and alcohol related experiences and symptoms 
indicative of alcohol dependence.  It is highlighted that although these findings may 
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appear contrary to what may be expected, findings fit with previous research 
indicating that upon initial problem recognition substance use may be exacerbated.  
The Taking Steps scale was indicated as predictive of lower alcohol intake and 
reduction in alcohol related problems at two-year follow-up (Collins et al., 2012).  
Further support was indicated for the Taking Steps subscale and alcohol use outcomes 
in a one year follow-up from discharge from residential alcohol treatment.  However, 
no other significant relationships were found between the other subscales and alcohol 
use outcomes (Bauer, Strik, & Moggi, 2014).  
Similar findings were indicated in a sample of medical inpatients with 
unhealthy alcohol use three months following hospitalisation (Bertholet, Cheng, 
Palfai, Samet & Saitz, 2009).  The highest scores of Taking Action were found to be 
predictive of a decrease in drinking IRR [95% CI] 0.42 [0.23, 0.78]).  Higher levels of 
problem awareness and recognition (third quartile) were associated with higher levels 
of drinking at 3 months follow-up IRR [95% CI] 1.94 [1.02, 3.68]).  However, an 
adapted two-factor structure of the measure was administered for this study; 
Perception of Problems and Taking Steps subscales (Bertholet et al., 2009).   
Mitchell and Angelone (2006) found a positive correlation between scores on 
the Recognition and Ambivalence subscales and length of stay in treatment. Higher 
scores on both scales were associated with more days spent in treatment indicating 
that an awareness of substance related problems and consideration of the costs and 
benefits of addressing these issues are beneficial for retention in treatment.   In a 
sample of 390 dually diagnosed participants, at 9-month follow-up from baseline, the 
Ambivalence scale of the SOCRATES significantly predicted alcohol use severity (p 
< .01) (Zhang et al., 2004).  
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In terms of predictive validity of the scale in relation to drug misuse, findings 
appear to be less consistent. Gossop, Stewart and Marsden (2006) investigated the 
associations between the SOCRATES 8D and drug use outcomes after receiving 
treatment (n = 1075).  At one-year follow-up, no significant relationships were found 
between the SOCRATES and drug use outcomes.   However, some support has been 
reported for the predictive validity of the Taking Steps subscale.  In a study of 
adolescents (n = 174) presenting for alcohol and drug misuse treatment the Taking 
Steps scale was found to significantly predict percentage of days abstinent at six-
month follow-up (p = .054) (Maisto et al., 2011).  Again, in this study, an adapted 
two-factor approach of the measure was used, Recognition and Taking Steps.   
Further support was indicated for the predictive validity of the Taking Steps 
subscale in substance misuse outcomes in an adolescent sample (n = 225).   A 
significant relationship between the Taking Steps subscale and percentage of days 
abstinent at 4 months follow-up was reported (Hall et al., 2014).  However, 
generalisation of these findings merit consideration, both being adolescent samples 
and, therefore, findings may not be representative of the adult population.  
Additionally, predictive validity was only found for the Taking Steps subscale, with 
no significant findings for the Recognition subscale.   
Mixed findings are reported by Napper et al., (2008) when investigating 
predictive validity of the SOCRATES 8D and substance use outcomes in a sample of 
drug users not currently accessing treatment (n = 377).  Length of time spent in 
treatment differed between the stages F(4, 372) = 6.24, p < .001., with those in the 
determination stage spending longer in treatment than those in other stages.  A 
difference was also found in general drug use over the previous 30 days F(4, 348) = 
5.32, p < .001., with those in the Action stage using less drugs than those in other 
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stages.    However, small effect sizes for differences in behaviour predicted by stage 
of change are reported (η = .06).  Furthermore, no significant differences were found 
between different stages of change and incidence of injecting drugs, or use of crack 
within the previous 48 hours.   
Use of the assessment within the forensic population has indicated some 
support in terms of predictive validity.  In a US study of 1708 records of offenders 
receiving community based treatment, during a twelve-month follow-up of 
commencement of treatment, higher scorers on the Recognition scale were reported as 
more likely to be re-arrested.  Those who scored highly on the Ambivalence scale 
were more likely to be arrested for a drug related crime, with those scoring higher on 
the Taking Steps scales being less likely to be arrested for a drug related crime 
(Prendergast et al., 2009).    
SOCRATES scores were found to be predictive of the amount of time spent in 
treatment in longitudinal research of 141 male offenders with substance misuse  
(Brocato & Wagner, 2008).  Higher total scores for the scale were associated with 
more days spent in treatment.  A significant relationship was found between 
Recognition subscale scores at treatment entry and retention in treatment, indicating 
that raised awareness and acknowledgement of a substance misuse may be predictive 
of engagement in treatment.  However, no significant relationship was found between 
the Ambivalence or Taking Steps subscales and length of time spent in treatment.   
 
Construct validity 
Dancey and Reidy (2007) highlight the relevance of factor analysis when evaluating 
the construct validity of a measure, emphasising the relationship between constructs 
and factors (p. 459).  Early stages of measure development incorporated four 
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subscales, each containing eight items. This was tested in a sample of 224 participants 
receiving treatment for substance misuse.  Factor analysis using alpha extraction with 
varimax rotation yielded 4 factors with several items loading significantly on two 
factors.  As such, it was identified that precontemplation and determination items 
loaded onto one factor, problem recognition.   
The SOCRATES version 3.0 was developed revising items loading onto two 
factors and further factor analysis completed with a clinical sample.  This yielded a 
clearer factor structure, with six items being amended.  Subsequent factor analysis (n 
= 125) identified two items requiring rewording to improve consistency, resulting in 
Version 5.0 of the measure.  From this, a short form 20-item scale was developed 
comprising the four strongest loading factor items from each scale.  This short form 
scale was tested in a large-scale multi-site clinical trial (n=1672) of psychosocial 
treatment of alcohol misuse.  Factor analysis using both orthogonal and 
nonorthogonal rotations revealed one item with low factor loadings.  This item was 
removed from the scale resulting in the current 19-item version of the measure.   
Support for the internal reliability of the three-factor model has been indicated 
amongst forensic populations.  Brocato and Wagner (2008) administered the 
SOCRATES in a longitudinal American study investigating treatment retention in 141 
substance-misusing offenders. Findings provided support for the internal consistently 
of the three-factor model with alpha coefficients ranging from .79 to .90  (Nochajski 
& Stasiewicz, 2005).  A number of further studies have indicated support for a three-
factor model including in dually diagnosed samples (e.g. Zhang et al., 2004), in 
forensic samples (e.g. Brocato & Wagner, 2008) and in clinical inpatient samples (e.g. 
Demmel et al., 2004). 
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Whilst some research supports a three-factor model, a two-factor solution has 
also been suggested.  A two-factor structure is suggested as a better fit for data in 
some populations, with the first factor combining the ambivalence and recognition 
scales and the second taking steps (e.g. Burrow-Sanchez & Lundberg, 2007; Figlie et 
al., 2005; Maisto et al., 1999).  As such, this adapted two-factor model has been tested 
and used in some studies of readiness to change (e.g. Bertholet et al., 2009a; Maisto et 
al., 2011).  It has been suggested that differences in factor structure may arise from 
difficulties in differentiating between Recognition and Ambivalence due to confusion 
arising from item content or due to overlap between the two concepts.  Furthermore, 
varying statistical analysis procedures used between studies may account for some 
differences in findings (Figlie et al., 2005).   
In terms of the most appropriate factor structure for the measure, it has been 
suggested that this may be dependent upon the type of population and the setting in 
which the scale is administered.  A three-factor model is suggested as more 
appropriate for populations seeking treatment in specialised substance misuse and 
psychiatric settings, whereas, a two-factor model may be more suited to those in more 
generalised settings not actively seeking treatment (Bertholet et al., 2009b).  
 
Content validity 
Content validation involves assessing whether a test is a comprehensive measure of 
the domain, whether it includes all facets of the construct that it proposes to assess 
(Hammond, 1995).  The SOCRATES was developed as a parallel measure to the 
URICA, based upon the Stage of Change transtheoretical model.  Miller (1987) 
identified a set of initial items for the scale which were reviewed by a number of 
professionals working in the substance misuse research field, for which feedback was 
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provided and adjustments made.    Each subscale was initially designed to correspond 
with four of the five separate stages of change as proposed within the Transtheoretical 
Model; precontemplation, contemplation, determination and action.  The maintenance 
stage was not represented in the scale at this point as the measure was initially 
designed for use only with those in early stages of presenting for treatment.  Version 3 
of the measure was revised to include the maintenance stage, therefore, incorporating 
all stages of the construct.    
However, factor analysis revealed a three-factor model with different stages of 
change combined within sub-scales of the SOCRATES.  As such, the scale authors 
acknowledge that the scale does not seem to measure the distinct, sequential stages of 
change as proposed by Prochaska and DiClemente (1992) and advised against using 
the original stage names.  Instead, it is suggested that the scale provides insight into 
understanding motivational processes underpinning change.  In a review of measures 
assessing readiness to change, Carey et al., (1999) reiterate that the scale does not 
directly replicate the original distinct stages identified within the Stages of Change 
model, rather just three scales incorporating items from the original five stages. It 
would appear that content validity issues correspond with the previously mentioned 
criticisms of the model.  This may support a more fluid view of change (Burrowes & 
Needs, 2009), that an individual may sit within a number of stages at any one time 
rather than be categorised into an exclusive clearly defined stage at any one time.      
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Discussion and Conclusions 
In summary, the SOCRATES (8A/D) is a widely used, well-established scale.  
Benefits include being relatively quick and easy to administer, as such, does not incur 
significant time or financial implications, lending itself well to both clinical and 
research settings.  It is used within a range of settings including psychiatric and 
forensic environments to help to further explore and understand a client’s readiness to 
make changes to alcohol and/or drug use.  It is an interval level data scale and 
normative data is available for interpretation of scores, albeit limited.  However, there 
is no published manual to guide administration, scoring and interpretation of the 
measure.  Additionally, the scale is described as an experimental measure and 
findings should be interpreted accordingly.   
Based upon the findings of this critique, research would appear to indicate 
moderate to good internal reliability for the measure.  Reliability findings for the 
Ambivalence subscale are not as consistent as those for the Recognition and Taking 
Steps subscales.  Some indications of test retest reliability for the measure are 
reported.  However, findings are limited by small sample sizes and very short time 
intervals between testing.  In terms of validity, mixed findings are reported.  Some 
support is indicated in the literature for the concurrent validity of the measure, with 
correlations found between the SOCRATES and other measures specifically assessing 
attitudes to changing substance use.  The weak strength of some of these associations 
should be noted when assessing concurrent validity.   
Predictive validity assessment of the measure has shown some promising 
findings, particularly in relation to alcohol use.  Information on face and content 
validity is limited resulting in difficulties in assessment of these areas.  In terms of 
construct validity, it would appear that there is some dispute in the literature as to 
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whether a three-factor or two-factor model is the most appropriate, with suggestions 
that this may be dependent upon the context in which the measure is administered.  It 
would appear that the measure does not completely correspond with the Stages of 
Change model from which it was developed, with distinct stages not represented by 
associated subscales.  In consideration of the criticisms levied against the notion of an 
individual being in a unique category (stage) at any one time, the measure would 
appear to challenge this notion too.   
The research base for the measure is varied both in terms of context and 
populations.  Contexts include clinical, non-clinical and secure settings.  Samples 
represented in the research include males and females, adults and adolescents, those 
with comorbid serious mental illness and substance use problems, alcohol users, drug 
users and multi-substance users.  The scale has been translated into a number of other 
languages, validated and used in several different countries.   The three-factor 19-item 
scale has been indicated to be more appropriate for use in psychiatric settings with 
people seeking substance misuse treatment.   
Research has indicated mixed findings, particularly in terms of validity.  
However, the scale has been identified as providing useful insight into client’s 
motivation and beliefs pre-intervention, during and following intervention. This 
insight into attitudes towards substance misuse problems and views on need for 
change may be beneficial for treatment providers to better understand clients and 
select appropriate treatment approaches (Carey, 2002).  Understanding readiness to 
change may be beneficial in working to build motivation both prior to engagement in 
treatment and continuing to develop this throughout treatment.   Whilst caution should 
be applied when interpreting findings of the measure considering the issues identified 
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within the literature relating to validity and reliability of the measure, the insight 
provided may be a very useful tool to support and enhance treatment.   
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CHAPTER FOUR:   
EFFECTIVENESS OF THE BEHAVIOURAL TREATMENT FOR 
SUBSTANCE MISUSE PROGRAMME IN A FORENSIC PSYCHIATRIC 
POPULATION:  A MIXED METHODS EVALUATION  
 
 
Abstract 
The link between serious mental health problems, comorbid substance use and a range 
of adverse consequences has been established.  Comorbid serious mental health 
problems and substance use lead to a range of negative impacts for a significant 
number of people.  There is a lack of treatment provision for this population within 
the forensic environment and the treatment available often lacks empirical support for 
effectiveness.  This mixed methods study aimed to evaluate a group treatment 
programme designed to reduce substance use in participants with a history of 
offending behaviour, serious mental health problems and/or personality disorder.  
Participants were residing in low secure, rehabilitation or community settings.    
Four self-report measures were used to assess change in a range of factors: the 
Stage of Change Readiness and Treatment Eagerness Scale (SOCRATES - 8A & 8D), 
the Drug-Taking Confidence Questionnaire for Drugs and Alcohol (Shortened 
Version) (DTCQ-8), the Internal, Powerful Others, and Chance Locus of Control 
Scale (IPC LOC) and the General Self-Efficacy Scale (GSES).  Measures were 
completed pre and post group intervention and further at six-month follow-up.  
Substance use was measured by urinary drug screening (UDS) results and self-report.  
A sample of participants engaged in semi-structured interview exploring their 
experiences of the programme.   
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Data meeting assumptions of normality was analysed using One-Way 
Repeated Measures Analysis of Variance comparing mean differences in pre, post and 
follow-up psychometric measures scores.  Data not meeting these assumptions was 
analysed using Friedman Page’s L and post hoc testing where appropriate.  Substance 
use was reported descriptively.  Results indicated a significant change in ‘taking 
steps’ towards reducing substance use after completion of the intervention, however, 
no other significant effects were found.  Qualitative data from semi-structured 
interviews was analysed using a thematic approach to establish emerging themes.   
Potential reasons for the results are considered as well as study limitations and 
directions for future research.   
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Introduction 
The significant consequences associated with comorbid serious mental health and 
substance misuse problems are well documented within the research literature 
(Barrowclough et al., 2013; Daff & Thomas, 2014; Elbogen & Johnson, 2009; 
Morgan et al., 2013).  Given the implications on the individual, on service provision 
and on society in terms of risk of harm, distress and financial consequences, the need 
for a response to this significant problem has been emphasised (Graham et al., 2001; 
McKeown, 2010).  Recent government best practice guidelines for improving mental 
health treatment responses incorporate supporting those with co-morbid substance 
misuse and mental health problems, in order to improve outcomes and reduce 
financial costs (Department of Health, 2012).  However, the complex and diverse 
needs of this population have led to challenges for treatment providers (Turning Point, 
2011).   
Three main approaches to the treatment of co-existing substance use and 
serious mental health problems in clinical populations have been identified within 
service providers; sequential, parallel and integrated treatment (Kavanagh & 
Connelly, 2009).  The sequential approach targets each problem consecutively, 
providing treatment for one disorder prior to providing treatment for another.  This 
type of treatment is suggested as more beneficial when the relationship between the 
disorders is clear.  However, as outlined further in Chapter one, identification of 
causal and temporal relationships is often unclear and complex within comorbidity 
(Gregg et al., 2007), and is, therefore, problematic for a sequential approach.  Parallel 
treatment targets both disorders concurrently, with intervention generally provided by 
different services. 
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A number of challenges have been suggested within the literature relating to 
both a sequential and parallel approach to treatment, including problems with 
treatment availability, treatment efficacy, service user experience and financial 
implications.  Barriers to accessing intervention have been identified, with assessment 
of moderate severity in one or both areas potentially excluding eligibility for 
treatment (Kavanagh & Connelly, 2009).  Additionally, treatment efficacy has been 
suggested as limited by differing goals and policies between agencies, along with 
ineffective communication and information sharing.  In the situation of treatment 
being provided by separate services and/or clinicians, the responsibility of integrating 
treatment has been noted to be placed on the service user, frequently described as 
already ‘struggling’ to manage complex difficulties (Mueser, Noordsy, Drake & Fox, 
2003).  Limited or ineffective linkage between service providers has been suggested 
as negatively impacting treatment provision (Havassy, Alvidrez & Mericle, 2009).   
Furthermore, a comorbid diagnosis has been noted as having excluded clients from 
treatment in some situations, creating the potential for an individual to fall outside of 
treatment criteria for both mental health and substance misuse services (Todd et al., 
2004).  In terms of financial implications, Baker et al., (2007) have suggested that a 
fragmented rather than an integrated approach to treatment elevates treatment costs, in 
addition to increasing stress for the service user.   A disjointed approach to treatment 
provision resulting in conflicting messages to those accessing intervention, has been 
identified as contributing to reduced motivation and disengagement from services 
(Barrett, 2009). 
Consequentially, an integrated approach to treatment is recommended, 
incorporating both substance misuse and mental health difficulties (Department of 
Health, 2008; Kavanagh & Connelly, 2009; Morisano, Babor & Robaina, 2014), with 
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the need to provide evidence-based interventions for the treatment of dual diagnosis 
emphasised (Department of Health, 2002).   Drake and Mueser (2000) note that in 
order for comorbid mental disorder and substance misuse treatment to be fully 
integrated, significant emphasis should be placed on the outpatient environment, as 
this is the context in which relapse is most likely to occur.  They suggest that a fully 
integrated approach to treatment should incorporate a range of factors including 
substance misuse and mental illness intervention combined with case management, 
close monitoring, community-based rehabilitation activities, secure and stable 
housing and medication.   
Whilst the evidence base for an integrated approach to the treatment of dual 
diagnosis in generic services is growing, the need for further empirical evaluation of 
both specific interventions and within integrated models of care is recommended 
(Sterling, Chi & Hinman, 2011).  As discussed in Chapter Two, evaluation of 
intervention addressing comorbid substance misuse and serious mental health 
problems in the general population has shown inconclusive findings.  Barrowclough 
et al., (2010) compared 164 patients attending an integrated dual diagnosis 
intervention incorporating cognitive-behavioural and motivational interviewing 
therapy with 163 patients receiving treatment as normal.  No significant differences 
were found at follow-up in a number of outcomes including hospitalisation, frequency 
of substance use or perceptions of associated negative consequences.  Increased 
readiness to change substance use was indicated upon completion of integrated 
therapy in comparison to treatment as normal, however, the difference was not 
significant or maintained at follow-up.  A significant reduction was found in the 
amount of substances used when consumed in the experimental condition suggesting 
some positive treatment outcome of this intervention.    
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Support has been indicated in community samples for more integrated 
approaches to the treatment of comorbid serious mental health and substance misuse 
diagnoses.  The Cognitive-Behavioural Integrated Treatment (C-BIT) programme 
(Graham, 2004) takes an integrated harm reduction approach to safer management of 
both serious mental health problems and substance misuse.  Significant improvements 
in treatment engagement were reported along with reductions in alcohol consumption 
and change in positive alcohol related beliefs over an eighteen-month period for 
clients attending this programme (Graham et al., 2006).  In systematic reviews of 
community non-forensic psychosocial treatments for comorbidity, mixed findings of 
treatment efficacy have been reported (Cleary et al., 2008; Hunt et al., 2014).  No 
single approach was identified as producing more effective treatment outcomes in 
terms of substance use or mental health.  However, a number of factors have been 
identified that potentially limit findings of these reviews, including differences in 
outcome measures used between studies, a lack of standardised approaches, poorly 
reported methodology and limited sample sizes.   
 
Treatment for forensic clients 
Treatment addressing comorbid serious mental health problems and substance misuse 
developed for the forensic population remains limited, both in terms of availability 
and empirical assessment.  The importance of effective treatment in reducing the risk 
of violent behaviour in individuals with co-existing mental health problems and 
substance misuse has been emphasised (Volavka, 2013).  Given the problems with 
treatment engagement experienced in this population as noted in Chapter One, this 
raises concerns.  Research has suggested that non-completion of treatment can 
increase risk factors for offending, with treatment attrition associated with heightened 
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risk of recidivism, especially when the treatment is community based (McMurran & 
Theodosi, 2007).  Poor levels of motivation to address risk factors and engage with 
treatment in turn have been found to be associated with non-completion of treatment, 
with potential to exacerbate risk.  Furthermore, even for those completing 
intervention, treatment outcomes may be negatively impacted by motivational 
problems, with learning less likely to be internalised along with limited recognition of 
the benefits of change (McMurran & Theodosi, 2007). 
The lack of treatment provision for substance misuse problems in forensic 
populations with serious mental health problems is highlighted within the literature 
(Derry, 2008).  An independent review of mental health provisions in the criminal 
justice system commissioned by the Department of Health (The Bradley Report, 
2009), found disconnected mental health and substance misuse services within the 
prison environment, with a dual diagnosis restricting access to services.  This report 
made recommendations for the urgent development of improved services for 
prisoners with dual diagnosis of mental health and substance misuse problems.  
Furthermore, limited availability of ongoing substance misuse and mental health 
treatment in the community, along with the fragmented nature of the treatment, can 
make the transition from the secure forensic environment to the community even 
more challenging.  
Derry (2008) emphasised the need for development and evaluation of dual 
diagnosis treatment within the forensic environment.  The results of a national survey 
of treatment for substance misuse in medium secure psychiatric care raised concerns 
regarding diverse and inconsistent approaches to intervention being used in situations 
outside of evidence from trials resulting in inadequate treatment (Durand et al., 2006).  
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A recent forensic mental health services report highlighted the lack of empirical 
research in this area and the need for development of the evidence base for dual 
diagnosis treatment in secure settings (Clark & Sandbrook, 2013).   
Several factors have been suggested as contributing to the limited provision of 
and paucity of empirical evaluation of comorbidity treatment in secure forensic 
settings.  It has been suggested that limited treatment provision may arise from 
service providers placing reduced emphasis on dual diagnosis as a treatment need for 
people detained in the secure environment, due to the more limited availability of 
substances and associated reduction in problematic behaviour within this environment 
(McMurran, 2002).  Consequently, treatment of co-occurring substance use with 
mental illness is not identified as a priority by secure services, with more focus placed 
upon other treatment needs.  Challenges to empirical assessment of interventions that 
are available, have been suggested to include difficulties in assessing treatment 
efficacy, with intervention outcomes measured prior to patients having unrestricted 
access to drugs and/or alcohol (Long & Hollin, 2009). As such, it has been 
recommended that treatment outcomes in the forensic environment include 
assessments of motivation, confidence, readiness to change and coping strategies, in 
order to ensure that measures are relevant to the environment (Swain, Boulter & Piek, 
2010).  
 
Behavioural Treatment for Substance Misuse (BTSA) (Bellack, Bennett & Gearon, 
2007) 
Behavioural Treatment for Substance Misuse (BTSA) is a structured, integrated 
treatment programme addressing substance misuse in individuals with serious mental 
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health problems.  The BTSA programme was developed to address the significant 
problems posed to the mental health system by substance misuse in the absence of 
substance misuse interventions for the severely mentally ill population (Bellack et al., 
2006).  The programme was designed to be part of an integrated treatment system for 
those with serious mental health problems and substance use (Bellack et al., 2006).  
Strategies which had been indicated as effective in substance users without mental 
health problems were tailored and integrated with strategies that had support of being 
effective when working with individuals with these problems.   
The programme employs a harm reduction approach to treatment rather than 
promoting total abstinence, in recognition of the difficulties people with serious 
mental health problems encounter when trying to achieve abstinence (Bellack et al., 
2006).  The effectiveness of a harm reduction approach to substance misuse treatment 
has been suggested in the literature (e.g. Graham et al., 2006; NICE, 2011).  It is 
suggested that this approach is also beneficial when treating dual diagnosis (Cleary et 
al., 2008), specifically in increasing engagement in treatment and limiting risk of 
treatment attrition through increased individualisation of treatment planning (Phillips, 
2010).    
 
A contingency management component of BTSA 
A key difference between BTSA and other substance misuse interventions offered 
within the forensic population is the contingency management approach of BTSA.  
This is a major component of the programme incorporated as both a treatment 
approach and as motivational reinforcement.  Best practice guidelines endorse the 
introduction of contingency management to the treatment of co-existing substance 
misuse and serious mental illness (NICE, 2011).  Kavanagh and Connelly (2009) 
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emphasised the importance of building and maintaining engagement in those seeking 
treatment for co-existing mental health and substance misuse problems.  The 
provision of external rewards, for example, contingencies including small monetary 
payments have been suggested as useful in building and maintaining engagement.  
However, the significance of the development of intrinsic motivation to change is 
highlighted in order for sustained maintenance of motivation.   
Some support is indicated within the literature for a contingency management 
approach to treatment of comorbidity.  In a study comparing contingency 
management in addition to treatment as usual in outpatients with comorbid serious 
mental illness and substance misuse, positive effects of the contingency management 
approach were indicated both during treatment and in the follow-up period (McDonell 
et al., 2013).  Participants within the contingency management aspect of the study 
were 2.4 (CI=1.9-3.0) times more likely to return a negative drug screen during the 
treatment period than those within the control condition.  Additionally, significantly 
fewer days of substance and/or alcohol use were self-reported in the contingency 
management condition following completion of the intervention.    
A randomised community control trial in the USA comparing BTSA with a 
psychoeducational group indicated that participants who had engaged in BTSA were 
significantly more likely to return negative drug screens, to complete treatment, have 
less subsequent inpatient admissions and reported increased life satisfaction (Bellack 
et al., 2006).  Meta-analysis of psychosocial interventions addressing substance 
misuse provided further support for a contingency management approach to 
intervention.  Within this review, Dutra et al., (2008) found highest effect sizes for a 
contingent approach to treatment.  Particularly high effect sizes were found for a 
combination of contingency management and cognitive behavioural therapy.  
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However, the very small number of studies included in the review taking this 
approach (n = 2) may limit generalisability of findings.    
 
Key underlying principles of the BTSA programme have been identified as:  
• the provision of a supportive and reinforcing treatment environment to help 
participants to manage any barriers to treatment  
• a motivational approach to managing substance misuse problems  
• a broad based treatment approach 
• integrated with other mental health services (Bellack et al., 2006)   
 
The BTSA programme includes six core components.  The first, a 
motivational interviewing approach aims to promote and increase readiness to address 
substance use.  Contingency management provides immediate behavioural 
reinforcement through rewarding attendance and negative drug and alcohol screening 
to encourage maintenance of this behaviour.  Structured goal setting enables 
identification of short-term, realistic goals to promote reduced substance use.  Social 
skills training is introduced to support group members in developing effective drug 
refusal skills and help to manage situations of stress and pressure.  Education about 
the implications of substance use, particularly when combined with mental health 
problems, aims to increase motivation to change.  Relapse prevention training 
promotes self-efficacy in helping clients to manage high-risk situations.  This 
combined approach to treatment is identified as producing significantly better 
outcomes than more standardised, limited approaches to treatment (Callaghan & 
Jones, 2010).  A repetitive, structured approach is used to facilitate the programme in 
order to accommodate the cognitive difficulties often experienced by those with 
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serious mental health problems (Bellack et al, 2006).    
Edwards et al., (2011) evaluated a treatment programme based upon the BTSA 
model delivered within a medium secure unit.   A qualitative approach was taken to 
this study to explore the perceptions of group attendees (n = 6) and facilitator’s 
reflections on the experience of the group.  A number of themes emerged including 
the significance of raising awareness of comorbid substance use problems within 
forensic psychiatric services, the challenges faced by staff in providing intervention, 
the strengths and weaknesses of the BTSA programme and the significance of the 
context in which intervention is provided.  The contingency management approach is 
noted to have been the source of some contention amongst staff, arising with concerns 
towards the perceptions of other service users not involved in the BTSA programme 
and the potential that token monetary rewards would be perceived as patronising by 
attendees.   This study concluded that a programme taking this approach to reduction 
of harm through substance use might not be completely suited for delivery within 
secure inpatient settings.   
 
The current research 
As discussed, despite the significance of the problem of dual diagnosis, both in terms 
of prevalence and associated consequences, a paucity of research investigating 
treatment effectiveness, especially within the forensic population is evident.  A recent 
meta-analysis reported the lack of primary research into the role of dynamic risk 
factors including substance misuse in therapies aimed at reducing risk of violent 
behaviour in adults with psychosis (Witt et al., 2013).  A limited evidence base 
assessing effectiveness of treatment of dual diagnosis is reported (Department of 
Health, 2009) with implications for clinical utility and cost effectiveness of treatment 
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being provided to service users.  Additionally, NICE guidelines recommend that 
treatment offered to young people and adults with comorbid serious mental illness 
and substance misuse problems should be evidence-based and designed to encompass 
both treatment needs (NICE, 2011).   
Within the forensic population evaluation of treatment provision is identified 
as lacking an evidence base and, consequently, ineffective and inconsistent treatment 
may be provided to vulnerable clients.  These concerns, in conjunction with the 
association between recidivism, combined mental illness and substance misuse, 
makes evaluation of substance misuse treatment provided for the forensic population 
with serious mental disorder a priority.   
A behavioural intervention was chosen for the current research as this 
treatment had been specifically developed for those with co-existing mental health 
and substance misuse problems.  The contingency management approach to treatment 
is not commonly used when working with those with additional difficulties of 
offending behaviour but has been indicated to have clinical utility when working with 
those with comorbid serious mental health problems and substance misuse (NICE, 
2011).  Behavioural outcomes of intervention were assessed through indications of 
substance use over the duration of the programme, through data gathered from UDS 
testing and self-report.  As such, the impact of intervention on substance use 
behaviour was evaluated within the research.  Whilst the programme takes a 
behavioural approach to changing problematic behaviour, building and maintaining 
motivation to change is identified as a core component of the intervention.  
Assessment of motivation to change behaviour, prior to undertaking intervention, 
immediately after completing intervention and after a follow-up period was 
incorporated into the study design to provide insight into the impact of intervention on 
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building motivation to change and whether any changes in motivation were sustained 
after completion of intervention.  As motivation to change is indicated as a key 
predictor of future substance use (e.g. Zhang et al., 2004) the inclusion of this 
assessment was considered relevant to the current research. 
To date, to the author’s knowledge, there is no published research available 
taking a mixed methods approach to evaluating the BTSA programme delivered for 
offenders with co-existing mental health disorder detained in inpatient secure settings 
and residing in community settings.   
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Research Aims and Objectives 
Considering the limited existing evidence available for treatment for individuals with 
co-existing serious mental health and substance misuse problems detained within 
forensic environments, the main aim of the present study was to evaluate using mixed 
methods the effectiveness of the BTSA programme in helping participants to 
minimise harm through reduction and safe management of substance use.  The 
programme aims of increasing self-efficacy and developing confidence in managing 
high risk situations were explored using validated psychometric measures 
administered at baseline, end of intervention and at six-month follow-up.  The 
empirical measurement of change was related to the programme goals and aimed to 
establish the efficacy of the programme in achieving the aims of changing motivation, 
attitudes and behaviour of participants towards substance use and increasing 
confidence to improve general functioning.  The research study therefore aimed to 
contribute to the evidence base informing future dual diagnosis treatment for the 
forensic population.  
Hypotheses 
In order to achieve the study aims, five quantitative hypotheses were tested: 
H1  It was predicted that there would be a significant difference in 
readiness to change following the intervention as measured by the Stage Of Change 
Readiness and Treatment Eagerness Scale shown by an increase in ‘recognition’ and 
‘taking steps’ scores and a decrease in ‘ambivalence’ scores between baseline, end of 
treatment and follow-up score   
H2  It was predicted that there would be a significant difference following 
the intervention in confidence towards controlling substance use as measured by the 
  105  
Drug Taking Confidence Questionnaire shown by an increase in confidence scores 
between baseline, end of treatment and follow-up scores 
H3  It was predicted that there would be a significant difference following 
the intervention in levels of general self-efficacy as measured by the General Self-
Efficacy Scale shown by an increase in scores between baseline, end of treatment and 
follow-up scores 
H4   It was predicted that there would be a significant difference in locus of 
control following the intervention as measured by the IPC Locus of Control scale 
shown by an increase in internal scores and a decrease in external scores between 
baseline and post and follow-up measures 
H5  It was predicted that there would be a significant difference in 
substance use shown by a decrease in positive Urinary Drug Screens, breathalyser 
results and self-reported substance use 
In addition, semi-structured interviews were conducted in order to explore 
participants’ experience of the programme including what they had enjoyed, what 
they had found useful, perceptions of the therapists and suggestions for improvements 
for the programme.    
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Study Methods 
The study was submitted for NHS ethical review and approval was received in March 
2015 from NRES Committee East Midlands – Northampton reference 15/EM/0051 
(see Appendix 8).  NHS R&D approval was received from both clinical locations for 
the study. 
 
Design 
The study used mixed methods (quantitative and qualitative) in order to explore the 
hypotheses and questions outlined above. A mixed methods approach has been 
suggested to provide a richer, more in-depth understanding of the subject of the 
research (Venkatesh, Brown & Bala, 2013).  Additionally, a triangulation approach to 
data collection has been recommended for increasing validity of research findings 
(Mathison, 1988).  Therefore, outcome assessments for the current study incorporated 
multiple measures including self-report measures, urinary drug testing and interviews. 
A mixed methods repeated measures programme evaluation design was adopted.  
Quantitative data was collected through administration of measures at three points 
from research participants, at baseline prior to commencement of the intervention, 
immediately at end of treatment and at six-month follow-up from baseline 
assessment.  Urinary drug screens were completed for each participant for every 
BTSA session attended where the participant was willing to provide a urine sample.  
Alcohol use was assessed during each session through the use of breathalysers where 
these were available; where breathalysing equipment was not available alcohol use 
was measured using self-report.  
The research study adopted a quantitative methodology to investigate 
attitudinal change following completion of the BTSA intervention and at follow-up.  
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Behavioural change as indicated by substance use was assessed throughout the 
intervention.  There was also a qualitative aspect to the research exploring themes 
arising from interview relating to participants’ experience of the programme.  A 
prospective approach to dual diagnosis treatment evaluation using appropriate 
longitudinal methodology has been recommended (McMurran, 2002).  As such, 
follow-up measures were included for attitudinal measures in the design of the current 
research.  However, due to the time constraints of the research project, collection of 
long-term outcome data beyond 6 months after treatment was not possible.   
A control condition for the research was considered as part of the design but 
deemed impractical as potential comparable participants (service users with serious 
mental health problems and substance misuse problems) were either receiving 
intervention or about to receive an intervention.  BTSA was the only structured 
substance misuse intervention available in the two locations being assessed, and, 
therefore, service users with substance misuse treatment needs assessed as having 
sufficient capacity to consent were referred to this programme.  As such, even if those 
delayed treatment entry were used as controls, it was likely that participants in a 
control condition would cross over into the experimental condition during the time 
period of the study, potentially invalidating the control condition and contaminating 
findings.    
 
Recruitment 
A sample size of 40 was planned for recruitment for the research. A priori power 
analysis indicated with alpha = 0.05, power = 0.80 and a repeat measures ANOVA 
with 40 participants would be able to reliably detect an effect size of f = 0.291 
(equivalent to a Cohen’s d = 0.6).  Participants were adult males (aged 18 years or 
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over) accessing low secure, rehabilitation and community forensic services.  All 
participants had a history of offending and aggressive behaviour.  Participants had co-
existing serious mental disorder and problematic substance use.   Referrals were made 
to the BTSA programme by the clinical or community team as part of a wider 
treatment plan and participation in the programme was voluntary.   Where participants 
experienced difficulties in understanding English, translation support was provided.  
Potential participants were assessed regarding capacity to consent to treatment prior to 
referrals being made by their clinical team.  All those referred to the programme were 
eligible to participate in the research and were given the opportunity to do so 
providing they were considered to have capacity to understand research requirements 
and provide informed consent to participate.   
 
The treatment intervention 
The intervention was delivered based upon a detailed procedure manual developed by 
Bellack et al., (2006).  Adopting a skills training approach to learning grounded in 
social learning theory principles, BTSA aims to increase motivation and confidence in 
participants to reduce future substance use.  The general approach to treatment is a 
skills training approach based upon behavioural rehearsal.  Each session follows a 
similar format and is highly structured.  A repetitive approach is taken to learning in 
response to the difficulties in cognition commonly experienced within this population.  
The treatment was designed to be integrated into a person’s overall care system and 
promotes joint working with other care providers/professionals.   The role of the 
therapist in treatment and the ways in which treatment can be tailored in response to 
individual clients’ needs are documented within the treatment manual.  Treatment is 
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delivered on a modular basis, with three individual modules defined, each of which is 
briefly summarised below.  
The social skills and drug refusal skills training module incorporates general 
social skills training and more specific drug refusal skills training with the main focus 
on developing effective drug refusal skills.  This module aims to increase participants’ 
abilities to interact with others and develop skills to make new social contacts.  It is 
anticipated that development of these skills will help in building a social support 
network that is drug-free and develop confidence to try new activities that do not 
involve drugs.  The second module, education about substance use and coping skills 
training, incorporates both didactic and interactive elements relating to consequences 
of substance use, biological theories of serious mental illness, the impact of substance 
on mental health symptoms and the impact of substance use on physical health.  
Within this module participants are encouraged to consider high-risk situations and 
triggers to substance use and develop strategies to escape or safely manage these 
situations.  The final module, relapse prevention and problem solving, introduces 
high-risk situations that clients are likely to face in the future and application of 
refusal, escape or avoidance coping skills or developing new coping skills to manage 
these situations.  Problem solving is actively encouraged to support the identification 
of safe options to manage high-risk situations. 
 
Training and support 
Treatment delivery was robustly monitored and supervised.  Staff delivering 
the treatment were experienced with working with clients with serious mental health 
problems and trained in delivery of the programme.   Each session was facilitated by a 
minimum of two and maximum of four members of staff.  Facilitators included a 
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forensic psychologist, a clinical and forensic psychologist, trainee forensic 
psychologists, assistant psychologists, nursing staff, Community Forensic Team staff 
and a peer facilitator.  All staff were supervised by a Senior Psychologist during the 
delivery of the programmes.  Planning sessions were completed in advance of each 
session delivery in order to ensure familiarity with session content, consider group 
dynamics and individual needs and allocate facilitation responsibilities.  Facilitators 
participated in debrief meetings following each session, spending time reflecting upon 
session delivery, group interaction and dynamics and development of facilitation 
skills.   
Sessions ran on average twice weekly for 90 minutes each, with programmes 
lasting between four and five months.  Programmes evaluated within the current 
research study had a minimum of 26 sessions and a maximum of 35 sessions.  
Sessions took place outside of the secure hospital units, with inpatients utilising 
approved leave in order to attend sessions.  This served to increase community 
contact and, as such, provided more realistic exposure to substances rather than being 
completely limited to the more artificial secure environment.  
Study hypotheses, design and methodology were informed by previous 
research findings (Bellack et al., 2006). 
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Outcome Measures 
Self-report measures 
Self-report measures were administered to research participants at baseline, end of 
treatment and at six-month follow-up to baseline assessment.  Standardised validated 
measures were used.  Measures were chosen to assess a range of attitudes and views 
to assess treatment outcomes related to key programme targets (e.g. confidence in 
coping, readiness and motivation to change, locus of control) and indicated as more 
amenable to change for participants detained within secure settings (Swain et al., 
2010).  Additionally, these measures assessed key theoretical conceptual factors 
related to predicting future substance use.  Considerable evidence has been reported 
supporting the predictive value of self-efficacy in substance misuse treatment 
outcomes (Kadden & Litt, 2011).  Research has suggested that self-efficacy towards 
managing future high risk situations is the strongest predictor of reduction in alcohol 
use (e.g. Ilgen, McKellor & Tiet, 2005; Moos & Moos, 2006) following treatment and 
a significant factor in the reduction of drug use post treatment (e.g. Hayaki et al., 
2007; Worley et al., 2014).   Meta-analyses of more general self-efficacy beliefs 
(Bandura and Locke, 2003) have indicated the predictive power of resilient self-
efficacy coping with stress and perseverance in managing difficulties.   Considering 
the indicated contribution of stress and difficulties in coping to the onset of co-
existing mental health and substance misuse problems as discussed in Chapter One, 
higher levels of broader self-efficacy would appear to be protective in managing 
future problems potentially contributing to substance use, in addition to specific self-
efficacy towards substance use.    
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Motivation and readiness to change has been indicated as a key treatment 
outcome predictor of substance misuse treatment within the theoretical literature base 
(e.g. Miller & Tonigan, 1996; Sobell et al., 1996; Zhang et al., 2004).   A high 
external locus of control has been indicated within the literature to have significant 
associations with continued substance use (e.g. Haynes & Ayliffe, 1991), with more 
internalised locus of control predicting better treatment outcomes for both drug use 
(e.g. Dekel, Benbenishty & Amram, 2004; Hall, 2001) and alcohol use (e.g. 
Blagojevic-Damasek, Frencl, Perekovic, Cavajda & Kovacek, 2012; Huckstadt, 1987; 
Soravia, Schlafli, Stutz, Rosner & Moggi, 2015).     
  
The measures used and psychometric properties were: 
1. The Stage of Change Readiness and Treatment Eagerness Scale (SOCRATES - 8A 
& 8D) (Miller & Tonigan, 1996) 
The SOCRATES is designed to assess an individual's motivation to enter substance 
misuse treatment and can be used as a post programme measure to evaluate progress.  
Two separate questionnaires, one for alcohol (8A) and one for drugs (8D) assess 
motivation to change across three subscales; Recognition, Ambivalence and Taking 
Steps.  Table 4 presented below describes concepts assessed within each of these 
scales.  The SOCRATES (8A/D) comprises 19 items and is a shortened version of the 
original Stage of Change Readiness and Treatment Eagerness Scale.  The 
SOCRATES was developed for use with the adult population, established within a 
sample of outpatients.  The SOCRATES (8A/D) is reported as having satisfactory 
internal consistency and reliability.  Table 4 presents subscale information and 
internal reliability scores.   (A full critique of this measure is provided in Chapter 
Three of the present thesis).  Participants were asked to complete the drug or alcohol 
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scale for their identified primary substance.   A positive treatment effect would be 
shown by an increased score on the recognition and taking steps subscales and a 
decreased score on the ambivalence subscale.  A copy of the SOCRATES 8A/D can 
be found in Appendix 9. 
 
Table 4  
SOCRATES subscale descriptions and psychometric properties (from Miller & 
Tonigan, 1996) 
Subscale Number 
of items 
Score 
range 
Internal 
consistency  
(Alpha) 
Description 
Recognition 7 7 - 35 .85 Higher scorers acknowledge 
problems relating to 
drug/alcohol use 
Ambivalence 4 4 – 20 .60 A higher score indicates 
uncertainty towards 
drug/alcohol use 
Taking Steps 8 8 - 40 .83 High scorers indicate that 
positive changes are already 
being made in drug/alcohol 
use 
 
2. The Drug-Taking Confidence Questionnaire for Drugs and Alcohol (Shortened 
Version) (DTCQ-8) (Sklar & Turner, 1999) 
The DTCQ-8 is a shorted version of the original 50-item Drug-Taking Confidence 
Questionnaire incorporating the Situational Confidence Questionnaire (Graham, 
1988).  Research supports the reliability and validity of this measure in assessing self-
efficacy towards controlling substance use (Sklar, Annis & Turner, 1997).  The 
shortened version DTCQ-8 assessing coping self-efficacy in 8 high-risk situations for 
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drug and alcohol users, is recommended for use in clinical samples for practicality of 
administration (Sklar & Turner, 1999). The DTCQ-8 has been developed for the adult 
population with drug and alcohol problems.  Good internal consistency reliability 
(alpha co-efficient .89) and a high correlation between total scores of the DTCQ and 
DTCQ-8 (.97) indicated that the short-version is a reliable substitute for the full 
version (Sklar & Turner, 1999).   The DTCQ has two separate questionnaires, one for 
drug use and one for alcohol use (see Appendix 10).  A positive treatment effect 
would be suggested by increased scores on this scale indicating increased confidence 
in managing high risk situations for substance use.  Participants were asked to 
complete the drug or alcohol scale for their identified primary substance.   
 
3. The General Self-Efficacy Scale (GSES) (Schwarzer & Jerusalem, 1995)   
The GSES assesses an individual's beliefs in their ability to cope with a variety of 
challenging situations (see Appendix 11).  High scores indicate high levels of self-
efficacy.  The GSES is an established, widely used scale, suitable for use with the 
adolescent and adult population.  The scale is suitable for use in clinical populations 
and appropriate for assessment of rehabilitation programmes (Schwarzer, 1995).  
Good scale validity and reliability is reported (Cronbach's alpha ranging from .76 to 
.90) (Schwarzer, 1995).  The findings of a large-scale assessment (n = 19 120) of the 
scale’s psychometric properties across 25 countries supported reliability, internal 
consistency for the whole sample was α .86 (Scholz, Gutiérrez-Doña, Sud, & 
Schwarzer, 2002).  A positive treatment effect would be suggested by an increased 
score on the GSES. 
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4. The Internal, Powerful Others, and Chance Locus of Control Scale (IPC LOC) 
(Levenson, 1973)   
The Internal, Powerful Others, and Chance Locus of Control scale takes a 
multidimensional approach to measuring the construct of locus of control, indicating 
whether this is more internalised or attributed to chance or to powerful others (see 
Appendix 12).  Higher perceived control of one's own behaviour indicates a more 
internalised locus of control, whereas, beliefs that behaviour is beyond personal 
control indicate a more externalised locus of control.  Locus of control is assessed 
across three subscales; internal, chance and powerful others.  Higher scores on the 
internal subscale indicate more perceived control over one’s own behaviour, with 
higher scores on the chance and powerful others subscales indicating a perceived lack 
of personal control over own behaviour.  The IPC LOC Scale is a well-established 
scale reported to be suitable for use among psychiatric patients.  The combined scale 
is reported to have acceptable validity and reliability (Levenson, 1973).  Table 5 
presents further scale details and psychometric properties.   
 
Table 5   
IPC LOC subscale descriptions and psychometric properties (from Levenson, 1973) 
Subscale Number 
of items 
Score 
range 
Internal 
consistency  
(Alpha) 
Description 
Internal 8 0 - 48 .67 Higher scores indicate more 
perceived personal control 
over events and behaviour 
Powerful 
Others 
8 0 - 48 .82 Higher scores indicate more 
perceived influence by 
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others over events and  
behaviour 
Chance 8 0 - 48 .79 Higher scores indicate a 
higher perception of chance 
influencing events and 
behaviour 
 
Semi-structured interviews 
At six-month follow-up to baseline assessment, research participants were invited to 
take part in a semi-structured interview exploring their experience of the group.  
Participation in this interview was optional.  All interviews were conducted by the 
author.  Questions focused upon participant perceptions of what they had found useful 
during the programme, aspects that they had particularly enjoyed, what could be done 
differently and perceived benefits of attending (see Appendix 13 for interview 
schedule).  
 
Behavioural data collection 
Behavioural data was collected from urinary drug screening results and breathalyser 
testing results, where equipment was available.  Due to lack of availability of 
breathalyser equipment, self-reported use of alcohol was recorded for four of the five 
programmes being evaluated.  This data was collected for all participants for the time 
period encompassing baseline data collection to programme completion.  
 
Attempts to Limit Potential Bias 
The researcher was not involved in programme delivery thus reducing potential for 
researcher opportunity and bias.   
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Procedure 
Recruitment and consent 
Potential participants were first approached by their clinical team to discuss 
programme details and obtain consent to participate in the programme.  Following 
this, the researcher along with a member of the clinical team approached programme 
participants to explain the purposes and requirements of the research. The researcher 
assessed participants’ ability to provide informed consent and where concerns were 
noted in this area in terms of impairment of understanding, these participants were 
excluded from the study.  Participant information sheets were provided to potential 
participants and the consent process explained (see Appendix 14). It was clarified 
with potential participants that participation in the research was voluntary and that 
there were no penalties for deciding not to participate in the research.  The right to 
withdraw from the research to the point where data was anonymised was explained, 
along with clarification that there would be no consequences for participants who 
chose to withdraw from the study. Participants were informed of their right to 
withdraw by the researcher both verbally and in writing. Participants were informed 
that withdrawal from the research study would not influence treatment and would not 
have negative consequences for participants. Written consent was obtained from all 
research participants prior to taking part (see Appendix 15). 
Administration of measures 
Initial self-report measures were administered to research participants during their 
first session of the BTSA programme and prior to any exposure to treatment.   
Participants were requested to identify their primary substance and complete the self-
report measures accordingly.  This information was verified with the clinical team.  
Each participant completed four measures at each time point:  the Stage of Change 
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Readiness and Treatment Eagerness Scale (SOCRATES), the Drug Taking 
Confidence Questionnaire (DTCQ), the General Self-Efficacy Scale (GSES) and the 
IPC Locus of Control Scale (IPC LOC).  The measures were administered to 
participants by the researcher or by the clinical team in a group environment and 
support was provided for literacy difficulties.  The same measures were administered 
to participants in the final session of the programme, again in a group environment 
and at six-month follow-up on an individual basis.  All measures were administered in 
a battery in counterbalanced order to limit fatigue, boredom effects and minimise 
bias.  Substance use data was collected during every session of attendance with the 
facilitation team completing a urinary drug screening for each participant, 
administering breathalyser testing where breathalysing equipment was available and 
collecting self-reported data.  At six-month follow-up from baseline, participants’ 
were invited to take part in a short semi-structured interview with the researcher to 
explore their experience of the treatment.  All interviews were completed at the 
corresponding clinical location by the researcher on an individual basis.  Participants 
were asked a series of questions relating to what had been enjoyable and useful during 
the programme, what they had not enjoyed, their interactions with the therapists and 
what could be improved about the programme.   
Quantitative and Qualitative Data Analysis Plan 
Quantitative data analysis 
Quantitative data analysis of information collected at baseline, end of treatment and 
follow-up was completed by the author of the current research using SPSS Version 21 
software (IBM Corp, 2012).  The independent variable was time tested at three stages; 
baseline, end of treatment and six-month follow-up.  The within subject factors were 
programme participants with repeated measures across the three time points.  Data 
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meeting normal distribution assumptions for parametric testing were analysed using 
six One-Way Repeated Measures Analyses of Variance evaluating the impact of the 
treatment on outcome measures (recognition of a need to change, ambivalence 
towards change, general self-efficacy and locus of control).   Non-parametric tests 
(Friedman Page’s L) were completed for two scales violating assumptions of normal 
distribution (taking steps towards change and self-efficacy towards substance use).  A 
significance level of .05 was used for all statistical tests.  In consideration of the 
mixed distribution of the data and limited power due to the small sample size, with 
the associated increased likelihood that individual differences would significantly 
impact on results, a more idiographic approach exploring individual trends within the 
data was then taken.   This multiple method approach to treatment evaluation has been 
recommended in previous research with similar populations (Oddie & Davies, 2009).   
 
Qualitative data analysis 
Brief, semi-structured interviews were conducted by the author at six-month follow-
up (n = 16).  Data collected from interviews was systematically analysed using a 
thematic approach.  Each transcript was analysed and arising themes identified 
through the recording of individual codes in the index to enable assessment of 
concepts and categories (Corbin & Strauss, 1990).  Once this procedure had been 
repeated for all transcripts, codes were then matched to identify main themes within 
the data.  Due to time constraints it was not possible to have the codes independently 
reviewed.  However, the thematic methods promoted by Braun and Clark (2006) were 
followed to in order to ensure robust analysis of data.   Any theme arising four or 
more times within interviews was presented in a table of findings using ‘In Vivo’ 
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coding, i.e. recording direct quotes from interviews in participants own terminology 
(Strauss, 1987).  
 
Ethical considerations 
The research was designed in a way to minimise potential risks to participants, with 
participants engaging in treatment regardless of their participation in the research 
study.  Measures used to collect data were not emotional in content and, therefore, 
were deemed unlikely to cause distress.  Diversity issues were identified and 
addressed with additional support provided where required.  For example, for one 
participant with English not his first language, translation support was provided for 
him whilst completing pre, post and follow-up measures and during the interview.  In 
order to minimise potential risk to the researcher, data was gathered in accordance 
with site safety procedures and debriefs were completed with clinical staff before and 
after collecting data.  Participation in the current research did not result in the 
provision of additional treatment or refusal to participate in the research did not result 
in the withholding of any treatment.  In order to maintain participant confidentiality 
data was stored securely at both clinical locations and once data had been collected 
documents linking individual data sets with participants names were destroyed in 
order to make data anonymous.  No identifiable information for any participant was 
included in the writing up of the research report.    
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Results 
Sample 
Only participants completing measures at all three time points (baseline, end of 
treatment and follow-up) were included in the current research as the purpose of the 
research was to assess the impact of treatment.  The final sample consisted of twenty 
participants completing measures at all three time points.  However, one of these 
participants only completed two of the four follow-up measures (DTCQ and GSES).  
A total of sixteen participants took part in semi-structured interviews.  Figure 5 
provides participants throughout all stages of the study.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Consort flowchart to illustrate participants’ flow throughout the stages of 
the study 
Approached to participate in the research  
N =46  
Agreed to participate in the research 
N = 27   
Completed end of treatment measures 
N = 21   
Completed 6 month follow-up measures 
N = 20  
(16 participants agreed to take part in interview)  
Refused to participate 
N = 19   
Did not complete treatment 
N = 6   
Did not complete follow-up measures 
N = 1   
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In terms of exposure to treatment for each participant, this varied between participants 
and programmes.  Overall participant attendance was high, on average, participants 
attended 87.95% (SD = 12.65) of available sessions, with only two participants 
attending less than 70% of sessions (see Appendix 16 for full details of exposure to 
treatment).   
 
Demographic Information 
All participants had a forensic history.  Index offences were predominantly violent 
offences (70%) including murder, attempted murder and manslaughter.   Other 
offence types included sexual offences (20%), possession of a weapon (5%) and arson 
(5%).  Further details of index offences can be found in Appendix 17.  Participants 
were either currently detained under sections of the Mental Health Act (1983 updated 
2007) or had been previously detained.  All participants had a diagnosis of mental 
disorder and co-existing substance misuse problems, either alcohol, drugs or both.  At 
point of entry into the intervention and research, the primary substance for each 
participant was defined with both the participant and with the clinical team.  At the 
time of commencement of participation in the research, participants’ ages ranged 
between 21 and 59 years (Mean = 41 years, SD = 10.8 years).   
Participants were residing in low secure conditions (50%), rehabilitation 
conditions (30%) or in community settings (20%).  Whilst attending the programme 
and during the follow-up period, all participants had access to community leave and, 
therefore, potential opportunity to access substances.  Participants attended the BTSA 
programme at one of two clinical sites, Northamptonshire or South London.  The 
current research evaluated five groups, three in London and two in Northamptonshire.  
Further participant demographic information can be found in Table 6 detailed below.   
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Table 6 
Participant Demographic Information 
 n Percentage % 
Psychiatric diagnosis   
Schizophrenia 12 60% 
Schizoaffective disorder 1 5% 
Bipolar affective disorder 1 5% 
Personality disorder 3 15% 
Dual mental health diagnosis 3 15% 
Primary substance   
Alcohol 7 35% 
Cannabis 7 35% 
Cocaine 5 25% 
Crack cocaine 1 5% 
Ethnicity   
White British 9 45% 
White Other 2 10% 
Black Caribbean 1 5% 
Black British 3 15% 
Mixed White British/Black Caribbean 4 20% 
Mixed White British/Black African 1 5% 
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Exploratory data analysis 
Comparison of baseline data for programme completers and non-completers 
Initially, mean differences in baseline measures for programme completers and 
programme non-completers were compared to identify any significant differences 
between the two groups.  Baseline data was tested using Kolmogorov-Smirnov (K-S) 
tests to identify whether the data met assumption of normality.  All baseline datasets 
were found to have normal distribution with the exception of the ‘taking steps’ 
subscale.  Therefore, all baseline scores for the two groups with the exception of the 
‘taking steps’ subscale were compared using Independent t tests.  No significant 
differences were found between the two groups as presented in Table 7.  As the data 
for the ‘taking steps’ subscale did not meet parametric assumptions, a Mann Whitney 
test was used to test data (see Table 7).  Mean baseline scores were higher for 
completers than non-completers, however, this difference was not significant (p = 
.604).  Therefore, all tests indicated that baseline data was not significantly different 
for those who completed intervention when compared with those who did not 
complete intervention.   
 
Distribution of treatment sample data 
Following completion of comparison of baseline data, prior to conducting statistical 
analysis, all pre, post and follow-up data for programme completers were tested using 
Kolmogorov-Smirnov (K-S) tests to identify whether the data was normally 
distributed (see Table 8).  The Stage of Change Readiness and Treatment Eagerness 
‘recognition’ and ‘ambivalence’ subscales, all IPC Locus of Control subscales and the 
General Self-Efficacy scale were found to have normal data distribution, facilitating 
the use of parametric testing.  The Drug Taking Confidence Questionnaire and the 
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Stage of Change Readiness and Treatment Eagerness ‘taking steps’ subscale were 
found to be significantly different to a normal population and, therefore, non-
parametric tests were used for these measures.  Table 8 provides a summary of 
findings from data analysis.   
 
Table 7 
Mean baseline scores for programme completers and programme non-completers 
Measure Completers 
Mean score (SD) 
(N = 19) 
Non-completers    
Mean score    (SD)     
(N = 6) 
p-value 
 
SOCRATES Recognition   
 
18.79   (6.696)  
 
24.83 (7.731) 
 
.076 
 
SOCRATES Ambivalence 
 
11.53  (4.087)  
 
14.50  (5.167) 
 
.157 
 
SOCRATES Taking Steps 
 
13.42  
 
11.67 
 
.604 
 
DTCQ 
 
69.25  (22.226) (n=20) 
 
53.75  (27.917) 
 
.17 
 
GSES 
 
32.05  (4.936) (n=20) 
 
30.33  (9.004) 
 
.546 
 
IPC LOC Internal 
 
34.68  (9.034)  
 
35.83  (6.585) 
 
.782 
 
IPC LOC Powerful Others 
 
23.37  (9.02)  
 
23.00  (12.391) 
 
.938 
 
IPC LOC Chance 
 
19.58  (9.436)  
 
26.17  (12.844) 
 
.184 
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Table 8 
Kolmogorov Smirnov Test Results 
Measure -Subscales Kolmogorov  
Pre  
 
Smirnov Z 
Post  
 
 
Follow-up  
 
SOCRATES (Motivation to 
change substance use)  
  Recognition 
 
 
.051 (n=19) 
 
 
.200 
 
 
.200 
  Ambivalence .171 (n=19) .200 .185 
  Taking steps .042* (n=19) .200 .027* 
DTCQ (Confidence in 
controlling substance use) 
 
.200 (n=20) 
 
.017*  
 
.011*  
GSES (General self-efficacy) .111 (n=20) .200 .200 
IPC LOC (Locus of control) 
  Internal 
 
.182 (n=19) 
 
.076 
 
.171 
  Powerful Others .070 (n=19) .200 .200 
  Chance .200 (n=19) .200 .200 
* p < 0.05 
 
 
 
 
 
 
  
  127  
Table 9 
Mean scores, standard deviations and results for all measures pre, post and follow-up intervention 
Measure n Baseline  
Mean    SD 
Post Programme  
Mean  SD 
Follow-up 
Mean SD 
Results  p-value 
SOCRATES -Stage of Change Readiness 
and Treatment Eagerness Scale 
   Recognition of problems 
 
 
19 
 
 
18.79  (6.70) 
 
 
16.89  (6.38) 
 
 
17.32  (6.27) 
 
 
F = 1.026 
 
 
.369 
   Ambivalence towards substance use 19 11.53  (4.09) 10.21  (3.91) 9.95  (4.60) F = 1.642 .208 
  Taking Steps towards change 19 32.84  (8.54)  30.95  (8.07) 35.37  (5.47) χ2 = 8.806 .012* 
DTCQ - Drug Taking Confidence 
Questionnaire 
20 69.25  (22.23) 76    (25.88) 78.81  (27.68) χ2 = 5.200 .074 
GSES -General Self-Efficacy Scale 20 32.05  (4.94) 32.05  (5.84) 33.50  (4.81) F = .786 .463 
IPC LOC – Internal, Powerful Others, 
Chance Locus of Control 
  Internal  
 
 
19 
 
 
34.68  (9.30) 
 
 
35.95  (8.44) 
 
 
37.05  (8.59) 
 
 
F = .565 
 
 
.573 
  Powerful Others 19 23.37  (9.02) 21.47  (10.29) 19.11  (11.69) F =  1.671 .202 
  Chance 19 19.58  (9.44) 18.37  (10.92) 17.37  (10.19) F = .463 .633 
* p < 0.05 
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Below, the results are reported and examined in relation to each of the five 
hypotheses tested. In order to aid clarity the five hypotheses are re-stated prior to 
reporting results for each. 
 
Hypothesis 1 
It was predicted that treatment would increase participants’ readiness to change as 
measured by the Stage of Change Readiness and Treatment Eagerness Scale. More 
specifically a statistically significant increase was predicted between baseline, post 
and follow-up Recognition and Taking steps subscale scores.  A statistically 
significant decrease was predicted between baseline, post and follow-up Ambivalence 
subscale scores.  
Recognition of problems associated with substance use subscale 
The results of the Kolmogorov-Smirnov (K-S) test showed that the data for the 
‘recognition’ subscale met assumptions for parametric testing (see Table 8).  A one-
way repeated-measures ANOVA was used to test differences in participants’ scores 
on the ‘recognition’ subscale between baseline, end of treatment and follow-up.  
Overall, no significant differences were found in ‘recognition’ scores F(2, 36) = 
1.026,  p = .369.   It was predicted that scores on the ‘recognition’ scale would 
increase between baseline and end of treatment measures indicating increased 
recognition of problems associated with substance use.  However, mean scores 
decreased between baseline and end of treatment measurement with scores at follow-
up remaining lower than baseline assessments (baseline mean scores =18.79, end of 
treatment mean scores =16.89 and follow-up mean scores =17.32) contrary to 
hypothesis predictions.   
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Ambivalence towards substance use subscale 
The results of the Kolmogorov-Smirnov (K-S) test showed that the data for the 
‘ambivalence’ subscale met assumptions for parametric testing (see Table 8).   A one-
way repeated-measures ANOVA was used to test differences in participants’ scores 
on the ‘ambivalence’ subscale between baseline, end of treatment and follow-up.  
Overall, no significant differences were found in ‘ambivalence’ scores F(2, 36) = 
1.642,  p = .208.   It was predicted that scores on the ‘ambivalence’ subscale would 
decrease between baseline and end of treatment measures indicating reduced 
ambivalence towards substance use.  Mean scores decreased between baseline and 
post programme measurement and decreased again at follow-up (baseline mean score 
= 11.53, post programme mean score = 10.21 and follow-up mean score = 9.95) in 
line with the hypothesis predictions even though not statistically significant.   
Taking steps towards changing substance use subscale 
The results of the Kolmogorov-Smirnov (K-S) test indicated that the data for the 
‘taking steps’ subscale did not meet assumptions for parametric testing (see Table 8).  
Therefore, Friedman Page’s L test was used to test differences in participants’ scores 
on the ‘taking steps’ subscale between baseline, end of treatment and follow-up.  A 
statistically significant difference was found in ‘taking steps’ scores χ2(2) = 8.806, p = 
0.012.  Post hoc analysis with Wilcoxon signed-rank tests was conducted with a 
Bonferroni correction applied, resulting in a significance level set at p < 0.017. 
Median (IQR) scores for pre, post and follow-up treatment conditions were 36 (28 to 
40), 31 (28 to 38) and 37 (32 to 40), respectively. There were no significant 
differences found between the baseline and end of treatment measures (Z = -1.479, p 
= 0.139) or between the baseline and follow-up measures (Z = -1.825, p = 0.068).  A 
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statistically significant increase in taking steps scores was found between the end of 
treatment and follow-up measure scores (Z = -2.589, p = 0.01) providing support for 
hypothesis predictions. 
Exploring individual case indications of clinical change  
Normative data is available for the SOCRATES based upon a sample of adults (n = 
1726) presenting for treatment for alcohol problems (Project MATCH) to enable 
interpretation of scores as high, medium or low relative to this sample (see Appendix 
18 for details).  Individual scores for participants completing all SOCRATES 
subscales (n = 19) were examined to identify clinical change within participants.   
Findings are presented below. 
Recognition of problems associated with substance use 
In comparison with the normative data, only one participant indicated clinical change 
from baseline to end of treatment scores, moving from very low range of problem 
recognition to the low range of recognition in line with hypothesis predictions.  All 
other participants remained consistently in the very low range across all time 
conditions.  Individual participant changes in scores from baseline to follow-up can be 
seen in Figure 6.   Figure 6 illustrates and confirms that for the majority of 
participants there was little change in recognition scores over the study period.  Very 
few cases showed more change e.g. 6; 7; 11 and 12, however, change was insufficient 
to move participants into different clinical ranges of problem recognition.     
 
Ambivalence towards substance use 
In comparison with the normative data, only four participants (21.05%) showed 
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clinical increases in indications of ambivalence towards substance use after 
completion of the programme and at follow-up.  The low levels of ambivalence 
indicated in baseline assessment for a significant number of participants (73.68%) 
provided little opportunity for clinical change in scores in the anticipated direction at 
end of treatment and in follow-up measures.  Eight participants (42.11%) indicated no 
clinical change in comparison with the normative data, remaining in the low or very 
low ranges of ambivalence over all three time points.  The remaining participants 
(36.84%) indicated clinical change in the anticipated direction, moving from higher 
clinical ranges in baseline assessments to lower ranges in post programme measures.  
Figure 3 provides an illustration of individual change on the ambivalence subscale.   
Taking steps towards changing substance use 
In comparison with the normative data, only three participants (15.79%) 
moved into a lower clinical range of taking steps towards addressing substance 
immediately after completing the programme.  A ceiling effect was observed for four 
participants (21.05%), scoring maximum points at baseline assessment.  For three of 
these four cases (5; 8; and 17), maximum scores were maintained immediately post-
programme, at follow-up or consistently over both time periods.  For the fourth case 
(13), scores remained in the high clinical range of taking steps towards changing 
substance use.  Two further participants did not demonstrate any clinically significant 
change in comparison with the normative data over any of the assessed time points.  
The remainder of participants either indicated positive clinical change immediately 
following the programme, at follow-up or consistently over both time periods.  Figure 
6 provides an illustration of individual change on the taking steps subscale.   
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Figure 6.  Individual scores at pre, post and follow-up for problem ‘recognition’ 
 
Figure 7.  Individual scores at pre, post and follow-up for ‘ambivalence’ 
 
Figure 8.  Individual scores at pre, post and follow-up for ‘taking steps’  
0510
152025
3035
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 20
Participants 
Pre Recognition scores Post Recognition scoresFollow-up Recognition scores
05
1015
20
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 20
Participants 
Pre Ambivalence scores Post Amibivalence scoresFollow-up Ambivalence sores
010
2030
4050
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 20
Participants 
Pre Taking Steps scores Post Taking Steps scoresFollow-up Taking Steps scores
  133 
Hypothesis 2 
It was predicted that treatment would increase participants’ confidence towards 
controlling substance use as measured by the DTCQ.  More specifically a statistically 
significant increase was predicted between baseline, post and follow-up confidence 
measure scores.  
The results of the Kolmogorov-Smirnov (K-S) test indicated that the data for the 
DTCQ did not meet assumptions for parametric testing (see Table 8).  Therefore, 
Friedman Page’s L test was used to test differences in participants’ scores on the 
DTCQ between baseline, end of treatment and follow-up.  Overall, no significant 
differences were found in DTCQ scores χ2(2) = 5.200, p = 0.074.  It was predicted 
that scores on the DTCQ would increase between baseline and immediately post 
group programme measures indicating increased confidence in self-ability to manage 
substance use.  Mean scores increased between baseline and post programme 
measurement and increased again at follow-up (baseline mean score = 69.25%, post 
programme mean score = 76% and follow-up mean score = 78.18%) in line with the 
hypothesis predictions even though not statistically significant.   
Exploring individual case indications of clinical change  
There are no normative data available or clinical cut-off guidelines for the DTCQ.  
Therefore, individual scores for all participants completing the DTCQ (n = 20) were 
examined on a case-by-case basis to observe any trends in scores increasing or 
decreasing between pre and post programme conditions.    
A case-by-case examination of the data revealed that only 3 participants (15%) 
decreased in indications of self-efficacy towards controlling substance use 
immediately after completion of the programme and again at six-month follow-up.  A 
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ceiling effect was observed for 3 participants, scoring 100% confident during baseline 
assessment.  Given that high levels of self-efficacy were consistent for these 
participants over all three time points there was no opportunity for increases in scores 
in post programme and follow-up measures.  The remaining participants were 
observed to increase in confidence towards controlling substance use either post-
programme, at follow-up or consistently over both time periods.  Individual 
participant changes in scores from baseline to follow-up can be seen in Figure 9.   
 
Figure 9.  Individual participant scores on the DTCQ at pre, post and follow-up 
assessments  
Figure 9 illustrates and confirms that for most participants; the confidence 
scores were relatively high to start with (as mentioned some had maximum scores) 
and showed little change over the study period. Only a few cases showed more 
change e.g. 14; 16; 18 and 20 and where changes were evident the pattern of change 
was mixed, however, in all cases of more change confidence towards controlling 
substance use was higher in post intervention assessment than in baseline assessment. 
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Hypothesis 3 
It was predicted that treatment would increase participants’ beliefs in their own 
abilities as measured by the General Self-Efficacy Scale.  Specifically a statistically 
significant increase was predicted between baseline, end of treatment and follow-up 
self-efficacy scores. 
The results of the Kolmogorov-Smirnov (K-S) test indicated that the data for the 
GSES met assumptions for parametric testing (see Table 8).    Therefore, a one-way 
repeated-measures ANOVA was used to test differences in participants’’ scores on 
the GSES between baseline, end of treatment and follow-up.  Overall, no significant 
differences found were in GSES scores F(2, 38) = .786,  p = .463.  It was predicated 
that scores on the GSES would increase between baseline and post programme 
measures indicating increases in participants’ self-confidence in their ability to 
manage a variety of different situations.  Mean scores remained consistent between 
baseline and immediately post programme measurements and increased at follow-up 
(baseline mean score = 32.05, post programme mean score = 32.05 and follow-up 
mean score = 33.50). 
Exploring individual case indications of clinical change  
There are no normative data available or clinical cut-off guidelines for the GSES.  
Therefore, individual scores for all participants completing the GSES (n = 20) were 
examined on a case-by-case basis to observe any trends in scores increasing or 
decreasing between pre and post programme conditions.   
A case-by-case examination of the data revealed that only four participants 
(20%) decreased in indications of general self-efficacy immediately at the end of 
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treatment and again at follow-up.   The remaining participants (80%) were observed 
to increase in confidence in their abilities to manage a variety of challenging 
situations either post-programme, at follow-up or consistently over both time periods.  
Individual participant changes in scores from baseline measures to follow-up 
measures can be seen in Figure 10.   
 
Figure 10.  Individual participant scores on the GSES at pre, post and follow-up 
assessments 
Figure 10 illustrates and confirms that for the majority of participants; change 
over the study period was limited with baseline assessment scores relatively high.  
The majority of individual case change indicated increases in self-efficacy and in the 
cases where decreases were indicated e.g. 1; 9; 15 and 17, reductions were limited.   
Hypothesis 4 
It was predicted that treatment would increase participants’’ internal locus of control 
and decrease external locus of control as measured by the IPC LOC scale.  More 
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specifically a statistically significant increase was predicted between baseline, post 
and follow-up internal subscale scores.  A statistically significant decrease was 
predicted between baseline, post and follow-up powerful others and chance subscale 
scores. 
The results of the Kolmogorov-Smirnov (K-S) test showed that the data for all IPC 
LOC subscales met assumptions for parametric testing (see Table 8).    Therefore, a 
series of one-way repeated-measures ANOVAs were used to test differences in 
participants’ scores on the IPC LOC internal, powerful others and chance subscales 
between baseline, end of treatment and follow-up.  Results are presented below for 
each IPC LOC subscale.  
Internal locus of control 
No significant differences were found in internal locus of control subscale scores F(2, 
36) = .565,  p = .573.  It was predicated that scores on the internal subscale would 
increase between baseline and immediately post programme measures indicating a 
more internalised locus of control.  Whilst findings were not statistically significant, 
mean scores increased between baseline and post programme measures and increased 
again at follow-up (baseline mean score = 34.68, post mean score = 35.95 and follow-
up mean score = 37.05) in line with hypothesis predictions.   
Powerful others 
No significant differences were found in powerful others scores F(2, 36) = 1.671,  p = 
.202.  It was predicated that scores on the powerful others subscale would decrease 
between baseline and immediately post programme measures indicating a reduction in 
participants’ perceptions of the influence of others over their behaviour.  Whilst 
  138 
findings were not statistically significant, mean scores decreased between baseline 
and post programme measures and decreased further at follow-up (baseline mean 
score = 23.37, post programme mean score = 21.47 and follow-up mean score = 
19.11) in line with hypothesis predictions.   
Chance 
No significant differences were found in chance scores F(2, 36) = .463,  p = .633.  It 
was predicated that scores on the chance subscale would decrease between baseline 
and immediately post programme measures indicating a reduction in participants’ 
perceptions of the influence of chance on their behaviour.  Whilst findings were not 
statistically significant, mean scores decreased between baseline and post programme 
measures and decreased again at follow-up (baseline mean score = 19.58, post 
programme mean score = 18.37 and follow-up mean score = 17.37) in line with 
hypothesis predictions.   
Exploring individual case indications of clinical change  
There are no normative data available or clinical cut-off guidelines for the IPC LOC.  
Therefore, individual scores for all participants completing the IPC LOC subscales (n 
= 19) were examined on a case-by-case basis to observe any trends in scores 
increasing or decreasing in post programme measurements.   
Internal subscale 
A case-by-case examination of the data revealed that only three participants (15.79%) 
decreased in indications of internalised locus of control immediately following 
treatment and again at six-month follow-up.  One participant remained consistent in 
scores over all three time periods.  The remaining participants increased in indications 
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of more internalised locus of control either post programme, at follow-up or 
consistently over both time periods.  Individual participant changes in scores from 
baseline to follow-up can be seen in Figure 11.   In comparison with baseline 
measures for indications of more external locus of control on the powerful others 
subscale (see Figure 12) and chance subscale (see Figure 13), internal locus of control 
subscale scores were higher for sixteen participants (84.21%) prior to commencing 
treatment.   
Powerful others subscale 
Only four participants (21.05%) increased in indications of perceptions of others 
influencing behaviour immediately following treatment and again at six-month 
follow-up. The remaining participants (78.95%) decreased in powerful others scores 
post intervention or at follow-up or consistently over both time periods.  Individual 
participant changes in scores from baseline to follow-up can be seen in Figure 12.  
Chance subscale 
Individual case examination of the data revealed mixed findings for perceptions of 
influence of chance on programme participants.   Eight participants (42.1%) had 
decreased in scores on the chance subscale immediately following programme 
completion with reductions maintained at follow-up.  A further two participants 
(10.5%) decreased in scores immediately post programme but reductions were not 
maintained at follow-up.  The remaining participants (47.4%) increased in scores 
either immediately upon programme completion or at follow-up.  Figure 13 illustrates 
individual change on the IPC LOC chance scale.   
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Figure 11.  Individual scores at pre, post and follow-up for internal locus of control  
 
 
Figure 12.  Individual scores at pre, post and follow-up for powerful others 
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Figure 13.  Individual scores at pre, post and follow-up for chance  
 
Hypothesis 5 
It was predicted that there would be a significant difference in substance use shown 
by a decrease in positive Urinary Drug Screens, breathalyser results and self-
reported substance use 
Participant’s alcohol and drug use throughout the duration of treatment was assessed 
through frequent urine drug screens (UDS), breathalyser testing and participant self-
report.  Urine drug testing was completed at the commencement of each session and 
breathalyser testing was administered at the same time where equipment was 
available.  However, due to the limited number of breathalysing equipment in good 
working order, consistent testing was limited to one programme only.  Of a total of 
308 breathalyser tests, all results were negative (100%).   Data gathered from urine 
drug screens and self-reported drug and alcohol use indicated that a large number of 
participants (75%) remained drug and alcohol free for the duration of the programme.  
Of the total urine drug screens completed for all of the programmes, only 0.91% 
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tested positive suggesting a positive effect of intervention on substance use.  
Appendix 24 presents details of substance use for the periods of the BTSA 
programmes.    However, there is no urine drug screen data available for participants’ 
substance use prior to starting treatment or in the period following treatment 
completion.  Therefore, it has not been possible to compare substance use during 
treatment to substance use prior to treatment or to assess whether any changes have 
been maintained.  
All participants in the current research returned negative urine drug screens on 
their first screening.  Of the participants who self-reported alcohol and/or drug use (n 
= 4) during the programme, reasons provided for this were; celebrating at Christmas 
(n = 3), feeling angry in response to perceptions of being attacked and belittled by 
others (n = 1), feeling angry (n = 1), in the company of peers drinking alcohol (n = 1) 
and feeling frustrated (n = 1).  In terms of the stage of treatment where drug or 
alcohol use occurred, this was varied.  Identifying trends in substance use in terms of 
stage of intervention is further complicated by inconsistencies in the duration of 
individual programmes, with treatment ranging between 26 and 35 sessions in length.  
In summary, it would appear that some support is provided for hypothesis 
five, however, findings are limited by the lack of breathalyser results and reliance on 
self-report and a lack of comparison data to identify change from pre to post 
treatment.   
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Qualitative results 
The qualitative interviews were analysed by the author using thematic analysis 
methods (Harding, 2013).  A thematic approach was taken to qualitative data analysis, 
using ‘In Vivo’ coding, participants own terminology (Strauss, 1987), to analyse data 
collected from interviews.   The main themes arising from analysis of interview data 
are presented in Table 10.  Themes were identified in terms of frequency of 
recurrence with those mentioned by four or more participants included as main 
themes.   
 
Table 10 
Main themes arising from semi-structured interviews (N =16) 
Themes ‘verbatim quotes’ 
 
‘….liked getting out of the 
hospital’ 
P1 ‘it was off the ward, that was a good thing’ 
P4 ‘Got off the ward, out of the grounds’ 
P6 ‘I liked getting out of the hospital’ 
P18 ‘I liked going out obviously, going to town on the 
bus’ 
‘…enjoyed learning’ P2 ‘It was informative, helped me to learn’ 
P4 ‘you got paid and you learnt – it was really good’ 
P6 ‘learnt a lot and enjoyed learning’ 
P17 ‘helped me to learn lots of new things’ 
‘enjoyed being paid’ P3 ‘enjoyed being paid’ 
P4 ‘you got paid and you learnt – it was really good’ 
P5 ‘It was good to get the money for attending’ 
P16 ‘they were really encouraging us to come to group 
by paying us’ 
‘…liked being in a group’ P10 ‘enjoyed the group comradeship, other group 
members’ 
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P3 ‘enjoyed meeting new people’ 
P17 ‘I liked being in a group’ 
P16 ‘being able to participate and integrate with others’ 
‘learning to say no’ P2 ‘learning to say no’ 
P5 ‘refusal skills, the whole process will be useful, for 
example, I might have found it hard to say no if 
someone wanted to come round and smoke weed.  
More confident now I would be able to refuse’ 
P17 ‘role play will help me to say no and walk away’ 
P14 ‘specific things like refusal skills helps me to refuse 
offers of illicit substances or alcohol in situations I’m 
in.  Had the opportunity to use my refusal skills, 
sometimes there are temptations but I refuse it firmly.  
Been really successful.’ 
P18 ‘just getting used to refusal skills – this will work 
for a lot of things in life.  It was more to get used to 
doing that….I realised that a lot of my refusal skills 
were quite basic so good to practice them a bit more.’ 
‘useful learning from each 
other’ 
P4 ‘useful learning from each other in the group’ 
P9 ‘good to listen to other people talk and share their 
experiences’ 
P10 ‘learning off other people, learning how you can 
beat addiction and have a normal life’ 
P16 ‘talking about each other’s lifestyles, what we are 
going to do in the future and we have done in the past’ 
‘…boost my confidence’ P1 ‘having the confidence to say to friends that I’m not 
going to smoke’ 
P2 ‘helped to boost my confidence’ 
P4 ‘my confidence in groups has increased and my 
socialisation skills have got better’ 
P5 ‘helped me to develop a relapse prevention plan for 
the community with realistic coping strategies –makes 
me feel fairly secure’ 
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P8 ‘feel more confident about the future after doing this 
course’ 
P14 ‘I feel more confident now in managing difficulties’ 
P15 ‘the group has made me more confident’ 
P17 ‘I feel like I can do it’ 
‘therapists…make it easy 
to understand’ 
P1 ‘therapists broke it down to make it easy to 
understand.  If you were struggling with understanding 
something they would take time to explain it to you’ 
P8 ‘therapists explained things well, clearly’ 
P3 ‘clearly presented’ 
P15 ‘very clear, lucid….they were very thorough in 
what they were doing’ 
P14 ‘able to explain things properly and make things 
clear to people who do not understand’ 
P18 ‘they were clear – gave instructions’ 
‘therapists supported us 
well’ 
P5 ‘They weren’t judgmental, I felt like I could speak 
freely and honestly’ 
P6 ‘the way they presented, confident, always listened 
to what people had to say’ 
P8 ‘they weren’t too serious or formal, made me feel 
quite at ease’ 
P9 ‘they tried to encourage people to talk about their 
experiences, they were supportive and offered support 
after the groups’ 
P10 ‘therapists supported us well’ 
P15 ‘therapists were very understanding’ 
P16 ‘therapists were very hospitable’ 
P17 ‘made me feel comfortable and looked after’ 
P18 ‘they encouraged people to take part and supported 
people’ 
P19 ‘they handled everyone differently, they were kind, 
polite, smiled’ 
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As illustrated in Table 10, within interviews the large majority of participants 
indicated that they had had a positive experience of BTSA and found it to be useful.  
It appeared that a number of varying factors had contributed to participants’ 
enjoyment of the group including leaving the hospital environment; being in a group 
situation with others with similar experiences and being paid.  Key themes arising 
regarding the most useful components of the treatment included developing refusal 
skills; learning from the experience of others and increasing self-confidence.   Only 
one participant indicated that he had not found the programme useful but attributed 
this to having recently completed a different substance misuse intervention at a 
previous hospital which he felt was more relevant to his individual needs.  A further 
key theme noted related to the responsivity of therapists to group members.  A 
number of participants suggested that they had found therapists responsive to their 
needs and supportive towards them.   
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Discussion 
The aim of the current study was to explore, using mixed methods, the efficacy of a 
specifically designed substance misuse treatment (BTSA) for offenders with serious 
mental health problems.  The need for further empirical research in this field has been 
emphasised within the literature, as discussed within Chapter Two and in the 
introduction to this empirical study.  Therefore, the current study aimed to contribute 
towards the research base informing future treatment within forensic environments for 
individuals with co-existing serious mental health and substance misuse problems.  
The main aim was to evaluate a structured substance misuse treatment through 
exploration of treatment outcomes relating to programme aims and key conceptual 
factors identified within the literature as relevant in predicting future substance use 
including motivation and readiness for change, self-efficacy (general confidence to 
deal with difficulties and confidence specifically relating to substance use), locus of 
control and substance use.  Treatment outcomes were assessed investigating within 
group changes using self-report measures, drug and alcohol use and information 
gathered from semi-structured interviews.  
  
Summary of findings 
The systematic literature review presented in Chapter Two indicated mixed findings 
in terms of treatment outcomes for identified studies assessing effectiveness of 
substance misuse intervention for offenders with serious mental health problems.  
These mixed findings are reflected within the current research study, with limited 
change indicated by quantitative evaluation although some suggestion of change from 
participant reports within qualitative findings overall.   
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Current research study findings and comparisons with previous research 
findings are discussed below in relation to each key concept measured.   
 
Readiness for change 
Hypothesis one predicted that treatment completion would increase readiness to 
change in programme participants as measured by the SOCRATES.  There was one 
significant change found in readiness to change in the present study; a significant 
increase (p < .05) was found in indications of ‘taking steps’ towards managing 
substance use in post programme assessments.  This outcome indicated a positive 
effect of treatment on making active changes in substance use.  These findings are in 
accord with previous research of Baker et al., (2014) who also found significant 
increases (p < .05) for the ‘taking steps’ subscale following substance misuse 
treatment.   The positive treatment effects of increased scores in taking steps towards 
managing substance is supported by previous research which has indicated higher 
scores on the ‘taking steps’ subscale to be predictive of making effective changes to 
substance misuse (Bauer et al., 2014; Collins et al., 2012).  
Previous research has suggested that, due to the confines of the secure 
environment, difficulties in completing methodologically robust research within these 
parameters and the complexities of both the environment and the individuals detained, 
individual case indication of change may be beneficial when assessing treatment 
outcomes (Long, Fulton & Hollin, 2008).  In terms of individual clinical change for 
taking steps towards changing substance use, indications were positive in movements 
on this scale with the majority of participants either remaining within a consistent 
clinical range over all three time points or moving into a higher range in post 
programme conditions.  Only three participants indicated change in a negative 
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direction, moving to lower clinical ranges after treatment completion.  This again 
suggests a positive effect of treatment on participants’ readiness to make changes to 
their substance use.   
Baseline assessment scoring was relatively high, with almost half of the 
sample (47.37%) scoring within the high or very high clinical range for ‘taking steps’ 
towards changing substance use.  This would appear to suggest that motivation within 
the current sample was high and that a number of participants considered themselves 
to already be taking active steps to address substance use difficulties prior to 
commencing treatment.  In view of the voluntary nature of participation in the 
treatment programme and the current research, it could be hypothesised that group 
members with lower motivation and confidence towards reducing substance use 
elected not to engage in treatment or to participate in the research.  Those who 
volunteered to participate presented with relatively high levels of motivation and 
confidence prior to engaging in treatment.  
No significant differences were found in post programme recognition of 
problems associated with substance use or ambivalence towards substance use scores.  
Problem recognition scores decreased immediately following programme completion 
and again at follow-up, potentially indicating a negative effect of treatment on 
participants’ ability to recognise the negative impact of substance misuse.  Individual 
examination of the data revealed that only one participant demonstrated clinically 
significant change, with all other participants remaining within the very low clinical 
range of problem recognition.  Similar findings to those of the current research study 
are reported by Rice, Hagler and Tonigan (2014).   Problem recognition as indicated 
by the SOCRATES decreased once participants had made changes to reduce 
problematic drinking, suggesting that responses to these items were influenced by 
  150 
personal views.  For example, whether someone still considered themselves to be 
classified as ‘alcoholic’ once they were abstinent was suggested to be influenced by 
individual beliefs.  Item level analysis of measurement properties was recommended 
for future research in order to evaluate wording and interpretation of individual items 
in the measure (Rice et al., 2014).  
Several factors may explain the findings for problem recognition within the 
current study.  Firstly, it may be that treatment had no effect or a negative effect on 
participant’s motivation or abilities to recognise problems associated with substance 
use.  An alternate explanation may be that, for participants detained within secure 
settings, identification of current problems could be perceived as detrimental for 
progress, as discharge to community settings is contingent on progress in treatment.  
Therefore, this demand characteristic may have influenced participant responses in 
terms of minimising the experience of current problems.    
Furthermore, the normative population for the SOCRATES may have 
restricted opportunity for clinical change in the current sample.  Normative data for 
the measure was developed from a clinical sample, however, the population within 
the current study had a range of co-occurring clinical problems.  All participants 
within the current research study had substance misuse problems and mental health 
problems, some dually diagnosed mental health problems, in addition to forensic 
difficulties.  Therefore, in view of the significant difficulties experienced within the 
sample of the current research, clinical ranges provided by the normative sample may 
not have been representative of this particularly troubled population.  Previous 
research has suggested that interpretation of clinical change in functioning through 
comparison to normative data may not be appropriate or representative for all 
psychiatric disorders (Jacobson & Truax, 1991).     
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A further possible explanation of these findings may be the psychometric 
property limitations of the ‘recognition’ subscale as discussed in Chapter Three.  It is 
suggested that problems with face validity of specific items within this subscale may 
have contributed to these findings.   Temporal wording of a number of items, for 
example, ‘If I don’t change my drinking/drug use soon, my problems are going to get 
worse’ and ‘My drinking/drug use is causing a lot of harm’ appeared to be confusing 
for participants already receiving treatment with a number seeking clarification for 
several items within this subscale when completing the measure.  This is supported by 
previous research findings of Figlie et al., (2004) who reported items within the 
‘recognition’ scale as having low reliability and participants experiencing difficulties 
in understanding some items.  
In terms of ambivalence towards substance use, whilst levels reduced in post 
programme measures, changes were not statistically significant.  One interpretation of 
these findings may be no positive effect of treatment on reducing levels of uncertainty 
towards continued substance use.  However, individual examination of the data 
revealed low levels of ambivalence at baseline assessment, with the majority of 
participants (73.68%) scoring within the low or very low clinical ranges of 
ambivalence.  As such a large proportion of the sample were scoring low on levels of 
ambivalence towards substance use prior to treatment it was unlikely that, within the 
current sample, a significant effect of treatment would be found relating to this 
concept.  This may suggest that the current sample were high in motivation to change 
and low in ambivalence towards change prior to selection for the group and were, 
therefore, ready to engage in treatment. Due to the voluntary nature of the programme 
and the research, it is more likely that those electing to attend the treatment and 
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participate in the current research would have higher levels of motivation and less 
ambivalence towards change than those who would elect not to attend. 
Inconsistent findings towards effects of treatment on ambivalence towards 
substance use have been reported in previous research within forensic settings.   Some 
significant positive effects of substance misuse treatment on levels of ambivalence are 
reported within the review in Chapter Two.  Morris and Moore (2009) found 
significant reductions (p < .05) in indications of ambivalence towards change 
following completion of treatment.  It is worth noting that, within this sample, mean 
baseline scores for ambivalence were higher than in the current research sample 
indicating higher levels of ambivalence towards substance use prior to engaging in 
treatment and increased opportunity for change.  In contrast, Baker et al., (2014) 
found a significant increase (p = .05) in ambivalence in post intervention measures 
indicating that uncertainty towards substance use had increased after completing 
treatment.   
 
Self-efficacy (towards future substance use and general coping abilities) 
In relation to hypothesis two and hypothesis three, no significant differences were 
found in self-efficacy, either in confidence towards managing substance use as 
measured by the DTCQ or towards managing a range of difficult situations as 
measured by the GSES.   Results on both measures of self-efficacy indicated that 
confidence towards managing future substance use and confidence towards managing 
situations of potential stress had increased after completing the intervention, however, 
this was not to a statistically significant extent.  Individual exploration of clinical 
change in confidence towards controlling future substance use indicated high levels of 
self-efficacy already present in baseline assessments, with fourteen participants (70%) 
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scoring 60% or higher in confidence towards controlling substance use.   This 
suggested good levels of self-belief in participants’ own abilities to manage substance 
use prior to commencing the treatment.  As such, the opportunity for statistically 
significant increases in scores following completion of treatment was more limited.  
Furthermore, three participants (15%) scored maximum points at each assessment 
stage providing no opportunity at all for increases in indications of confidence 
following treatment.   
In terms of more general self-efficacy, again high scores were indicated in 
levels of general self-efficacy prior to treatment.  Almost two-thirds of the sample 
(65%) of the sample scored 75% or higher confidence in their ability to deal with a 
variety of challenging situations in baseline assessment, limiting opportunity for 
statistically or clinically significant change.   However, despite this limited 
opportunity for change, individual case examination of the data suggested a positive 
treatment effect in increasing self-confidence, with a large proportion of the sample 
(80%) increasing in indicated self-efficacy in post programme conditions.   In a 
population noted to have pervasive and enduring problems (Mueser et al., 1997), with 
poorer responses to substance misuse treatment (Sacks & Pearson, 2003) this high 
proportion of the sample indicating increases in general self-confidence would appear 
to suggest a positive effect of the current treatment.  
Further indications of the positive effect of treatment on increased confidence 
were indicated within the qualitative element of the current research.  Emerging key 
themes from interview data suggested both increased general self-confidence (‘boost 
my confidence’) and increased confidence in using refusal skills (‘learning to say 
no’).  This is supported by the previous research findings of Morris & Moore (2009) 
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as reported in Chapter Two, also indicating increased confidence in changing future 
substance use following completion of structured substance misuse group treatment.   
When considering the indications of increased general levels of confidence 
and more specifically towards managing future substance use, there are several 
factors which may have influenced findings.  Firstly, the secure environment in which 
the majority of participants (80%) were detained may have artificially inflated 
confidence levels, with associated limited exposure to high-risk situations and limited 
access to substances (Swain et al., 2010).  However, the availability of illicit 
substances within secure forensic hospitals is widely acknowledged (Bowers & 
Jeffery, 2008; Derry, 2008; Dolan & Kirwan, 2001; Phillips et al., 2003), in 
conjunction with all participants within the current research having access to 
community leave and, therefore, the potential to use substances should they elect to 
do so.  As such, the impact of the secure environment on research findings may be 
more limited.   
Furthermore, ‘Faking good’ or presenting oneself in a socially desirable light, 
and the arising potential contamination of validity of data from self-report measures 
through response bias has been highlighted as confounding clinical research findings 
(Saunders, 1991).   When considering the findings relating to self-efficacy, the 
transparent nature of the DTCQ and the GSES and the associated opportunity for 
social desirability response bias should be considered.  Despite data within the current 
research being anonymous, influence of response bias may still be a useful 
consideration when interpreting findings potentially arising from participants’ 
potential limited insight and realistic recognition of own risk or due to a learnt pattern 
of responding to self-report measures due to the associated anticipated consequences.   
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Locus of control 
In relation to hypothesis four, no significant changes were found for differences in 
locus of control following completion of treatment.  Whilst scores moved in line with 
hypothesis predictions, increasing for internal locus of control and decreasing for the 
influence of powerful others and chance in post programme conditions, changes were 
not statistically significant.   
A case-by-case exploration of the data provided more insight into individual 
change. High levels of internalised locus of control were indicated in baseline 
assessments with all participants (100%) indicating higher internal locus of control in 
comparison with external locus of control (powerful others and chance).  This would 
appear to indicate that locus of control was already more internalised for a large 
proportion of the sample prior to commencing treatment, again limiting opportunity 
for statistically significant increases.  High levels of internal locus of control were 
indicated to be maintained throughout treatment and during the follow-up period 
suggesting that treatment may have been beneficial in supporting participants in 
feeling in control of their own autonomy in decision-making and behavioural choices.  
High internal locus of control has been suggested as protective factor in terms of 
recovery and risk reduction (Soravia et al., 2015).   Within the forensic population a 
key element of recovery has been suggested as the ability of the individual to attribute 
blame internally and take increased ownership and responsibility for their own 
behaviour (Drennan, 2012).  Therefore, the high levels of internal control indicated 
within the present sample would appear to be positive in terms of risk reduction and 
may be indicative of their current stage of treatment and recovery.   
Similar findings in relation to internal locus of control have been reported in 
the literature previously.   As described in the systematic review of literature in 
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Chapter Two, Ritchie et al., (2004; 2011) found no significant effect of treatment in 
locus of control scores with participants noted to have consistently higher scores on 
internal locus of control throughout the study period.   After completing treatment, a 
significant proportion of the current sample (78.95%) indicated feeling less controlled 
by other people and more in control of their own decision-making and actions.  This 
would appear to suggest a positive effect of intervention on participants’ feeling able 
to take more control of their own lives.   
Substance use 
The fifth hypothesis related to the behavioural component of the research, predicting 
that there would be a significant difference in substance use whilst engaging in the 
treatment.   Findings indicated consistently low levels of substance use throughout 
treatment.  All baseline screenings for substance use were negative, suggesting that 
participants’ may have already reduced their substance use prior to attending the 
programme.   Previous research has indicated that pre-treatment reductions in 
substance misuse have been found to have significant effects on continued reductions 
in substance use following treatment (Zhang et al., 2004).  However, due to the lack 
of follow-up data relating to substance use in the current study, it is not possible to 
compare findings following treatment.  Positive changes in substance use were 
indicated as consistent throughout treatment with 75% of participants remaining drug 
and alcohol free throughout treatment and all participants testing negatively for 
substances at the end of treatment.  This may be indicative of the positive effect of 
treatment on substance use.  This is supported by previous research as described in 
Chapter Two whereby reduced substance use was indicated immediately post 
treatment, with 72% of participants testing negative by the end of treatment (Miles et 
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al., 2007).  However, the absence of data measuring substance use in the follow-up 
period of the current research makes further comparisons not possible.   
These behavioural findings would appear to be consistent with the high levels 
of motivation and confidence in addressing substance misuse indicated in a large 
proportion of participants in baseline measures and indications that participants had 
already taken steps towards addressing substance use. Furthermore, as attendance in 
the intervention was voluntary, it may be that only those who were already making 
changes to substance use elected to attend, with those still using substances choosing 
not to engage in the intervention.   
 
Arising themes from qualitative interviews 
Themes arising from interviews indicated that participants had predominantly enjoyed 
engaging in the programme and perceived it as useful for them in some way.  A key 
theme arising was the good support that participants perceived from the programme 
facilitators.  A considerable body of research indicates the importance of therapeutic 
alliance in treatment outcomes (e.g. Elkin et al., 1990; Norcross & Hill, 2004; Serran 
& Marshall, 2010) with the indications of good therapist/client relationships within 
the current research potentially suggesting a positive impact on treatment outcomes.  
Furthermore, specifically within the field of substance misuse treatment, early 
therapeutic alliance has been suggested as a predictor of engagement and retention in 
treatment (Meier, Barrowclough & Donmall, 2005). 
Further key themes arising related to enjoyment in learning, the positive effect 
of the contingency management approach, group cohesiveness, developing refusal 
skills, learning from others, general developments in self-confidence and the benefits 
of clear facilitation styles.  Only one participant interviewed indicated that he felt that 
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he had taken nothing from the programme, citing the reason for this as having 
recently completed a substance misuse programme that he felt was more relevant to 
him.  Motivation and enjoyment of the programme indicated by the qualitative 
findings of the current research are consistent with the average attendance rate of 
87.95% within the programmes being assessed, suggestive of good levels of 
motivation to engage in the programme.  The good levels of motivation and 
enjoyment suggested within interviews are also consistent with the levels of 
motivation indicated in baseline assessments.  As presented within the systematic 
literature review in Chapter Two, Edwards et al., (2011) completed a qualitative 
evaluation of BTSA, with findings from this study including enjoying the group 
experience, the benefits of a contingency management approach, the usefulness of 
skills training and positive feedback regarding programme facilitators.   Some 
similarities can be noted in findings from the current study and findings from this 
previous study.   Downsworth & Jones (2014) found key arising themes of enjoyment 
of the programme and support of peers in the qualitative aspect of their research 
evaluating a structured substance misuse programme in a medium and low secure 
setting, also reflecting some of the positive indications of qualitative findings of the 
current research.   
 
Strengths of the current study 
The current research provides an initial, mixed methods evaluation of an integrative 
intervention in a real life setting addressing substance misuse specifically developed 
for those with mental health problems.  Furthermore, the programme was delivered 
with forensic clients in low secure, rehabilitation and community settings.  A lack of 
empirical research evaluating treatment interventions for this population in secure 
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settings has been identified (Tibber et al., 2015) with the existing research base in a 
wider range of settings limited to a small number of studies (Clark et al., 2013).  
Therefore, the current research is valuable in providing insight into an area with 
significant clinical and forensic implications.  A prospective approach was taken to 
the research as recommended within the literature incorporating a follow-up period in 
order to assess maintenance of any change indicated in treatment outcomes.   
Careful consideration was given to the measures included in the current 
research, incorporating measures capturing programme aims and key conceptual areas 
within the field of substance misuse.  Measures selected were not long or complex in 
nature, in response to participants and their likely associated difficulties.  A limited 
number of measures were included whilst still attempting to capture the range of 
treatment aims in order to provide an effective evaluation of outcomes.  Measures 
were selected based upon factors indicated within literature as more likely to change 
within secure forensic settings (Swain et al., 2010; Tibber et al., 2015).  Measures 
included in the research had adequate reliability and validity and had been identified 
as suitable for use within adult, clinical populations.  All participants, with the 
exception of one, who consented to engage in the research and completed the 
programme, were retained in the study at follow-up.  This high level of follow-up is a 
strength of the current study. As this population is noted as being particularly 
vulnerable and difficult to engage, the retention of this high level of participants for 
follow-up data collection would appear to suggest that the experience of completing 
the self-report measures at the earlier stages of the research was tolerable.   
A number of strengths were evident in the treatment model.  The treatment 
was highly structured and developed from empirically established risk factors for this 
population.   A manualised approach to treatment has been suggested as important in 
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maintaining treatment integrity, minimising therapist drift and allowing comparison 
with other treatments and replication in order to evaluate treatment effectiveness 
(Mann, 2009). Furthermore, this highly structured approach to treatment has the 
benefit of providing opportunity for comparison with future research, in order to 
continue to build upon and develop insight into this field.  The treatment approach 
was integrative, embedded within participants’ wider treatment plans with consistent 
support available from clinical and community teams. As noted previously, this 
integrative approach to treatment is identified as the most effective when working 
with this population and recommended within Department of Health guidelines (DoH, 
2008).   
The intervention was developed specifically for individuals with co-existing 
serious mental health and substance misuse problems, increasing the likelihood of 
being responsive and adaptive to difficulties within this complex group.  A further 
strength of this particular approach to treatment is the availability to both inpatient 
and outpatient forensic clients.  The outpatient environment has been identified as 
having high risk potential for relapse in substance use (Drake et al., 2000), and, 
therefore, provision of treatment is essential within community settings in addition to 
inpatient settings.   
The current study evaluated a harm reduction and contingency management 
approach to substance misuse treatment, that whilst supported by existing evidence, is 
rarely advocated for those within secure settings, thus providing the opportunity for 
original and valuable research.  As previously discussed, a harm reduction and 
contingency management approach to treatment has empirical support within the 
general population and is recommended as treatment approach within NICE 
guidelines (2011) when working with individuals with co-existing serious mental 
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health and substance misuse problems.  Some substance use was self-reported during 
the programme, with participants being willing to share this information.  This self-
reported information may be attributable to the less judgmental, harm reduction 
approach in comparison with an approach advocating abstinence.  However, it is 
interesting to note that self-reported substance use predominantly arose within 
community-based participants.  This may have arisen as a result of increased 
accessibility of substances within community settings or may be associated with 
participants’ anticipation of potential adverse consequences of reporting substance use 
whilst detained in secure settings.   
 
Limitations of the current study 
There are a number of limitations within the current study.  The first limitation is the 
absence of a control condition against which to compare findings.  The current 
research adopted a mixed methods programme evaluation design rather than 
randomly assigning participants to treatment or a control condition.  Although 
randomised assignment of participants is recommended to increase internal validity of 
research findings, due to the ethical implications of withholding treatment for those in 
need of intervention this design was not possible in the current study.  The lack of a 
comparison group to compare findings against makes assessment of the impact of 
intervention and the influence of extraneous factors difficult (Holloway et al., 2005).  
However, difficulties associated with randomising allocation for research purposes in 
the complex secure environment has been noted, with the need to evaluate treatment 
in usual conditions in real-world settings argued in the literature (Long et al., 2008). 
As discussed previously within this chapter, a ‘waiting list’ control condition 
was considered for the research.  However, all service users with comorbid serious 
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mental health and substance misuse problems were referred to this intervention and 
about to receive the treatment.  Therefore, the majority of those within the waiting list 
control condition would have crossed into the experimental condition during the study 
and potentially contaminated findings.  Additionally, a matched case-control approach 
to the research was considered when designing the study.  This approach involves 
matching cases to compare effectiveness of treatment.  However, as the only 
treatment available for substance use problems in the two locations being assessed 
was the BTSA programme there were no other groups to match against.  Furthermore, 
whilst attendance for the BTSA programme is voluntary, as this is the only structured 
dual diagnosis treatment available, the majority of those who are offered this 
treatment elect to participate in the programme.  This would make opportunities for a 
control group of those who had not attended intervention very limited.   
A further study limitation is the small sample size.  Prior to the 
commencement of the study, a priori power analysis indicated a target sample size of 
40.  However, difficulties were encountered in recruiting participants for the study.  A 
high proportion of individuals (41.3%) commencing treatment indicated that they 
were unwilling to participate in the research.  Reasons for not participating in the 
research, where provided, included lack of motivation “can’t be bothered”, dislike of 
psychometric measures “don’t like questionnaires” or mistrust in the motivation of 
the researcher and/or research “can’t trust what you are going to do with my 
answers”.  Several participants (n = 6) who commenced the programme and 
completed pre-programme measures did not complete the programme.  As these data 
sets were incomplete they were not included in data analysis in order to limit 
opportunity for attrition bias.  Small sample sizes have been suggested as a challenge 
characterising treatment outcome evaluation in secure settings (Tibber et al., 2015). 
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Small sample sizes have been found to increase the degree of sampling error 
(Dancey & Reidy, 2007) and limit generalisability of research findings.  Due to the 
reduced sample size it was not possible to complete some of the planned analysis and 
a lack of power may have influenced current research findings.  The opportunity of 
type 2 error is significantly increased in limited sample sizes.  In view of the problems 
associated with a very limited sample size, multiple methods were used to evaluate 
change including exploration at an individual level as recommended in previous 
research (Oddie & Davies, 2009).   Due to the time limitations of the research it was 
not possible to include additional groups in the current study in order to increase the 
sample size.  However, considering the pilot feasibility nature of the current study, 
this may be useful in directing future larger scale studies in a similar area.   
A further potential limiting factor for the current research is the lack of 
inclusion of assessment of socially desirable responding (Paulhus, 1998) and 
increased opportunity for response bias (Saunders, 1991), as previously discussed.  In 
view of the very high levels of motivation to change and self-efficacy, indicated in 
both general self-confidence and confidence towards managing future substance use 
at all stages of assessment; pre, post and follow-up, it is suggested that socially 
desirable responding may have influenced research findings.  The inclusion of a 
measure to assess social desirability, for example, the Balanced Inventory of 
Desirable Responding (BIDR) (Paulhus, 1998) may have been useful in assessing the 
participants’ willingness to respond to self-report measures in an honest and open 
manner, providing insight into the validity of responses and research findings.   The 
current research may have benefitted from the inclusion of assessment of participant’s 
tendency to provide socially desirable responses, and, therefore, increase insight into 
the validity and reliability of findings.  Considering the difficulties indicated in this 
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population with concentration and motivation (McMurran, 2002), the researcher felt 
that the inclusion of an additional measure may have been detrimental to participant 
well-being and also served as a potential barrier to participants’ willingness to engage 
in the research.   However, in view of findings of previous related research and the 
limited findings in the current research relating to the impact of intervention on locus 
of control, the inclusion of a measure of social desirability rather than an assessment 
of locus of control may have provided more insight.   
Whilst the current study included the collection of follow-up data, the limited 
follow-up time period may have influenced research findings.  Longitudinal studies 
are recommended when assessing intervention efficacy (Ritchie et al., 2011), 
however, due to time limitations of the current research it was not feasible to 
incorporate a longer follow-up period.  Additionally, the absence of follow-up data 
for substance use may have been a further limitation to the research.   
Additional confounding variables may require consideration in view of the 
results found in the current research.  Participants were requested to identify their 
primary substance within treatment and respond to measures accordingly.  This may 
have caused confusion and influenced responses from poly-substance users   
Additionally, severity and frequency of use were not controlled for in the research.  
The data was analysed for substance use as a whole rather than differentiating 
between drugs and alcohol, polysubstance use, or exploring differences between 
different types of drugs, potentially limiting findings.  Cohn and Mueser (2013) 
suggest that increased differentiation between drug use and alcohol use in those with 
co-occurring serious mental illness may be beneficial when exploring the efficacy of 
treatment provided.  
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The influence of the relationship of the researcher with the sites included in 
the research and with research participants should be given consideration when 
interpreting research findings.  Whilst the researcher was not involved in any BTSA 
programme delivery in order to limit the potential of researcher bias, the researcher 
was a part of the clinical team at one of the locations (Northamptonshire) for the 
duration of one programme delivery.  Whilst the researcher was not working in a 
direct therapeutic capacity with any of the research participants, she was familiar to 
the participants and this may have influenced the high recruitment rate for this 
programme (10 participants recruited for this programme).  This may have also served 
to increase social desirability in participants responses for this group, wishing to 
present themselves in a positive light to someone that they have perceived was in 
some way responsible and influential in decision making about future treatment and 
progress.   
The BTSA programme was developed specifically to treat individuals with a 
diagnosis of serious mental illness and substance misuse problems (Bellack et al., 
2006).  Therefore, the inclusion of personality disordered offenders who fall outside 
of the diagnostic category of serious mental illness within the treatment programmes 
being currently assessed may have influenced treatment outcomes.   
The representativeness of the current sample merits consideration.  Not all 
participants within the programmes evaluated within the current study consented to 
participate in the research.  It is suggested that a more representative sample would 
have included all programme participants, in view of the possibility that participants 
with higher levels of motivation volunteered to participate in the study influencing 
findings, whereas, those with increased difficulties or lower levels of motivation were 
more likely to decline to participate (Gudjonsson, Young & Yates, 2007).  
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Furthermore, as the treatment itself was voluntary, the nature of a self-selecting group 
presenting with high levels of motivation and internalised locus of control may limit 
generalisibility of findings to wider populations (Farren & McElroy, 2010).  Payment 
for participants to take part in the research may have provided a larger and more 
representative sample for the current study.  In view of the payments received for 
attending the intervention, the research could have adopted a similar approach, and 
provided limited payments to reward participants for their time in completing the 
additional measures required for the research.  A potential benefit of this approach 
may have been a larger sample size including participants with lower levels of 
motivation and/or confidence in ability to change.  As such, this may have increased 
reliability of findings and also generalisability to a wider population.  Whilst ethical 
concerns regarding paying vulnerable participants for taking part in research are 
widely discussed, recent Health Research Authority guidelines include a number of 
potential benefits of research payments.  These include reducing the power imbalance 
between the researcher/healthcare provider and the patient by payment for time rather 
than being asked to do a favour, providing clearer differentiation between the research 
and clinical intervention and providing more equal opportunities for vulnerable 
research participants when compared with those less vulnerable who are more likely 
to receive payment for research participation (Health Research Authority Guidance, 
2014).  A negative consequence of payment for participants would be the potential 
cost implications, particularly should the research attract a significant number of 
participants.  Finances for the current project were very limited, however, should 
future projects with less financial constraints take this approach, this may address 
some of the challenges experienced in the current project regarding sample size.   
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Implications for practice 
The findings from the current research provide some tentative, initial indications of 
the efficacy of a structured harm reduction, contingency management approach to 
substance misuse in a forensic population with mental health problems.  In particular, 
semi-structured interviews highlighted key areas that participants found beneficial and 
indicated that the majority of participants had found the experience of the intervention 
enjoyable.  Only one participant reported not enjoying the programme due to his 
perceptions of a lack of relevance to his stage of treatment or current needs.  This 
highlights the need for rigorous assessment for programme selection and 
consideration of suitability of potential intervention for individual service users. 
Careful consideration of treatment needs and sequencing of intervention (Stephenson, 
Harkins & Woodhams, 2013) along with a clear rationale developed collaboratively 
with the service user could potentially alleviate problems with engaging with 
treatment and improve treatment outcomes.   
The current study encountered similar difficulties to those identified in 
previous research within this population and challenges to empirical evaluation of 
intervention in this area, in terms of sample size, recruitment of research participants 
and the lack of a control condition.  Further replication research on a larger scale with 
a longer follow-up period is recommended in order to ensure that intervention 
provided is empirically supported.  Furthermore, controls for confounding variables 
including type of substance, classification of diagnosis, stage of treatment and context 
of detainment would provide further insight into what is working for whom.   
In view of the complexities of this population, reported within the literature 
and indicated within the current research study, exploration of attitudinal and 
behavioural change at an individual level may be a more informative approach to 
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analysing treatment outcomes.  Individual case examination and formulation may 
provide an understanding of an individual’s presenting problems, level of insight, 
expectations and attitude towards treatment.  This would enable more individualised 
and personally relevant of identification of treatment goals to increase opportunity for 
risk reduction.  As such, progress could be measured against these goals and treatment 
efficacy assessed against meaningful and relevant outcomes for each individual.  
 
Summary and conclusions 
The aim of the current research was to evaluate the effectiveness of a programme 
taking a specific behavioural approach to the treatment of substance misuse in a 
forensic population with comorbid serious mental health problems.  The current study 
suggests that a structured approach to substance misuse treatment can effect positive 
treatment change in terms of taking steps to actively manage substance use.  
Qualitative findings suggest perceived benefits of intervention from the participants’ 
viewpoint including increased coping skills, confidence and the supportive group 
experience.  Furthermore, individual exploration of clinical change provides some 
tentative support for treatment outcomes.  Therefore, the current research provides 
some tentative suggestion that the BTSA intervention is helping people with co-
existing mental health and substance use problems and a history of offending 
behaviour, however, findings are not conclusive.   
The lack of statistically significant quantitative findings may be explained by a 
range of reasons including limited treatment effect; the small sample size and 
associated lack of power; pre-treatment high levels of motivation, self-efficacy and 
internalised locus of control and the mixed assessments used within the current 
research study.  In view of the limitations of the current study, future replication 
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research is advocated using larger scale studies or taking a more individual approach 
to analysing outcomes. This further research is necessary to inform treatment for this 
vulnerable population facing the significant challenges of managing co-existing 
difficulties of serious mental health problems, substance misuse and offending 
behaviour.  
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CHAPTER FIVE: 
DISCUSSION 
Overall aims of the thesis 
This thesis aimed to consider the impact and treatment of co-existing serious mental 
health and substance misuse problems in the context of the forensic population.  More 
specifically, the links between co-existing mental health problems, substance misuse 
and offending behaviour were explored through evaluation of existing literature with 
particular emphasis on psychological interventions.  The literature suggested a 
significant impact of co-existing serious mental health problems and substance misuse 
upon both general life quality (Bahorick et al., 2013; Barrowclough et al., 2014) and 
increased likelihood of offending behaviour (Soyka, 2000; Swanson et al., 1990; 
Volavka, 2013).  The evidence base for evaluation of treatment for co-existing mental 
health and substance misuse problems for the general population has been suggested 
to be considerable (McKeown, 2001), however, research exploring treatment within 
forensic populations has been identified as limited in terms of availability and 
empirical support (Clark et al., 2013; Derry, 2008; Durand et al., 2006).  Given the 
considerable forensic (Daff & Thomas, 2014; Fazel et al,, 2010; Morgan et al., 2013) 
and clinical difficulties (Walsh & Copello, 2014) noted within this population this  
limited availability of treatment is particularly concerning.  Furthermore, the 
implications of treatment provision to a vulnerable population not based on empirical 
support raises additional ethical concerns.  Therefore, a systematic literature review 
was conducted to explore the effectiveness of current provision of substance misuse 
treatment for offenders with serious mental health problems detained within secure 
settings.  Further to the findings of this review, an empirical research study was 
undertaken to explore, in real world settings, the effectiveness of a structured 
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substance misuse intervention in an offending inpatient and community population 
with serious mental health problems.  The purpose of the research was to provide 
insight into an identified gap in the literature and to contribute to the evidence base 
for treatment for offenders with these additional complex difficulties.    
 
Summary of main findings 
Chapter One – Introduction to the thesis  
The consequences associated with, and difficulties arising from, co-existing substance 
misuse and serious mental health problems reviewed in Chapter One have been 
shown to be serious and pervasive.   The extent of this problem has been difficult to 
accurately estimate due to inconsistencies including variations in diagnostic criteria, 
data reporting and reluctance of the client group to seek help (Gregg et al., 2007).  
However, the available data relating to prevalence indicates the significant extent of 
the problem, suggested to be higher in the forensic population than in general 
community samples (DoH, 2009), with comorbidity associated with a range of 
offending behaviour.  Research has suggested that over half of people experiencing 
mental health difficulties also experience difficulties with substance misuse (Hunt et 
al., 2014) and that lifetime prevalence within this population is suggested to be as 
high as 50% (Mueser et al., 1997).  The links between serious mental health 
problems, substance misuse and violence are discussed within the literature, with 
research indicating increased likelihood of violent and aggressive behaviour in this 
population (e.g. Elbogen et al., 2009; Mericle et al., 2008; Swanson et al., 1990;).  In 
addition to violent offending, increased risk of general offending has been suggested 
for individuals experiencing serious mental health problems and substance misuse 
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(Short et al., 2013) and a higher likelihood of recidivism (Baillargeon et al., 2010; 
Bonta et al., 2014).   
 
Chapter Two – Systematic review of the literature 
Chapter two presented a systematic review of studies exploring a variety of treatment 
outcomes in substance misuse interventions available for individuals with co-existing 
serious mental illness detained within secure forensic environments.  All studies 
meeting the inclusion criteria were included in the review due to the limited number 
of studies available, providing support for the limited empirical research base for this 
type of intervention.  Thirteen studies using a variety of methodological designs to 
assess treatment efficacy were included in the review.  Reviewed studies included 
observational, mixed methods, comparison group and qualitative designs.   
Empirical support for effectiveness of treatment programmes in the thirteen 
included studies was mixed.  Findings indicated some benefits of treatment in terms 
of changes in attitudes towards substance use, reductions of risk behaviours and 
indications of improvements in psychological functioning.  Furthermore, initial 
suggestions of reduction in substance use and rates of recidivism were indicated.  
However, findings were not consistent throughout studies with a number of 
methodological limitations observed.  In view of these limitations, implications for 
the reliability of research findings and generalisability to the wider field of treatment 
of co-existing mental health and substance misuse problems should be guarded and 
requires further consideration. 
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Chapter Three – Critique of the SOCRATES (8A/D) 
Chapter three examined the psychometric properties of the Stage of Change 
Readiness and Treatment Eagerness Scale (8A/D) (Miller & Tonigan, 1996).  This 
self-report measure was selected for critical review due to its wide use within the field 
of substance misuse treatment and ease of administration. In addition the measure 
provides insight into a range of aspects associated with readiness to change; problem 
recognition, ambivalence towards change and active change.  A number of 
psychometric property limitations were identified despite the measure being well-
established and widely used in clinical settings, with potential implications for the 
findings of the current thesis.  Mixed findings were reported for the validity and 
reliability of the measure, with limited information reported relating to face and 
content reliability.  However, despite these limitations, the scale has been shown to 
provide useful insight into attitudes towards substance use and views towards change 
beneficial in clinical settings (Carey 2002).  Furthermore, critical review of a wide 
range of psychometric measures assessing motivation to change suggested that no one 
single measure had higher clinical utility than any other (Carey et al., 1999).  
 
Chapter Four – Empirical research study 
The empirical research study presented in Chapter Four explored the effectiveness of 
structured group treatment (BTSA) for offenders with serious mental health problems 
using a mixed methods design.  The intervention was developed from a social 
learning perspective, taking a highly structured skills based training approach to 
treatment (Bellack, 2006).  The intervention has been adapted for use with an adult 
population with a history of offending behaviour and detainment with secure settings.  
The research evaluated five programmes across two clinical locations, with 
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participants presenting with a range of psychiatric diagnoses and offending 
behaviours.  The research evaluated the first two BTSA programmes delivered for 
forensic NHS clients in Northamptonshire, prior to this there was no dual diagnosis 
treatment available for offenders within this clinical location.  The BTSA intervention 
had been available in the South London clinical location for several years, however, 
no previous prospective research had been undertaken within this location to evaluate 
treatment outcomes.  Furthermore, the current research assessed intervention provided 
jointly to inpatient and community forensic clients, as far as the author is aware, there 
is no published research assessing this type of intervention within this mixed sample.    
The intervention aimed to increase motivation and confidence in participants 
in order to reduce future problematic substance use.  A skills based training approach 
was taken to support participants in the development of skills to aid substance refusal, 
engagement in alternate social activities and association with other non-substance 
using individuals.  Within the research study, empirical measurement of change was 
related to the programme goals and key theoretical conceptual factors related to 
predicting future substance use; changing motivation, attitudes and behaviour of 
participants towards substance use and increasing confidence to improve general 
functioning. Participants’ experiences of the programme were explored through semi-
structured interviews.  
Measures evaluating attitudinal change showed a statistically significant 
difference in taking steps towards changing substance use.   A significant 
improvement was found between the end of treatment and follow-up.  Scores had 
increased from baseline measures to post programme and significantly increased from 
post programme to follow-up.  This would appear to indicate that the positive changes 
indicated in substance use immediately post treatment had continued within the 
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follow-up period and participants’ confidence had continued to grow in the self-
management strategies being used to control substance use.   
All other attitudinal measures moved in the direction of hypothesis predictions 
with the exception of the SOCRATES recognition of problems associated with 
substance use subscale.  All other measures indicated positive effects of treatment, 
however, not to a statistically significant extent.  High scores within baseline 
measures indicating good self-confidence, motivation and readiness to change, 
confidence towards controlling substance use and internal locus of control suggested 
that participants may have already made decisions and begun to take action to reduce 
substance use prior to starting intervention.  Furthermore, the predominantly high 
baseline scores limited opportunity for statistically or clinically significant change 
following treatment.  Findings from attitudinal measures were supported by substance 
use data.  All participants tested negative for substance use at the start and at the end 
of treatment, with substance use remaining low throughout treatment for the majority 
of participants.   
In terms of the qualitative findings of the research, emerging themes suggested 
that participants had enjoyed their experience of the programme and felt that the skills 
training had been beneficial, in particular, drug refusal skills training.  The therapeutic 
relationship emerged as another key theme arising from the data, indicating that 
participants had felt supported by therapists.  Further key themes included group 
cohesiveness, benefits of the contingency management approach and general 
developments in self-confidence.   
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Future research recommendations 
This thesis explored the effectiveness of treatment in a real life setting for a 
vulnerable population with severe and enduring difficulties including a history of 
offending.  A gap was identified in the literature relating to both the provision of 
treatment (Derry, 2008) and empirical investigation (Clark & Sandbrook, 2013) of 
intervention provided for offenders with substance misuse and mental health 
problems.  Considering the serious risks and consequences associated with co-existing 
serious mental health problems and substance misuse, further empirical research in 
this area is essential for reducing financial and social implications for society and 
managing risk and improving life quality in those with co-existing substance misuse 
issues and significant mental health difficulties.   
Further research would benefit from considerations of the methodological 
limitations encountered both within the current thesis and indicated in previous 
research.  Reliable and rigorous empirical evaluation may help to clearly establish 
more clearly effective principles and models of treatment, along with delivery 
approaches in order to optimise future treatment development and provision.  
Randomised controlled trials with sufficient power to limit confounding variables and 
compare treatment approaches would be beneficial providing research to help to 
implement new programmes and adapt existing programmes in order to ensure that 
treatment is cost-effective, evidence based and responsive to the risks and needs of 
the population receiving treatment.  Longer follow-up periods, incorporating periods 
of discharge to community living would provide indications on the more enduring 
effects of the treatment, particularly, when substances became more available and 
exposure more frequent.  It is suggested that future research may benefit from 
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consideration of payment for research participation with potential benefits of 
increasing sample size and providing a more representative sample. 
In light of the recommended integrated approach to treatment, research 
evaluating holistic treatment programmes and pathways as a whole rather than 
exclusively focusing upon the provision of individual intervention may be of further 
benefit.  A more individualised approach to treatment evaluation (Long et al., 2008) 
integrating the wider treatment pathway (Department of Health, 2008; Kavanagh & 
Connelly, 2009; Morisano et al., 2014), may provide additional insight into effective 
ways of working with this complex population to reduce future risk.  In view of the 
reluctance of some participants to volunteer to take part in the current research, 
investigation of barriers to participation in research may provide valuable insight into 
the difficulties within this group and make recommendations to ensure that future 
samples are more representative of the whole population.  However, in consideration 
of the current limited treatment provision for this population (Durand et al., 2006; The 
Bradley Report, 2009; Witt et al., 2013), psychometric property limitations in 
assessment measures (Carey et al., 1999) and indicated problems with motivation and 
engagement in treatment (Banerjee et al., 2002; Bellack, 2007; Drake et al., 2001), 
opportunity for longitudinal gold-standard research may be more limited. 
 
Thesis strengths and limitations 
The current thesis provides original contributions to an area identified as under-
researched and under-resourced, with serious implications for offending.  It provides a 
mixed-methods evaluation for a structured intervention addressing substance use in 
offenders with co-existing mental health problems.  This evaluation has the benefit of 
providing original, real life research with a mixed sample detained in secure settings 
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and living in community settings.  A mixed methods approach was used for the 
research study, suggested to provide a richer, more in-depth understanding of the 
subject of the research (Venkatesh et al., 2013).  A prospective approach was taken to 
evaluation incorporating a follow-up period to assess continuity of change beyond the 
period of engagement in treatment (McMurran, 2002).  Data collection incorporated 
some behavioural measures, assessing substance use, recommended for increasing 
validity of research findings (Mathison, 1988).  
There are a number of limitations to the current thesis requiring consideration.   
The systematic review presented in chapter two was potentially limited by publication 
and language bias as all research studies included in the review were published 
studies written in English language.  Treatment outcomes within the studies included 
a range of assessments including attitudes towards substance use, recidivism and/or 
readmission, substance use, psychological functioning, attitudes towards change and 
general satisfaction.  Due to the lack of standardised measures within the studies it 
was not possible to compare all study findings directly.  An additional weakness of 
the review was the inclusion of all the studies found, with none excluded on a quality 
basis due to the limited research in the area.  Inclusion of studies of varying quality 
may limit reliability and generalisability of findings to the wider population although 
reflect to some extent the stage of evidence development in the area. 
In terms of the empirical study, although data collection included 
measurement of drug/alcohol use, inclusion of additional behavioural measures may 
have strengthened the study design, providing more comprehensive data triangulation.  
Assessment of violent and/or aggressive behaviour during the study period or 
progress or deterioration in mental health may have provided insight into the effects 
of intervention on some of the wider problematic consequences indicated in the 
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literature to be associated with serious mental health problems and substance misuse.   
The quantitative aspect of the empirical research study was limited by the lack of 
power within the sample. The sample size was small, with not all participants in the 
intervention willing to take part in the research.  It could be hypothesised that 
participants’ consenting to take part in the current research presented with high levels 
of motivation prior to commencing treatment further suggesting that those with lower 
motivation were reluctant to make additional commitments.  This may have been 
associated with the additional work involved in completing psychometric assessments 
or may have been influenced by ambivalence towards change and limited confidence 
in their own abilities.   For the majority of participants’ taking part in the research, 
scores moved in the predicted direction in end of treatment measures with changes 
maintained at follow-up, however, only the taking steps towards changing substance 
use reached a level of statistical significance.  It is suggested that high baseline scores 
were a factor limiting opportunity for statistical significant change following 
completing treatment.  
Additionally, a further limiting factor of the current research is the absence of 
a control condition due to the lack of a comparable group engaging in alternate 
intervention.  All potentially comparable participants (service users with serious 
mental health problems and substance misuse problems) were either receiving 
intervention or about to receive an intervention.  However, the lack of a comparison 
group makes assessment of confounding variables difficult and limits reliability of 
research findings.   
When considering the findings of this thesis, the results may be open to 
interpretation in different ways.  Firstly, it could be interpreted that, due to a lack of 
significant findings from the majority of the outcome measures used, the research 
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suggests that the intervention is not having a positive effect on those completing it.  
However, to accept this interpretation would be largely ignoring that, for the majority 
of participants taking part in the research, scores moved in the predicted direction in 
end of treatment measures with changes maintained at follow-up.  More individual 
analysis of the data on a case-by-case basis, suggested either predominantly positive 
clinical change or maintenance of good levels of motivation, confidence and internal 
locus of control.  Furthermore, themes arising from the qualitative aspect of the 
current study indicated positive treatment experience and effects of the intervention.  
A second interpretation of the findings could be that participants electing to 
participate in the current research were already working through a treatment pathway 
and process of change, internally motivated to engage and making changes to their 
substance use prior to commencing the programme.  It could be hypothesised that 
participants’ consenting to take part in the current research presented with high levels 
of motivation prior to commencing treatment further suggesting that those with lower 
motivation were reluctant to make additional commitments.   Potential implications of 
socially desirable responding, presenting oneself in the best way in order to aid 
progress through a secure care pathway, should also be considered when interpreting 
findings.   
 
Conclusion 
This thesis supports and highlights the need for effective intervention for offenders 
with additional difficulties, co-existing substance use and serious mental health 
problems.  Some of the challenges to evaluation of programs such as BTSA in routine 
clinical settings have also been highlighted. The findings provide some promising 
initial indications of the benefits that a structured, harm reduction approach that 
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treatment can provide, particularly in terms of indications of qualitative findings and 
hence participants’ views.  The need for further empirical investigation is 
recommended with consideration of the methodological limitations of the current 
research including representativeness of the sample, sample size and limited follow-
up schedules.  
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Appendix 1:  Details of electronic databases searched, search terms and syntax used 
 
2.1  OVID PsycINFO - 1987 to June Week 4 2016 
1. (drug* or alcohol* or polydrug* or substance* or narcotic* or heroin or cocaine or 
crack or amphetamine or ecstasy or cannabis or benzodiazepines).mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
2. (abus* or misus* or disorder* or "use" or depend* or addict* or withdraw* or 
rehabilitat* or abstain* or illegal* or habit* or "relapse prevent*").mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
3. exp Drug Misuse/ 
4. exp Alcohol Misuse/ 
5. 1 and 2 
6. 3 or 4 or 5 
7. ("dual diagnosis" or "dual disorder" or co-morbid* or co-occur*).mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
8. (dual adj3 diagnosis).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
9. 7 or 8 
10. ("serious mental illness" or "psychiatric illness" or "serious mental disorder*" or 
"mentally ill offender*" or "mentally disordered offender*" or "bipolar disorder" or 
schizophrenia or "anxiety disorder*" or "major depressive disorder*" or "mental 
health" or "major mental illness").mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
11. exp Comorbidity/ 
12. 9 or 11 
13. ("forensic psychiatr*" or "forensic inpatient*" or offend* or crime* or crimin* or 
"high secur*" or "medium secur*" or "low secur*" or "special hospital" or sentenc* or 
"criminal justice" or jail or incarcerated or prison* or custod* or "forensic service*" 
or "forensic hospital*" or "special hospital*").mp. [mp=title, abstract, heading word, 
table of contents, key concepts, original title, tests & measures] 
14. (secure adj3 hospital).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] 
15. (forensic adj5 patient).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
16. 13 or 14 or 15 
17. exp Intervention/ 
18. exp Treatment/ 
19. (CBT or "motivational interview*" or "contingency manageme*" or psychosocial 
or therap* or groupwork or "skills training" or "relapse prevention" or behaviour* or 
behavior* or programme or "cognitive techniques" or psychotherap* or 
rehabilitat*).mp. or *therapy/ or "cognitive behav* therapy".mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
20. ((behaviour* or behavior* or cognitive or psycho*) adj3 therapy).mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & 
measures] 
21. 17 or 18 or 19 or 20 
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22. 6 and 10 and 12 and 16 and 21 
 
398 results 
 
 
2.2  OVID EMBASE - 1988 to June Week 4 2016 
1. (drug* or alcohol* or polydrug* or substance* or narcotic* or heroin or cocaine or 
crack or amphetamine or ecstasy or cannabis or benzodiazepines).mp. [mp=title, 
abstract, subject headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
2. (abus* or misus* or disorder* or "use" or depend* or addict* or withdraw* or 
rehabilitat* or abstain* or illegal* or habit* or "relapse prevent*").mp. [mp=title, 
abstract, subject headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
3. exp Drug Misuse/ 
4. exp Alcohol Misuse/ 
5. 1 and 2 
6. 3 or 4 or 5 
7. ("dual diagnosis" or "dual disorder" or co-morbid* or co-occur*).mp. [mp=title, 
abstract, subject headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
8. (dual adj3 diagnosis).mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
9. 7 or 8 
10. ("serious mental illness" or "psychiatric illness" or "serious mental disorder*" or 
"mentally ill offender*" or "mentally disordered offender*" or "bipolar disorder" or 
schizophrenia" or "mental health" or "major mental illness").mp. [mp=title, abstract, 
subject headings, heading word, drug trade name, original title, device manufacturer, 
drug manufacturer, device trade name, keyword] 
11. exp Comorbidity/ 
12. 9 or 11 
13. ("forensic psychiatr*" or "forensic inpatient*" or offend* or crime* or crimin* or 
"high secur*" or "medium secur*" or "low secur*" or "special hospital" or sentenc* or 
"criminal justice" or jail or incarcerated or prison* or custod* or "forensic service*" 
or "forensic hospital*" or "special hospital*").mp. [mp=title, abstract, subject 
headings, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
14. (secure adj3 hospital).mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] 
15. (forensic adj5 patient).mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] 
16. 13 or 14 or 15 
17. (CBT or "motivational interview*" or "contingency manageme*" or psychosocial 
or therap* or groupwork or "skills training" or "relapse prevention" or behaviour* or 
behavior* or programme or "cognitive techniques" or psychotherap* or 
rehabilitat*).mp. or *therapy/ or "cognitive behav* therapy".mp. [mp=title, abstract, 
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subject headings, heading word, drug trade name, original title, device manufacturer, 
drug manufacturer, device trade name, keyword] 
18. ((behaviour* or behavior* or cognitive or psycho*) adj3 therapy).mp. [mp=title, 
abstract, subject headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 
21. 17 or 18 
22. 6 and 10 and 12 and 16 and 19 
 
476 results 
 
 
2.3 OVID MEDLINE - 1946 to June Week 4 2016  
1. (drug* or alcohol* or polydrug* or substance* or narcotic* or heroin or cocaine or 
crack or amphetamine or ecstasy or cannabis or benzodiazepines).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier] 
2. (abus* or misus* or disorder* or "use" or depend* or addict* or withdraw* or 
rehabilitat* or abstain* or illegal* or habit* or "relapse prevent*").mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier] 
3. exp Drug Misuse/ 
4. exp Alcohol Misuse/ 
5. 1 and 2 
6. 3 or 4 or 5 
7. ("dual diagnosis" or "dual disorder" or co-morbid* or co-occur*).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier] 
8. (dual adj3 diagnosis).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] 
9. 7 or 8 
10. ("serious mental illness" or "psychiatric illness" or "serious mental disorder*" or 
"mentally ill offender*" or "mentally disordered offender*" or "bipolar disorder" or 
schizophrenia" or "mental health" or "major mental illness").mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
11. exp Comorbidity/ 
12. 9 or 11 
13. ("forensic psychiatr*" or "forensic inpatient*" or offend* or crime* or crimin* or 
"high secur*" or "medium secur*" or "low secur*" or "special hospital" or sentenc* or 
"criminal justice" or jail or incarcerated or prison* or custod* or "forensic service*" 
or "forensic hospital*" or "special hospital*").mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
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14. (secure adj3 hospital).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] 
15. (forensic adj5 patient).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] 
16. 13 or 14 or 15 
17. exp Intervention/ 
18. exp Treatment/ 
19. (CBT or "motivational interview*" or "contingency manageme*" or psychosocial 
or therap* or groupwork or "skills training" or "relapse prevention" or behaviour* or 
behavior* or programme or "cognitive techniques" or psychotherap* or 
rehabilitat*).mp. or *therapy/ or "cognitive behav* therapy".mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
20. ((behaviour* or behavior* or cognitive or psycho*) adj3 therapy).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier] 
21. 17 or 18 or 19 or 20 
22. 6 and 10 and 12 and 16 and 21 
 
320 results 
 
 
2.4  Health Management Information Consortium (HMIC) - 1979 to June 2016 
1. (drug* or alcohol* or polydrug* or substance* or narcotic* or heroin or cocaine or 
crack or amphetamine or ecstasy or cannabis or benzodiazepines).mp. [mp=title, other 
title, abstract, heading words] 
2. (abus* or misus* or disorder* or "use" or depend* or addict* or withdraw* or 
rehabilitat* or abstain* or illegal* or habit* or "relapse prevent*").mp. [mp=title, 
other title, abstract, heading words] 
3. exp Drug Misuse/ 
4. exp Alcohol Misuse/ 
5. 1 and 2 
6. 3 or 4 or 5 
7. ("dual diagnosis" or "dual disorder" or co-morbid* or co-occur*).mp. [mp=title, 
other title, abstract, heading words] 
8. (dual adj3 diagnosis).mp. [mp=title, other title, abstract, heading words] 
9. 7 or 8 
10. ("serious mental illness" or "psychiatric illness" or "serious mental disorder*" or 
"mentally ill offender*" or "mentally disordered offender*" or "bipolar disorder" or 
schizophrenia" or "mental health" or "major mental illness").mp. [mp=title, other title, 
abstract, heading words] 
11. ("forensic psychiatr*" or "forensic inpatient*" or offend* or crime* or crimin* or 
"high secur*" or "medium secur*" or "low secur*" or "special hospital" or sentenc* or 
"criminal justice" or jail or incarcerated or prison* or custod* or "forensic service*" 
or "forensic hospital*" or "special hospital*").mp. [mp=title, other title, abstract, 
heading words] 
  207 
12. (secure adj3 hospital).mp. [mp=title, other title, abstract, heading words] 
13. (forensic adj5 patient).mp. [mp=title, other title, abstract, heading words] 
14. 11 or 12 or 13 
15. exp Treatment/ 
16. (CBT or "motivational interview*" or "contingency manageme*" or psychosocial 
or therap* or groupwork or "skills training" or "relapse prevention" or behaviour* or 
behavior* or programme or "cognitive techniques" or psychotherap* or 
rehabilitat*).mp. or *therapy/ or "cognitive behav* therapy".mp. [mp=title, other title, 
abstract, heading words] 
17. ((behaviour* or behavior* or cognitive or psycho*) adj3 therapy).mp. [mp=title, 
other title, abstract, heading words] 
18. 15 or 16 or 17  
19. 14 and 18 
20. exp Psychoanalytic therapy/ or exp behaviour therapy/ or exp Cognitive behaviour 
therapy/ or exp Family therapy/ or exp Group therapy/ or exp Psychiatric drug 
therapy/ 
21. 15 or 16 or 17 or 20 
22. 10 and 9 and 14 and 21 
 
10 results 
 
 
2.5 Applied Social Sciences Index and Abstracts (ASSIA)  
(all (comorbid) OR all (dual diagnosis)) AND (all (offend*) OR all (crim*)) AND (all 
(intervention) OR all (treatment)) 
 
65 results 
 
 
2.6 Web of Science (ISI) 
Topic: (treatment) AND Topic: (secure) AND Topic (dual diagnosis) 
Timespan: All years.  Indexes: SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH. 
 
12 results 
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Appendix 2: Experts contacted by email 
 
The following professionals were contacted by email to request any further research 
details in addition to those already obtained: 
 
• Clive Long, St Andrew’s Healthcare and King’s College London, research 
interest women in secure psychiatric settings 
• Gordon Ritchie, The State Hospital, Carstairs, research interest treatment of 
dual diagnosis in mentally disordered offenders 
• Andrew Derry,  
 
Please find detailed below a template of the emails sent: 
 
To  
 
I am currently studying for a Doctorate in Forensic Psychology at the University of 
Birmingham and as part of my thesis I am required to complete a systematic literature 
review on substance misuse interventions for dually diagnosed individuals in secure 
forensic settings.  Whilst searching for literature I have come across several of your 
articles and I am now emailing you as I wondered whether you may have any related 
articles or studies either published or unpublished that you may be kind enough to 
forward to me.   
 
I am hoping to include all relevant research in my review and as such, would be very 
grateful if you were able to send me any studies that you may have. 
 
Many thanks for your time 
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Appendix 3: Inclusion/exclusion criteria checklist 
 
Inclusion criteria Criteria met 
 
Comment 
 
Population 
Adults aged 18+ with a co-
existing mental disorder and 
substance misuse problems 
 
Residing in a secure forensic 
setting 
 
 
Yes 
Unclear 
No 
 
 
Intervention 
Exposure to psychosocial 
groupwork structured 
intervention addressing 
substance misuse 
 
 
Yes 
Unclear 
No 
 
 
Outcome 
Substance use and/or 
Recidivism and/or 
Psychological functioning 
and/or 
Behaviour change 
 
 
Yes 
Unclear 
No 
 
 
Study design: 
Any with outcome measures 
 
 
Yes 
Unclear 
No 
 
 
If the answers to all questions are yes the study can be included in the review 
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Appendix 4:  Full articles obtained and excluded following the application of 
inclusion/exclusion criteria 
 
Authors and 
date 
Title Reason for exclusion Search 
source 
Iowa 
Department of 
Human Rights 
(2011) 
Process and Outcome 
Evaluation of the Iowa 
First Judicial District 
Department of 
Correctional Services 
Dual Diagnosis 
Offender Program 
(DDOP) 
 
Did not fit population 
inclusion criteria, 
under supervision for 
an offence rather than 
detained in the secure 
forensic environment 
Search of 
databases 
Ritchie, 
Weldon, 
Macpherson & 
Laithwaite 
(2010) 
Evaluation of a drug 
and alcohol relapse 
prevention programme 
in a special hospital: 
an interpretative 
phenomenological 
analysis 
 
Research used the 
same sample as 
included in a 
subsequent study 
which is included in 
the current review 
(Ritchie, Weldon, 
Macpherson & 
Laithwaite, 2011) 
Search of 
databases 
Long, Fulton, 
Dolley & 
Hollin (2010) 
Dealing with Feelings: 
The Effectiveness of 
Cognitive Behavioural 
Group Treatment for 
Women in Secure 
Settings 
 
Did not fit population 
criteria, co-morbid 
mental health 
problems rather than 
substance use 
Search of 
databases 
Easton, 
Oberleitner, 
Scott, 
Crowley, 
Babuscio & 
Carroll (2012) 
 
Differences in 
Treatment Outcome 
among Marijuana-
Dependent Young 
Adults with and 
without Antisocial 
Personality Disorder 
 
Did not fit population 
criteria, outpatients 
not resident in secure 
forensic environment 
Search of 
databases 
Osher (2006) Integrating Mental 
Health and Substance 
Misuse Services for 
Justice-Involved 
Persons with Co-
Occurring Disorders 
 
Did not fit inclusion 
criteria, summarises 
findings of studies  
Search of 
databases 
Long (2013) Delivering effective 
cognitive behavioural 
group treatment for 
women in secure 
psychiatric settings 
Did not fit 
intervention criteria, 
more generalized 
approach for assessing 
treatment 
Hand 
searching 
journals 
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Long, Dolley 
& Hollin 
(2011) 
 
Social problem-
solving interventions 
in medium secure 
settings for women 
Population did not fit 
criteria, dual diagnosis 
mental disorder rather 
than co-existing 
substance misuse and 
mental disorder 
 
Hand 
searching 
reference 
lists 
Hien, Wells, 
Jiang, Suarez-
Morales, 
Campbell, 
Cohen, Miele, 
Killeen, 
Brigham & 
Zhang (2009) 
 
Multi-site randomized 
trial of behavioural 
interventions for 
women with co-
occurring PTSD and 
substance use 
disorders 
Population did not fit 
criteria, community 
sample 
Hand 
searching 
reference 
lists 
Chandler & 
Spicer (2006) 
 
Integrated treatment 
for jail recidivists with 
co-occurring 
psychiatric and 
substance use 
disorders 
 
Population did not fit 
criteria, community 
sample 
Hand 
searching 
reference 
lists 
Newton, Coles 
& Quayle 
(2005) 
A form of relapse 
prevention for men in 
a high security 
hospital 
 
Intervention did not fit 
criteria, selection 
criteria did not 
stipulate substance 
misuse problems 
 
Hand 
searching 
reference 
lists` 
Rothbard, 
Wald, 
Zubritsky, 
Jaquette & 
Chhatre 
(2009) 
 
Effectiveness of a Jail-
Based Treatment 
Program for 
Individuals with Co-
Occurring Disorders 
Intervention did not fit 
criteria, intervention 
provided was 
individual jail-based 
treatment planning 
incorporating a 
number of varying 
treatments 
  
Search of 
databases 
Weiss, Griffin, 
Kolodziej, 
Greenfield, 
Najavits, 
Daley, Doreau 
& Hennen 
(2007) 
 
A Randomized Trial 
of Integrated Group 
Therapy Versus 
Group Drug 
Counseling for 
Patients With Bipolar 
Disorder and 
Substance 
Dependence 
 
Population did not fit 
criteria, not inpatients 
in secure environment 
Search of 
databases 
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Appendix 5: Quality assessment form – qualitative studies 
 
Questions Yes  No Unclear Comments 
Does the study clearly identify 
research aims? 
    
Is a qualitative approach 
appropriate to the research 
question/aims? 
    
 
Continue – Yes / No 
 
Questions Yes 
(2) 
Partial 
(1) 
No 
(0) 
Unclear Comments 
Is the research design appropriate 
to the study aims? 
     
Is there an explanation of how 
participants were recruited? 
     
Were participants recruited in an 
acceptable way? 
     
Are data collection methods 
clear? 
     
Are data collection methods 
justified and explicit? 
     
Has the relationship between 
researcher and participants been 
considered? 
     
Was research sufficiently 
explained to participants? 
     
Are ethical issues raised by the 
study discussed? 
     
Is the data analysis adequately 
described? 
     
Is data sufficient to support 
findings? 
     
Are findings clear and explicit?      
Are findings discussed in relation 
to the research question? 
     
Is the research discussed in the 
context of existing knowledge? 
     
Are new areas of research 
identified? 
     
Is generalisation of the study 
discussed? 
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Appendix 6: Quality assessment form – quantitative studies 
 
Questions Yes  No Unclear Comments 
Does the study address a clearly 
focused issue? 
    
Is the method used appropriate to 
the research question/aims? 
    
Are the outcome measures 
clearly defined? 
    
Is the sample population clearly 
described? 
    
 
Continue – Yes / No 
 
Questions Yes 
(2) 
Partial 
(1) 
No 
(0) 
Unclear Comments 
Were participants recruited in an 
acceptable way? 
     
Are participants representative of 
the target population? 
     
Is there a comparison group?      
Are ethical procedures detailed?      
Is description of the group(s) 
adequate? 
     
Are demographic factors 
included? 
     
Is the intervention clearly 
described? 
     
Was the intervention 
standardised for all participants? 
     
Have confounding variables been 
identified and controlled for? 
     
Is the study design appropriate?      
Were valid and reliable 
measurements used to assess 
outcome? 
     
Were measures fully described?      
Were the same measures used to 
assess outcomes for all groups? 
     
Were outcomes clearly 
described? 
     
Were participants blind to the 
study aims? 
     
Were outcome assessors blind to 
intervention outcome? 
     
Were all participants accounted 
for? 
     
Were reasons and rates of 
treatment drop out clearly 
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described? 
Were follow-up assessments 
included? 
     
Was the follow-up time period 
long enough? 
     
Are study results clear and 
applicable to the research 
question? 
     
Are results reported supported by 
statistical analysis? 
     
Was statistical analysis of data 
appropriate? 
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Appendix 7:  Data Extraction Form 
 
Author(s) 
 
 
Title 
 
 
Journal 
 
 
Year 
 
 
Volume/ Page 
number 
 
 
Location 
 
 
Study design 
 
 
Participants:  
Sample size  
Gender  
Age 
Recruitment method 
 
Intervention: 
Approach 
Duration 
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Frequency 
Measures: 
Quantitative: 
Measures used 
Validity of measures 
 
Qualitative: 
Data collection 
methods 
 
Outcomes: 
Quantitative: 
Statistical analysis 
Findings 
 
Qualitative: 
Themes  
Findings 
 
Limitations 
 
 
Quality score  
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Appendix 8:  NHS ethical approval 
  
  218 
Appendix 9:  SOCRATES 8A/D 
  
  219 
Appendix 10: DTCQ 
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Appendix 11 – GSES 
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Appendix 12: IPC LOC 
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Appendix 13 – Semi-structured interview questions 
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Appendix 14:  Participant Information Sheet 
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Appendix 15: Consent form 
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Appendix 16:  Exposure to treatment details 
 
Participants Number of 
sessions attended  
Number of 
sessions missed 
% treatment 
exposure 
P1 20 14 59% 
P2 32 2 94% 
P3 34 0 100% 
P4 33 1 97% 
P5 32 2 94% 
P6 33 1 97% 
P7 31 3 91% 
P8 32 2 94% 
P9 30 4 88% 
P10 31 3 91% 
P11 25 1 96% 
P12 24 2 92% 
P13 24 2 92% 
P14 22 6 79% 
P15 24 4 86% 
P16 15 13 54% 
P17 30 0 100% 
P18 28 2 93% 
P19 21 8 72% 
P20 26 3 90% 
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Appendix 17:  Index offences details 
 
 n Percentage % 
Index offence   
Murder 1 5% 
Attempted murder 2 10% 
Manslaughter 2 10% 
Rape 1 5% 
Rape and attempted murder 1 5% 
GBH 4 20% 
Indecent assault against an adult 2 10% 
Assault 1 5% 
Wounding (section 18) 2 10% 
Threats to kill 1 5% 
Possession of a firearm with intent 1 5% 
Arson  1 5% 
No current index offence – previous IO 
attempted murder 
1 5% 
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Appendix 18:  SOCRATES Decile Ranges (Project MATCH) 
 
 
Decile Scores Recognition Ambivalence Taking steps 
90 Very High  19-20 39–40 
80  18 37-38 
70 High 35 17 36 
60 34 16 34–35 
50 Medium 32-33 15 33 
40 31 14 31–32 
30 Low 29-30 12-13 30 
20 27-28 9-11 26–29 
10 Very Low 7-26 4-8 8-25 
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Appendix 19:  Differences between pre, post and follow-up mean scores for 
recognition of substance use problems as measured by the SOCRATES  
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Appendix 20:  Differences between pre, post and follow-up mean scores for 
ambivalence towards substance use problems as measured by the SOCRATES  
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Appendix 21.  Differences between pre, post and follow-up scores for internal locus 
of control as measured by the IPC LOC  
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Appendix 22.  Differences between pre, post and follow-up scores for powerful others 
as measured by the IPC LOC 
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Appendix 23.  Differences between pre, post and follow-up scores for chance as 
measured by the IPC LOC 
 
 
 
  
  233 
Appendix 24:  Substance use as indicated by Urinary Drug Screens and self-report 
 
Participants UDS Positive 
UDS 
Self-report Session 
numbers for 
positive results 
% clear 
(screens and 
self-report) 
P1 20 0 0  100% 
P2 32 0 0  100% 
P3 34 0 0  100% 
P4 33 0 0  100% 
P5 32 0 0  100% 
P6 33 0 0  100% 
P7 31 0 0  100% 
P8 32 0 0  100% 
P9 30 0 0  100% 
P10 31 0 0  100% 
P11 25 0 0  100% 
P12 24 0 3 15, 16, 23 87.5% 
P13 24 0 0  100% 
P14 22 0 0  100% 
P15 24 0 0  100% 
P16 15 0 2 17, 21 86.7% 
P17 30 0 0  100% 
P18 28 2 0 19, 23 92.9% 
P19 21 2 0 21, 25 90.5% 
P20 26 1 2 15, 25, 27 88.5% 
  
